Datasets:
ChatDOC
/
OCRFlux-pubtabnet-single

Dataset card Data Studio Files Community
image_name
stringlengths
68
68
type
stringclasses
2 values
gt_table
stringlengths
116
12.6k
274042f6d1a8de4a7fbcbddc2e5f1af0d39d88f6d003d4b7348ad627a6bc0cbb.png
complex
<table><tr><td>Studies</td><td>BCC +</td><td>SCC + (control)</td></tr><tr><td>Karahan, et al. [16]</td><td>20/20</td><td>0/20</td></tr><tr><td>Fan, et al. [28]</td><td>51/51</td><td>-</td></tr><tr><td>Krahl &amp; Sellheyer [29]</td><td>28/28</td><td>-</td></tr><tr><td>Ishida, et al. [30]</td><td>20/20</td><td>-</td></tr><tr><td>Filho, et al. [31]</td><td>20/20</td><td>-</td></tr><tr><td>Mashhood, et al. [32]</td><td>29/29</td><td>0/11</td></tr><tr><td>Tan &amp; Sunjaya [9]</td><td>23/23</td><td>-</td></tr><tr><td>Kirzhner &amp; Jakobiec [33]</td><td>13/13</td><td>-</td></tr><tr><td>Dasgeb, et al. [24]</td><td>24/24</td><td>1/11 (weak positive)</td></tr><tr><td>Patil, et al. [12]</td><td>9/9</td><td>-</td></tr><tr><td>Sellheyer, et al. [34]</td><td>17/17</td><td>0/75</td></tr><tr><td>Ansai, et al. [35]</td><td>30/31</td><td>-</td></tr><tr><td>BerEP4 positive</td><td>284</td><td>1</td></tr><tr><td>Ber EP4 negative</td><td>1</td><td>116</td></tr><tr><td>Total</td><td>285</td><td>117</td></tr><tr><td>Sensitivity</td><td colspan="2">284/285 &#215; 100 = 99.6%</td></tr><tr><td>Specificity</td><td colspan="2">116/117 &#215; 100 = 99.2%</td></tr><tr><td>Positive predictive value</td><td colspan="2">284/285 &#215; 100 = 99.6%</td></tr><tr><td>Negative predictive value</td><td colspan="2">116/117 &#215; 100 = 99.1%</td></tr></table>
e9732fde68cf78806363035d8f70775762e6e9e0d3e70093d8d9e419b939b865.png
simple
<table><tr><td>Code</td><td>Name</td><td>Classification algorithm(s) used</td></tr><tr><td>CAS</td><td>Chinese Academy of Sciences</td><td>Nai&#776;ve Bayes, Support Vector Machine</td></tr><tr><td>CBC</td><td>CapitalBio Corporation, China</td><td>k-Nearest Neighbor, Support Vector Machine</td></tr><tr><td>Cornell</td><td>Weill Medical College of Cornell University</td><td>Support Vector Machine</td></tr><tr><td>FBK</td><td>Fondazione Bruno Kessler, Italy</td><td>Discriminant Analysis, Support Vector Machine</td></tr><tr><td>GeneGo</td><td>GeneGo, Inc.</td><td>Discriminant Analysis, Random Forest</td></tr><tr><td>GHI</td><td>Golden Helix, Inc.</td><td>Classification Tree</td></tr><tr><td>GSK</td><td>GlaxoSmithKline</td><td>Nai&#776;ve Bayes</td></tr><tr><td>NCTR</td><td>National Center for Toxicological Research, FDA</td><td>k-Nearest Neighbor, Nai&#776;ve Bayes, Support VectorMachine</td></tr><tr><td>NWU</td><td>Northwestern University</td><td>k-Nearest Neighbor, Classification Tree, Support VectorMachine</td></tr><tr><td>SAI</td><td>Systems Analytics, Inc.</td><td>Discriminant Analysis, k-Nearest Neighbor, Machine Learning,Support Vector Machine, Logistic Regression</td></tr><tr><td>SAS</td><td>SAS Institute, Inc.</td><td>Classification Tree, Discriminant Analysis, LogisticRegression, Partial Least Squares, Support VectorMachine</td></tr><tr><td>Tsinghua</td><td>Tsinghua University, China</td><td>Classification Tree, k-Nearest Neighbor, Recursive FeatureElimination, Support Vector Machine</td></tr><tr><td>UIUC</td><td>University of Illinois, Urbana-Champaign</td><td>Classification Tree, k-Nearest Neighbor, Nai&#776;ve Bayes,Support Vector Machine</td></tr><tr><td>USM</td><td>University of Southern Mississippi</td><td>Artificial Neural Network, Nai&#776;ve Bayes, SequentialMinimal Optimization, Support Vector Machine</td></tr><tr><td>ZJU</td><td>Zejiang University, China</td><td>k-Nearest Neighbor, Nearest Centroid</td></tr></table>
4c1fc2b90587670cf6fe31ba05bf71582d1d678b4fe4b3d03cb7141e74f153ec.png
complex
<table><tr><td></td><td colspan="2">Not at all</td><td colspan="2">A little bit</td><td colspan="2">Moderately</td><td colspan="2">Quite a bit</td><td colspan="2">Extremely</td><td colspan="2">No/inappropriate answer</td><td colspan="2">Total</td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Any reminder brought back feelings about it</td><td>63</td><td>21.6</td><td>117</td><td>40.1</td><td>63</td><td>21.6</td><td>25</td><td>8.6</td><td>15</td><td>5.1</td><td>9</td><td>3.1</td><td>292</td><td>100</td></tr><tr><td>I had trouble staying asleep</td><td>206</td><td>70.5</td><td>37</td><td>12.7</td><td>28</td><td>9.6</td><td>8</td><td>2.7</td><td>1</td><td>0.3</td><td>12</td><td>4.1</td><td>292</td><td>100</td></tr><tr><td>Other things kept making me think about it</td><td>189</td><td>64.7</td><td>58</td><td>19.9</td><td>24</td><td>8.2</td><td>6</td><td>2.1</td><td>6</td><td>2.1</td><td>9</td><td>3.1</td><td>292</td><td>100</td></tr><tr><td>I felt irritable and angry</td><td>234</td><td>80.1</td><td>38</td><td>13.0</td><td>7</td><td>2.4</td><td>4</td><td>1.4</td><td>0</td><td>0.0</td><td>9</td><td>3.1</td><td>292</td><td>100</td></tr><tr><td>I avoided letting myself get upset when I thought about it or was reminded of it</td><td>145</td><td>49.7</td><td>91</td><td>31.2</td><td>24</td><td>8.2</td><td>17</td><td>5.8</td><td>5</td><td>1.7</td><td>10</td><td>3.4</td><td>292</td><td>100</td></tr><tr><td>I thought about it when I didn't mean to</td><td>133</td><td>45.5</td><td>100</td><td>34.2</td><td>31</td><td>10.6</td><td>14</td><td>4.8</td><td>3</td><td>1.0</td><td>11</td><td>3.8</td><td>292</td><td>100</td></tr><tr><td>I felt as if it hadn't happened or wasn't real</td><td>199</td><td>68.2</td><td>46</td><td>15.8</td><td>21</td><td>7.2</td><td>5</td><td>1.7</td><td>1</td><td>0.3</td><td>20</td><td>6.8</td><td>292</td><td>100</td></tr><tr><td>I stayed away from reminders about it</td><td>197</td><td>67.5</td><td>53</td><td>18.2</td><td>15</td><td>5.1</td><td>7</td><td>2.4</td><td>3</td><td>1.0</td><td>17</td><td>5.8</td><td>292</td><td>100</td></tr><tr><td>Pictures about it popped into my mind</td><td>193</td><td>66.1</td><td>59</td><td>20.2</td><td>14</td><td>4.8</td><td>8</td><td>2.7</td><td>3</td><td>1.0</td><td>15</td><td>5.1</td><td>292</td><td>100</td></tr><tr><td>I was jumpy and easily startled</td><td>172</td><td>58.9</td><td>63</td><td>21.6</td><td>24</td><td>8.2</td><td>11</td><td>3.8</td><td>9</td><td>3.1</td><td>13</td><td>4.5</td><td>292</td><td>100</td></tr><tr><td>I tried not to think about it</td><td>152</td><td>52.1</td><td>67</td><td>22.9</td><td>34</td><td>11.6</td><td>18</td><td>6.2</td><td>7</td><td>2.4</td><td>14</td><td>4.8</td><td>292</td><td>100</td></tr><tr><td>I was aware that I still had a lot of feelings about it,but I didn't deal with them</td><td>165</td><td>56.5</td><td>62</td><td>21.2</td><td>26</td><td>8.9</td><td>17</td><td>5.8</td><td>6</td><td>2.1</td><td>16</td><td>5.5</td><td>292</td><td>100</td></tr><tr><td>My feelings about it were kind of numb</td><td>162</td><td>55.5</td><td>70</td><td>24.0</td><td>35</td><td>12.0</td><td>6</td><td>2.1</td><td>2</td><td>0.7</td><td>17</td><td>5.8</td><td>292</td><td>100</td></tr><tr><td>I found myself acting or feeling as though I was back at that time</td><td>214</td><td>73.3</td><td>42</td><td>14.4</td><td>17</td><td>5.8</td><td>4</td><td>1.4</td><td>1</td><td>0.3</td><td>14</td><td>4.8</td><td>292</td><td>100</td></tr><tr><td>I had trouble falling asieep</td><td>212</td><td>72.6</td><td>38</td><td>13.0</td><td>14</td><td>4.8</td><td>10</td><td>3.4</td><td>4</td><td>1.4</td><td>14</td><td>4.8</td><td>292</td><td>100</td></tr><tr><td>I had waves of strong feelings about it</td><td>192</td><td>65.8</td><td>53</td><td>18.2</td><td>22</td><td>7.5</td><td>9</td><td>3.1</td><td>5</td><td>1.7</td><td>11</td><td>3.8</td><td>292</td><td>100</td></tr><tr><td>I tried to remove it from my memory</td><td>201</td><td>68.8</td><td>42</td><td>14.4</td><td>21</td><td>7.2</td><td>9</td><td>3.1</td><td>4</td><td>1.4</td><td>15</td><td>5.1</td><td>292</td><td>100</td></tr><tr><td>I had trouble concentrating</td><td>226</td><td>77.4</td><td>40</td><td>13.7</td><td>9</td><td>3.1</td><td>3</td><td>1.0</td><td>1</td><td>0.3</td><td>13</td><td>4.5</td><td>292</td><td>100</td></tr><tr><td>Reminders of it caused me to have physical reactions,such as sweating,trouble breathing,nausea,or a pounding heart</td><td>227</td><td>77.7</td><td>38</td><td>13.0</td><td>12</td><td>4.1</td><td>4</td><td>1.4</td><td>0</td><td>0.0</td><td>11</td><td>3.8</td><td>292</td><td>100</td></tr><tr><td>I had dreams about it</td><td>246</td><td>84.2</td><td>28</td><td>9.6</td><td>4</td><td>1.4</td><td>1</td><td>0.3</td><td>0</td><td>0.0</td><td>13</td><td>4.5</td><td>292</td><td>100</td></tr><tr><td>I felt watchful or on-guard</td><td>112</td><td>38.4</td><td>92</td><td>31.5</td><td>41</td><td>14.0</td><td>20</td><td>6.8</td><td>14</td><td>4.8</td><td>13</td><td>4.5</td><td>292</td><td>100</td></tr><tr><td>I tried not to talk about it</td><td>187</td><td>64.0</td><td>54</td><td>18.5</td><td>22</td><td>7.5</td><td>11</td><td>3.8</td><td>5</td><td>1.7</td><td>13</td><td>4.5</td><td>292</td><td>100</td></tr></table>
9cd63a506079241493c87fbbee70e5d5e85eeaa6a8d7430b0126c81a8307fc0b.png
simple
<table><tr><td></td><td>Sample 1</td><td>Sample 2</td></tr><tr><td>Control Slide</td><td>41</td><td>52</td></tr><tr><td>Splashing device</td><td>29</td><td>34</td></tr></table>
e394458bec767198ff4bf60b6c2640fbda848f0354fb22f5f464a3d45ba87491.png
complex
<table><tr><td>Variable</td><td>OAK and controlpreintervention<sup>b</sup></td><td colspan="2">OAK</td><td colspan="2">Control</td><td colspan="4">Difference in change between groups</td></tr><tr><td></td><td></td><td>8weeks</td><td>6months</td><td>8weeks</td><td>6months</td><td>Preinterventionto 8 weeks</td><td>95%CI</td><td>Preintervention to 6 months</td><td>95% CI</td></tr><tr><td>TUG (score)<sup>c</sup></td><td>12 (0)</td><td>10 (0.2)</td><td>10 (0.2)</td><td>11 (0.2)</td><td>11 (0.2)</td><td>-1.3</td><td>-1.81 to -0.86</td><td>-0.72</td><td>-1.35 to -0.08</td></tr><tr><td colspan="3">Muscle Strength (kg)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Left quadriceps</td><td>18.9 (0)</td><td>20.3 (0.5)</td><td>19.6 (0.7)</td><td>18.6 (0.5)</td><td>18.1 (0.7)</td><td>1.65</td><td>0.34 to 2.95</td><td>1.58</td><td>-0.31 to 3.47</td></tr><tr><td> Right quadriceps</td><td>18.0 (0)</td><td>19.6 (0.5)</td><td>18.9 (0.7)</td><td>17.8 (0.5)</td><td>18.2 (0.7)</td><td>1.79</td><td>0.33 to 3.24</td><td>0.66</td><td>-1.37 to 2.69</td></tr><tr><td> Left hamstring<sup>c</sup></td><td>8.0 (0)</td><td>10.1 (0.3)</td><td>9.5 (0.4)</td><td>8.6 (0.3)</td><td>8.79 (0.4)</td><td>1.47</td><td>0.63 to 2.30</td><td>0.74</td><td>-0.31 to 1.79</td></tr><tr><td> Right hamstring<sup>c</sup></td><td>7.6 (0)</td><td>10.2 (0.3)</td><td>9.8 (0.4)</td><td>8.4 (0.3)</td><td>8.7 (0.4)</td><td>1.80</td><td>0.89 to 2.70</td><td>1.18</td><td>0.06 to 2.29</td></tr><tr><td colspan="3">Range of motion (&#176;)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Left knee flexion<sup>c</sup></td><td>125 (0)</td><td>126 (0.8)</td><td>126 (0.9)</td><td>123 (0.8)</td><td>123 (0.9)</td><td>2.80</td><td>0.58 to 5.02</td><td>2.26</td><td>-0.32 to 4.86</td></tr><tr><td> Right knee flexion</td><td>123 (0)</td><td>123 (0.9)</td><td>121 (0.9)</td><td>121 (0.9)</td><td>121 (0.9)</td><td>1.56</td><td>-0.90 to 4.02</td><td>0.02</td><td>-2.53 to 2.57</td></tr><tr><td> Left knee extension<sup>c</sup></td><td>-4 (0)</td><td>-4 (0.3)</td><td>-4 (0.5)</td><td>-4 (0.3)</td><td>-3 (0.5)</td><td>0.1</td><td>-0.72 to 0.88</td><td>-1.39</td><td>-2.71 to -0.06</td></tr><tr><td> Right knee extension<sup>c</sup></td><td>-4 (0)</td><td>-4 (0.3)</td><td>-5 (0.5)</td><td>-5 (0.3)</td><td>-3 (0.5)</td><td>0.9</td><td>-0.03 to 1.78</td><td>-1.18</td><td>-2.63 to 0.26</td></tr></table>
a42e83e18c574825b78589cd8b198a2bfe6e7c79e91615b9b89b130e9034e8df.png
simple
<table><tr><td>Variable</td><td>n (%)</td></tr><tr><td>Sex</td><td></td></tr><tr><td> Female</td><td>330 (53.9%)</td></tr><tr><td> Male</td><td>282 (46.1%)</td></tr><tr><td>Age (years)</td><td></td></tr><tr><td> 10 - 14</td><td>305 (49.8%)</td></tr><tr><td> 15 - 19</td><td>307 (50.2%)</td></tr><tr><td>District of residence</td><td></td></tr><tr><td> Kigoma</td><td>107 (17.5%)</td></tr><tr><td> Kilombero</td><td>131 (21.4%)</td></tr><tr><td> Rufiji</td><td>176 (28.8%)</td></tr><tr><td> Ulanga</td><td>198 (32.3%)</td></tr></table>
47e253689cec42a4055ca5d52124d435090788acad22cd273c13699633915c33.png
simple
<table><tr><td>Groups for Comparions</td><td>Dependent Variables</td><td>Degrees of freedom</td><td>Chi-square</td><td><i>p</i></td></tr><tr><td>Control (n=14)</td><td>TBARs (nmol/g)</td><td>3</td><td>3.87</td><td>0.28</td></tr><tr><td>STZ (n=12)</td><td>SOD (U/mg)</td><td>3</td><td>6.40</td><td>0.09</td></tr><tr><td>P+STZ (n=12)</td><td>CAT (K/g)</td><td>3</td><td>5.98</td><td>0.11</td></tr><tr><td>STZ+P (n=13)</td><td>GSH-Px (U/mg)</td><td>3</td><td>3.46</td><td>0.33</td></tr></table>
7c2628d969359b90002e4f1f4df11047a33cc800691a162541323174fbbd2275.png
complex
<table><tr><td colspan="2">Scenario 4 - health, Work Cover &amp; employment data linked by researchers</td></tr><tr><td>Consent justifications</td><td>No consent justifications</td></tr><tr><td>Consent provides protection against potential impact of research (10)<sup>a</sup></td><td>Acceptable practice because of the benefits (5)</td></tr><tr><td rowspan="2">Access to identifiable data by researchers requires consent (9)</td><td>The findings are presented in de-identified form (3)</td></tr><tr><td>Practical considerations of obtaining consent from thousands (3)</td></tr><tr><td>Consent required when researchers do the linkage (7)</td><td>Acceptable due to cost and time constraints involved when obtaining consent (2)</td></tr><tr><td>Consent is required when other spheres of life (apart from health) are involved (7)</td><td>Consent lowers research participation rates (2)</td></tr><tr><td>Opt-out consent would result in more participants being involved (6)</td><td>Low participation rates impact on quality of research (2)</td></tr><tr><td>Consent required because of lack of separation of tasks (4)</td><td rowspan="2">The information is already there so it should just be used without consent (2)</td></tr><tr><td>People have right to choose (4)</td></tr><tr><td>Researchers may disclose information to third party (2)</td><td>Researchers are not interested in specific cases (2)</td></tr><tr><td>Someone on the research team may know the research participants (2)</td><td>Strict measures/guidelines provide protection (2)</td></tr><tr><td rowspan="2">To ensure people are not upset/do not object (2)</td><td>Getting consent could have detrimental effect on participants (1)</td></tr><tr><td>No need for consent if data linkage organisation is trustworthy (1)</td></tr><tr><td>Opt-in consent captures the people who really want to participate (2)</td><td rowspan="2">Researchers will not use information obtained without consent to harm participants (1)</td></tr><tr><td>Having the option to consent is good (2)</td></tr><tr><td>Information belongs to people (1)</td><td rowspan="2">Provided that the linkage organisation was involved so that tasks are separated (1)</td></tr><tr><td>People want to control their information (1)</td></tr><tr><td rowspan="2">Researchers using identifiable information without consent is intrusive (1)</td><td>Researchers will be dealing with de-identified data eventually (1)</td></tr><tr><td>Acceptable depending on study (1)</td></tr><tr><td rowspan="2">Consent required when participants are experiencing mental health issues, as they may not welcome people delving into their affairs at that point in their lives (1)</td><td>Consent would have been given at data collection point (1)</td></tr><tr><td>Information given to WorkCover can be shared with researchers, as it was given confidentially (1)</td></tr><tr><td>Consent should be sought for all research (1)</td><td>Retrospective use of data does not require consent (1)</td></tr><tr><td>Consent should be sought at initial point of data collection (1)</td><td rowspan="3">People have inflated view of how interesting they are to others (1)</td></tr><tr><td>Collecting this kind of information without consent may not be legal (1)</td></tr><tr><td>It is very good to obtain consent if it is simple to do so (1)</td></tr></table>
706f851c27b10e73d185e76bfd90a9e0543d413b2342a7f1f14a04a896afe512.png
complex
<table><tr><td> </td><td colspan="5">Dose-volume data</td></tr><tr><td>Swallowing structure</td><td>Dmean (Gy) Mean &#177; SD (range)</td><td>Dmax (Gy) Mean &#177; SD (range)</td><td>V60 (%) Mean &#177; SD (range)</td><td>V65 (%) Mean &#177; SD (range)</td><td>V70 (%) Mean &#177; SD (range)</td></tr><tr><td>PCM</td><td>66.03 &#177; 2.19 (63.17 - 69.96)</td><td>72.69 &#177; 1.62 (69.92 - 74.85)</td><td>89.24 &#177; 9.20 (73.27 - 99.92)</td><td>64.75 &#177; 22.79 (20.19 - 90.38)</td><td>27.91 &#177; 21.83 (0.00-65.33)</td></tr><tr><td>SPCM</td><td>68.35 &#177; 2.66 (63.29 - 71.65)</td><td>72.66 &#177; 1.64 (69.92 - 74.85)</td><td>99.14 &#177; 1.64 (94.98 - 100.00)</td><td>81.35 &#177; 26.41 (24.37 - 100.00)</td><td>37.66 &#177; 30.09 (0.00-83.03)</td></tr><tr><td>MPCM</td><td>65.30 &#177; 2.77 (61.28 - 69.62)</td><td>67.69 &#177; 2.60 (64.23 - 72.03)</td><td>97.63 &#177; 6.43 (79.56 - 100.00)</td><td>51.33 &#177; 45.38 (0.00 - 100.00)</td><td>4.80 &#177; 11.93 (0.00-37.40)</td></tr><tr><td>IPCM</td><td>59.96 &#177; 4.09 (50.39 - 63.35)</td><td>65.86 &#177; 3.18 (61.27 - 71.83)</td><td>58.50 &#177; 34.43 (2.35 - 100.00)</td><td>12.09 &#177; 19.33 (0.00-48.71)</td><td>0.62 &#177; 1.97 (0.00-6.22)</td></tr><tr><td>BOT</td><td>52.85 &#177; 13.03 (36.80 - 68.08)</td><td>70.02 &#177; 2.79 (65.36 - 74.00)</td><td>62.38 &#177; 32.78 (15&#8211;99.55)</td><td>34.12 &#177; 31.63 (0.01-90.03)</td><td>5.54 &#177; 11.05 (0.00-34.86)</td></tr><tr><td>Larynx</td><td>62.55 &#177; 5.76 (50.56 - 68.07)</td><td>70.43 &#177; 2.97 (64.45 - 73.54)</td><td>74.92 &#177; 28.33 (29.27 - 100.00)</td><td>52.05 &#177; 31.83 (0.00-89.83)</td><td>9.52 &#177; 12.30 (0.00-32.72)</td></tr><tr><td>PES</td><td>50.97 &#177; 3.22 (46.09 - 57.15)</td><td>53.78 &#177; 4.76 (47.11 - 61.75)</td><td>2.08 &#177; 4.40 (0.00 - 11.10)</td><td>0.00</td><td>0.00</td></tr></table>
14285363dcb14a165018fbb8279e20b8410fbb1141d6df825fc83d2d8641ef0d.png
complex
<table><tr><td rowspan="2">Variable</td><td colspan="2">Univariate</td><td colspan="2">Multivariate</td></tr><tr><td>Odds ratio (95%CI)</td><td>p value</td><td>Odds ratio (95%CI)</td><td>p value</td></tr><tr><td>Age</td><td>0.998(0.980-1.016)</td><td>0.829</td><td> </td><td> </td></tr><tr><td>Sex</td><td>1.033(0.549-1.943)</td><td>0.921</td><td> </td><td> </td></tr><tr><td>Diabetes mellitus</td><td>0.932(0.547-1.588)</td><td>0.797</td><td> </td><td> </td></tr><tr><td>Prior MI</td><td>1.869 (0.781-9.178)</td><td>0.092</td><td>1.745 (0.752-8.644)</td><td>0.495</td></tr><tr><td>LVEF</td><td>0.995 (0.968-1.022)</td><td>0.702</td><td> </td><td> </td></tr><tr><td>Time from symptom onset to PPCI</td><td>1.021 (1.008-1.208)</td><td>0.094</td><td>1.002 (0.979-1.195)</td><td>0.553</td></tr><tr><td>Creatinine</td><td>1.007 (0.997-1.017)</td><td>0.194</td><td> </td><td> </td></tr><tr><td>Neutrophil count</td><td>1.016 (0.935-1.104)</td><td>0.704</td><td> </td><td> </td></tr><tr><td>Hemoglobin</td><td>0.998 (0.986-1.010)</td><td>0.780</td><td> </td><td> </td></tr><tr><td>Lymphocyte count</td><td>1.019 (0.886-1.173)</td><td>0.790</td><td> </td><td> </td></tr><tr><td>Monocyte count</td><td>2.429 (1.022-5.776)</td><td>0.045</td><td>3.107 (1.199-7.052)</td><td>0.020</td></tr></table>
314194b41868045dd444801a32e62eccedd86718862a318437a6de1954ff4011.png
simple
<table><tr><td>Breed</td><td>Samples</td><td>GG</td><td>GA</td><td>AA</td><td>Freq. A</td><td>Exp GG</td><td>Exp GA</td><td>Exp AA</td></tr><tr><td>Abyssinian*</td><td>1955</td><td>1476</td><td>465</td><td>14</td><td>0.126</td><td>1493</td><td>431</td><td>31</td></tr><tr><td>Abyssinian (UK)</td><td>36</td><td>28</td><td>8</td><td>0</td><td>0.11</td><td>29</td><td>7</td><td>0</td></tr><tr><td>American Bobtail</td><td>10</td><td>10</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>American SH</td><td>51</td><td>51</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>American Wirehair</td><td>11</td><td>11</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Australian Mist (UK)</td><td>27</td><td>27</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Balinese</td><td>39</td><td>39</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Bengal*</td><td>1340</td><td>925</td><td>390</td><td>25</td><td>0.164</td><td>936</td><td>368</td><td>36</td></tr><tr><td>Bengal (UK)</td><td>1210</td><td>827</td><td>354</td><td>29</td><td>0.17</td><td>834</td><td>341</td><td>35</td></tr><tr><td>Birman</td><td>187</td><td>187</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>British SH</td><td>966</td><td>966</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>British SH (UK)</td><td>43</td><td>43</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Burmese</td><td>118</td><td>118</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Burmilla</td><td>38</td><td>38</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Cornish Rex</td><td>46</td><td>46</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Devon Rex</td><td>186</td><td>186</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Domestic SH/LH</td><td>76</td><td>62</td><td>13</td><td>1</td><td>0.099</td><td>62</td><td>13</td><td>1</td></tr><tr><td>Egyptian Mau</td><td>36</td><td>27</td><td>9</td><td>0</td><td>0.1</td><td>28</td><td>8</td><td>1</td></tr><tr><td>Exotic LH</td><td>91</td><td>91</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Exotic SH</td><td>645</td><td>644</td><td>1</td><td>0</td><td>0.0008</td><td>644</td><td>1</td><td>0</td></tr><tr><td>Himalayan</td><td>601</td><td>601</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Korat</td><td>41</td><td>41</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>La Perm</td><td>56</td><td>40</td><td>16</td><td>0</td><td>0.14</td><td>41</td><td>14</td><td>1</td></tr><tr><td>Maine Coon</td><td>118</td><td>103</td><td>15</td><td>0</td><td>0.064</td><td>104</td><td>14</td><td>0</td></tr><tr><td>Munchkin</td><td>19</td><td>19</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Norwegian Forest Cat</td><td>13</td><td>10</td><td>3</td><td>0</td><td>0.1</td><td>10</td><td>3</td><td>0</td></tr><tr><td>Ocicat</td><td>69</td><td>69</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Oriental LH</td><td>48</td><td>48</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Oriental SH</td><td>337</td><td>336</td><td>1</td><td>0</td><td>0.001</td><td>336</td><td>1</td><td>0</td></tr><tr><td>Persian</td><td>2226</td><td>2217</td><td>9</td><td>0</td><td>0.002</td><td>2217</td><td>9</td><td>0</td></tr><tr><td>Ragamuffin</td><td>20</td><td>20</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Ragdoll</td><td>1063</td><td>1063</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Russian Blue</td><td>14</td><td>14</td><td> </td><td> </td><td>0</td><td> </td><td> </td><td> </td></tr><tr><td>Savannah Cat</td><td>11</td><td>10</td><td>1</td><td>0</td><td>0.05</td><td>10</td><td>1</td><td>0</td></tr><tr><td>Scottish Fold</td><td>68</td><td>68</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Selkirk Rex</td><td>124</td><td>124</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Siamese</td><td>457</td><td>457</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Siberian Cat</td><td>377</td><td>360</td><td>16</td><td>1</td><td>0.024</td><td>359</td><td>18</td><td>0</td></tr><tr><td>Singapura</td><td>150</td><td>88</td><td>55</td><td>7</td><td>0.23</td><td>89</td><td>53</td><td>8</td></tr><tr><td>Singapura (UK)</td><td>168</td><td>60</td><td>77</td><td>31</td><td>0.414</td><td>58</td><td>81</td><td>29</td></tr><tr><td>Somali</td><td>633</td><td>527</td><td>104</td><td>2</td><td>0.0853</td><td>530</td><td>99</td><td>5</td></tr><tr><td>Somali (UK)</td><td>65</td><td>49</td><td>14</td><td>2</td><td>0.14</td><td>48</td><td>16</td><td>1</td></tr><tr><td>Sphynx</td><td>248</td><td>248</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Turkish Angora</td><td>31</td><td>31</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Unreported</td><td>111</td><td>98</td><td>13</td><td>0</td><td>0.059</td><td>99</td><td>12</td><td>0</td></tr><tr><td>Total</td><td>14179</td><td>12503</td><td>1564</td><td>112</td><td>0.063051</td><td>12447</td><td>1675</td><td>56</td></tr></table>
33d327753ef561113d30c77fe5c6b3008b0e6e6055f184fe734d1dcb801c44e8.png
simple
<table><tr><td>Demographic data and diagnoses</td><td>IPC + sevoflurane (N = 20)</td><td>IPC (N = 20)</td></tr><tr><td>Age (years)</td><td>68 &#177; 12</td><td>68 &#177; 11</td></tr><tr><td>Height (cm)</td><td>170 &#177; 11</td><td>170 &#177; 8</td></tr><tr><td>Weight (kg)</td><td>77 &#177; 17</td><td>75 &#177; 9</td></tr><tr><td>Male/female</td><td>14/6</td><td>13/7</td></tr><tr><td>Body-Mass-Index (BMI; kg.m<sup>-2</sup>)</td><td>27 &#177; 5</td><td>26 &#177; 3</td></tr><tr><td>Ankle-Brachial-Index (ABI)*</td><td>0.58 &#177; 0.18</td><td>0.56 &#177; 0.05</td></tr><tr><td>Side of surgery (right/left)</td><td>13 (65%)/7 (35%)</td><td>6 (30%)/14 (70%)</td></tr><tr><td>Fontaine grade (I/IIa/IIb/III/IV/V)</td><td>0/3/14/1/2 (0%/15%/70%/5%/10%)</td><td>0/5/14/0/1 (0%/25%/70%/0%/10%)</td></tr><tr><td>Obesity</td><td>5 (25%)</td><td>1 (5%)</td></tr><tr><td>Alcohol abuse</td><td>1 (5%)</td><td>1 (5%)</td></tr><tr><td>History of stroke</td><td>4 (20%)</td><td>1 (5%)</td></tr><tr><td>Diabetes mellitus</td><td>6 (30%)</td><td>5 (25%)</td></tr><tr><td>Hyperlipidaemia</td><td>14 (70%)</td><td>12 (60%)</td></tr><tr><td>Hypertonia</td><td>18 (90%)</td><td>17 (85%)</td></tr><tr><td>Hyperuricaemia</td><td>1 (5%)</td><td>5 (25%)</td></tr><tr><td>Coronary heart disease</td><td>9 (45%)</td><td>6 (30%)</td></tr><tr><td>Renal insufficiency</td><td>4 (20%)</td><td>1 (5%)</td></tr><tr><td>Smoking</td><td>9 (45%)</td><td>10 (50%)</td></tr></table>
14f645557275c1e4e43cc3db8e09eaa2e8c07ec7604edc2c2650034669efc27f.png
complex
<table><tr><td>Characteristics of children</td><td>Number of children (%)</td><td>Mean per year/per team (min/max)</td><td>Median per year/per team (P25/P75)</td></tr><tr><td colspan="4">Age of children</td></tr><tr><td> 0&#8211;1 y</td><td>885 (25%)</td><td></td><td></td></tr><tr><td> 1&#8211;10 y</td><td>1689 (47%)</td><td></td><td></td></tr><tr><td> 11&#8211;20 y</td><td>879 (24%)</td><td></td><td></td></tr><tr><td rowspan="2"> &gt; 20 y</td><td>116 (3%)</td><td>144 (43&#8211;240)</td><td>144 (103&#8211;196)</td></tr><tr><td>Total of children: 3607 (100%)</td><td></td><td></td></tr><tr><td colspan="4">Pathologies</td></tr><tr><td> Haematology/Oncology</td><td>1816 (50%)</td><td></td><td></td></tr><tr><td> Neurology-/Degenerative/Metabolic</td><td>989 (27%)</td><td></td><td></td></tr><tr><td> Other (Neonatology/Gastroenterology/Respiratory)</td><td>849 (23%)</td><td></td><td></td></tr><tr><td></td><td>Total: 3654 (100%)</td><td></td><td></td></tr><tr><td colspan="4">Curative/Palliative Patients</td></tr><tr><td> Curative patients</td><td>2540 (70%)</td><td>102 (1&#8211;181)</td><td>105 (82&#8211;135)</td></tr><tr><td> Palliative patients</td><td>910 (25%)</td><td>36 (10&#8211;86)</td><td>23 (20&#8211;58)</td></tr><tr><td> Undefined</td><td>157 (5%)</td><td></td><td></td></tr><tr><td></td><td>Total: 3607 (100%)</td><td></td><td></td></tr><tr><td colspan="4">Referral of new patients</td></tr><tr><td> From originating hospital</td><td>1848 (51%)</td><td></td><td></td></tr><tr><td> External hospital</td><td>108 (3%)</td><td></td><td></td></tr><tr><td>Total new patients</td><td>2056 (54%)</td><td></td><td></td></tr><tr><td></td><td>Total: 3607 (100%)</td><td></td><td></td></tr><tr><td>Length follow-up (children who died)</td><td></td><td>226 days/child (1&#8211;4612 days)</td><td>32 days/child (21&#8211;201 days)</td></tr><tr><td>&lt; 120 days</td><td>272 (64%)</td><td></td><td></td></tr><tr><td> 121&#8211;240 days</td><td>65 (15%)</td><td></td><td></td></tr><tr><td> 241&#8211;400 days</td><td>31 (7%)</td><td></td><td></td></tr><tr><td>&gt; 401 days</td><td>60 (14%)</td><td></td><td></td></tr><tr><td></td><td>Total: 428 (100%)</td><td></td><td></td></tr><tr><td colspan="4">Location of death</td></tr><tr><td> Hospital</td><td>200 (47%)</td><td>8 (2&#8211;22)</td><td>6 (6&#8211;10)</td></tr><tr><td> Home</td><td>221 (51%)</td><td>9 (1&#8211;22)</td><td>9 (3&#8211;16)</td></tr><tr><td> Others (respite care home, others)</td><td>7 (2%)</td><td>18 (3&#8211;32)</td><td>19 (12&#8211;26)</td></tr><tr><td></td><td>Total: 428 (100%)</td><td></td><td></td></tr></table>
bcbfd35f8077aa28a1cddaa92f5c11fe4b6f7a8549dfff12c84bcfb738fec66f.png
complex
<table><tr><td colspan="2">Acoustic lens properties</td></tr><tr><td>Excitation center frequency [MHz]</td><td>100</td></tr><tr><td>Max PRF [kHz]</td><td>100</td></tr><tr><td>Gain [dB]</td><td>40</td></tr><tr><td>Sampling rate [MSamples/s]</td><td>400</td></tr><tr><td>Focal resolution [&#956;m]</td><td>10</td></tr><tr><td>Aperture [&#956;m]</td><td>950</td></tr><tr><td>Aperture angle [&#176;]</td><td>55</td></tr><tr><td>Working distance [&#956;m]</td><td>900</td></tr></table>
842794f2c405f1edbb72a4793aca7e941b3d22ae8b23f64b196df4a48d8b6426.png
simple
<table><tr><td></td><td><i>N</i></td></tr><tr><td>Treatment interruption for reasons other than PD</td><td>5</td></tr><tr><td>Death for reason other than GBM</td><td>1</td></tr><tr><td>No measurable disease at time of randomization</td><td>6</td></tr><tr><td>No imaging available for central review</td><td>4</td></tr><tr><td>Total</td><td>16</td></tr></table>
ac2d79376f9de4f0fbb040035a29e419d09c8fc9594d130aa5cdf5a1c917fb73.png
complex
<table><tr><td rowspan="2">Behaviors</td><td colspan="3">Scores</td></tr><tr><td>1</td><td>2</td><td>3</td></tr><tr><td>Target: Cat touches a plastic chopstick or trainer&#8217;s finger with its nose</td><td>Stretching neck toward target</td><td>Purposeful movement towards target, but no touch; or touches with face but not nose</td><td>Actual contact with nose</td></tr><tr><td>Spin (in either direction): Cat turns body in a circle</td><td>Head follows or &lt;90 degree turn</td><td>Spins approximately 91&#8211;270 degrees</td><td>Spins approximately 271&#8211;360 degrees</td></tr><tr><td>Sit: Cat assumes a sitting position, with hind-end on floor and front paws touching the floor, in a weight-bearing stance</td><td>Some hind-end crouching</td><td>Hind-end on floor or in close proximity and/or front paws go up</td><td>Front paws on floor and hind-end contact with floor</td></tr><tr><td>High-five: Cat touches a trainer&#8217;s hand with a front paw</td><td>Any degree of front paw lift (one or both paws)</td><td>Movement towards hand with just one paw</td><td>Purposeful hand contact with one paw</td></tr></table>
ae1c284a458fb9d2fe0fffcd9bbb1a512bbbbfb222c79d09ac5524278bdf4bdf.png
simple
<table><tr><td>Risk group</td><td>N (%)</td><td>SE (%)</td><td>SP(%)</td><td>PPV (%)</td><td>NPV (%)</td><td>ICG-R (%)</td></tr><tr><td></td><td></td><td>(95% CI)</td><td>(95% CI)</td><td>(95% CI)</td><td>(95% CI)</td><td></td></tr><tr><td>1</td><td>162 (58.7)</td><td>100</td><td>0</td><td></td><td></td><td>5</td></tr><tr><td>2</td><td>84 (30.4)</td><td>85.2 (72.9-93.4)</td><td>69.4 (62.9-75.4)</td><td>40.4 (31.3-49.9)</td><td>95.1 (90.5-97.8)</td><td>29</td></tr><tr><td>3</td><td>30 (10.9)</td><td>40.7 (27.6-55.0)</td><td>96.4 (93.0-98.4)</td><td>73.3 (54.1-87.7)</td><td>87.0 (82.1-90.9)</td><td>73</td></tr></table>
a1428bb77388ae519ab6cc34898ccb0bc8cafd1b06c11a5e71a431abf5ca1ef4.png
simple
<table><tr><td></td><td>Odds ratio (95 % confidence interval)</td><td><i>P</i>-value</td></tr><tr><td>Age</td><td>1.0 (0.9&#8211;1.1)</td><td>0.11</td></tr><tr><td>Race</td><td></td><td></td></tr><tr><td> African American</td><td>1.3 (0.6&#8211;3.0)</td><td>0.47</td></tr><tr><td> Other</td><td>1.2 (0.7&#8211;2.3)</td><td>0.49</td></tr><tr><td>At least one previous prostate biopsy</td><td>0.7 (0.3&#8211;1.3)</td><td>0.26</td></tr><tr><td>Abnormal Digital Rectal Exam</td><td>30.5 (11.8&#8211;92.2)</td><td>&lt;0.001</td></tr><tr><td>Family history of prostate cancer</td><td>3.5 (1.8&#8211;6.8)</td><td>&lt;0.001</td></tr><tr><td>Prostate-specific antigen (ng/mL)<sup>a</sup></td><td>4.4 (3.3&#8211;5.9)</td><td>&lt;0.001</td></tr><tr><td>Sarcosine uM in 20uL serum<sup>a</sup></td><td>1.1 (0.7&#8211;1.8)</td><td>0.64</td></tr></table>
8df1150a67e489651dffd6d3859899d6f9903d771b2774894874048fab53df7a.png
complex
<table><tr><td> </td><td colspan="3">Intervention group</td><td colspan="3">Control group</td><td> </td></tr><tr><td> </td><td>Baseline (%)</td><td>End of study (%)</td><td><i>P</i>Value</td><td>Baseline (%)</td><td>End of study (%)</td><td><i>P</i>value</td><td>Intervention vs control ( <i>P </i>value)</td></tr><tr><td>Krece plus questionnaire</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Breakfast</td><td>99.2</td><td>98.2</td><td>0.11</td><td>99.8</td><td>99.2</td><td>0.18</td><td>0.50</td></tr><tr><td>Dairy product at breakfast</td><td>91.9</td><td>92.3</td><td>0.72</td><td>95.4</td><td>93.0</td><td>0.08</td><td>0.09</td></tr><tr><td>Cereals at breakfast</td><td>68.3</td><td>72.9</td><td>0.01</td><td>74.8</td><td>74.5</td><td>0.89</td><td>0.13</td></tr><tr><td>Pastry at breakfast</td><td>17.5</td><td>15.3</td><td>0.17</td><td>16.2</td><td>15.1</td><td>0.62</td><td>0.70</td></tr><tr><td>Daily fruit or natural juice</td><td>70.9</td><td>72.9</td><td>0.30</td><td>78.1</td><td>78.9</td><td>0.95</td><td>0.59</td></tr><tr><td>Fruit, second per day</td><td>38.3</td><td>42.6</td><td>0.03</td><td>38.4</td><td>37.6</td><td>0.78</td><td>0.14</td></tr><tr><td>Dairy product, second per day</td><td>81.9</td><td>80.6</td><td>0.43</td><td>85.9</td><td>84.2</td><td>0.4</td><td>0.81</td></tr><tr><td>Vegetables, daily</td><td>68.9</td><td>72.6</td><td>0.04</td><td>72.7</td><td>73.8</td><td>0.67</td><td>0.42</td></tr><tr><td>Vegetables, &gt;1 per day</td><td>25.7</td><td>32.0</td><td>0.001</td><td>23.2</td><td>26.9</td><td>0.13</td><td>0.50</td></tr><tr><td>Fish, regularly</td><td>73.9</td><td>74.8</td><td>0.65</td><td>76.10</td><td>74.3</td><td>0.4</td><td>0.35</td></tr><tr><td>Fast food, &gt;1 per week</td><td>7.9</td><td>8.9</td><td>0.41</td><td>7.9</td><td>8.7</td><td>0.63</td><td>0.92</td></tr><tr><td>Legumes &gt;1 per week</td><td>75.5</td><td>75.2</td><td>0.85</td><td>76.9</td><td>70.9</td><td>0.01</td><td>0.06</td></tr><tr><td>Candy &gt;1 per day</td><td>12.9</td><td>12.0</td><td>0.52</td><td>11.6</td><td>9.9</td><td>0.32</td><td>0.68</td></tr><tr><td>Pasta or rice, daily</td><td>57.3</td><td>57.9</td><td>0.80</td><td>59.9</td><td>62.2</td><td>0.37</td><td>0.58</td></tr><tr><td>Cooking with olive oil at home</td><td>96.6</td><td>97.4</td><td>0.32</td><td>97.1</td><td>97.9</td><td>0.38</td><td>0.85</td></tr><tr><td>AVall questionnaire</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><i>Before leaving home</i></td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Dairy products</td><td>84.3</td><td>82.4</td><td>0.20</td><td>86.6</td><td>83.8</td><td>0.15</td><td>0.65</td></tr><tr><td>Pastry</td><td>3.9</td><td>2.4</td><td>0.005</td><td>2.8</td><td>2.6</td><td>0.15</td><td>0.50</td></tr><tr><td>Cereals</td><td>37.6</td><td>38.2</td><td>0.87</td><td>38.4</td><td>39.7</td><td>0.83</td><td>0.94</td></tr><tr><td>Fresh fruit or natural juice</td><td>20.9</td><td>20.6</td><td>0.07</td><td>18.8</td><td>18.5</td><td>0.21</td><td>0.93</td></tr><tr><td>Sandwich</td><td>23.9</td><td>25.2</td><td>0.45</td><td>19.1</td><td>22.1</td><td>0.93</td><td>0.69</td></tr><tr><td>Juice packaged/soft drinks</td><td>9.6</td><td>7.2</td><td>0.93</td><td>8.4</td><td>8.9</td><td>0.32</td><td>0.46</td></tr><tr><td><i>Break (Midmorning)</i></td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Dairy products</td><td>17.3</td><td>12.7</td><td>0.79</td><td>13.7</td><td>10.1</td><td>0.29</td><td>0.51</td></tr><tr><td>Pastry</td><td>3.8</td><td>1.7</td><td>&lt;0.001</td><td>4.1</td><td>2.2</td><td>0.002</td><td>0.95</td></tr><tr><td>Cereals</td><td>6.5</td><td>5.6</td><td>0.68</td><td>5.2</td><td>4.7</td><td>0.45</td><td>0.71</td></tr><tr><td>Fresh fruit or natural juice</td><td>12.5</td><td>12.7</td><td>0.59</td><td>12.2</td><td>15.5</td><td>0.05</td><td>0.18</td></tr><tr><td>Sandwich</td><td>45.5</td><td>49.2</td><td>0.09</td><td>43.3</td><td>48.3</td><td>0.08</td><td>0.71</td></tr><tr><td>Juice packaged/soft drinks</td><td>11.4</td><td>6.1</td><td>0.67</td><td>9.9</td><td>12.8</td><td>0.48</td><td>0.41</td></tr></table>
23fe556ab183e86a79e2b1da239bae0f39d69b00c3276e82e6fdbe4c41a05fa2.png
simple
<table><tr><td>Position</td><td>Mutation</td><td>Run1</td><td>Run2 <sup>b</sup></td><td>Highest of 2 run (95 CI)</td></tr><tr><td>21</td><td>M41L(A-&gt;C)</td><td>0.02%</td><td>0.01%</td><td>0.02% (0.01 to 0.03)</td></tr><tr><td>94</td><td>K65R(A-&gt;G) <sup>a</sup></td><td>0.31%</td><td>0.09%</td><td>0.31(0.19 to 0.42)</td></tr><tr><td>99</td><td>D67W(G-&gt;A)</td><td>0.07%</td><td>0.02%</td><td>0.07% (0.01 to 0.13)</td></tr><tr><td>109</td><td>K70R(A-&gt;G)</td><td>0.09%</td><td>0.06%</td><td>0.09% (0.03 to 0.16)</td></tr><tr><td>120</td><td>L74V(T-&gt;G)</td><td>0.02%</td><td>0.00%</td><td>0.02% (0.00 to 0.01)</td></tr><tr><td>198</td><td>L90I(T-&gt;A)</td><td>0.00%</td><td>0.00%</td><td>0.00% (0.00 to 0.03)</td></tr><tr><td>209</td><td>K103N(A-&gt;C)</td><td>0.02%</td><td>0.01%</td><td>0.02% (0.01 to 0.03)</td></tr><tr><td>210</td><td>K103N(A-&gt;T)</td><td>0.02%</td><td>0.02%</td><td>0.02% (0.01 to 0.03)</td></tr></table>
4eebc34946677e6047c895afc72e6fd9852ea7509ecba3e76057a50cbc14d8a6.png
complex
<table><tr><td></td><td>Seed 05</td><td>Seed 07</td><td>Seed 08</td><td>Seed 09</td><td>Leaf</td><td>Root</td><td>Stem</td><td>All tissues</td></tr><tr><td colspan="9">BUSCO (%):</td></tr><tr><td> Completeness</td><td>86</td><td>76</td><td>79</td><td>83</td><td>74</td><td>84</td><td>84</td><td>83</td></tr><tr><td> Duplicated</td><td>18</td><td>18</td><td>19</td><td>20</td><td>18</td><td>18</td><td>17</td><td>24</td></tr><tr><td> Fragmented</td><td>5</td><td>16</td><td>13</td><td>9</td><td>13</td><td>7</td><td>8</td><td>10</td></tr><tr><td> Missing</td><td>7</td><td>7</td><td>7</td><td>7</td><td>11</td><td>7</td><td>7</td><td>5</td></tr><tr><td colspan="9">RMBT to themselves:</td></tr><tr><td> % mapped</td><td>86.1</td><td>96.3</td><td>87.6</td><td>86.6</td><td>88.8</td><td>85.6</td><td>86.2</td><td>90.9</td></tr><tr><td> % properly paired</td><td>75.9</td><td>87.5</td><td>76.6</td><td>75.9</td><td>81.0</td><td>76.8</td><td>77.9</td><td>80.1</td></tr><tr><td> % singletons</td><td>3.8</td><td>1.3</td><td>3.4</td><td>3.7</td><td>3.4</td><td>3.9</td><td>3.6</td><td>3.2</td></tr><tr><td> Total bp</td><td>16,523,554</td><td>17,276,866</td><td>17,753,884</td><td>17,041,720</td><td>13,759,496</td><td>23,850,824</td><td>14,396,240</td><td>120,602,584</td></tr><tr><td colspan="9">RMBT to Full:</td></tr><tr><td> % mapped</td><td>95.5</td><td>96.3</td><td>96.0</td><td>95.4</td><td>97.2</td><td>94.5</td><td>97.4</td><td>95.9</td></tr><tr><td> % properly paired</td><td>86.2</td><td>87.5</td><td>87.4</td><td>86.3</td><td>89.9</td><td>86.2</td><td>89.0</td><td>87.3</td></tr><tr><td> % singletons</td><td>1.4</td><td>1.3</td><td>1.3</td><td>1.5</td><td>1.0</td><td>1.4</td><td>1.0</td><td>1.3</td></tr><tr><td> Total bp</td><td>16,523,554</td><td>17,276,866</td><td>17,753,884</td><td>17,041,720</td><td>13,759,496</td><td>23,850,824</td><td>14,396,240</td><td>120,602,584</td></tr></table>
1bb30a190e7544cae0f123a34ace9c9a916b6a88623da05161563ad8519a63e1.png
complex
<table><tr><td></td><td>In-person workshop group (<i>n</i> = 25)</td><td>Patients and caregivers in in-person workshop (<i>n</i> = 18)</td><td>Online wiki-inspired group (<i>n</i> = 26)</td><td>Patients and caregivers in online wiki-inspired group (<i>n</i> = 19)</td></tr><tr><td colspan="5">Age</td></tr><tr><td> 18&#8211;39 years</td><td>3 (12)</td><td>1 (5.6)</td><td>4 (15.4)</td><td>4 (21.1)</td></tr><tr><td> 40&#8211;64 years</td><td>14 (56)</td><td>9 (50)</td><td>16 (61.5)</td><td>9 (47.4)</td></tr><tr><td>&#8805; 65 years</td><td>8 (32)</td><td>8 (44.4)</td><td>6 (23.1)</td><td>6 (31.6)</td></tr><tr><td colspan="5">Sex</td></tr><tr><td> Male</td><td>13 (52)</td><td>11 (61.1)</td><td>11 (42.3)</td><td>9 (47.4)</td></tr><tr><td> Female</td><td>12 (48)</td><td>7 (38.9)</td><td>15 (57.7)</td><td>10 (52.6)</td></tr><tr><td colspan="5">Role</td></tr><tr><td> Patient</td><td>12 (48)</td><td>12 (66.7)</td><td>11 (42.3)</td><td>11 (57.9)</td></tr><tr><td> Caregiver</td><td>6 (24)</td><td>6 (33.3)</td><td>8 (30.8)</td><td>8 (42.1)</td></tr><tr><td> Health Care Provider</td><td>6 (24)</td><td>-</td><td>6 (23.1)</td><td>-</td></tr><tr><td> Policymaker</td><td>1 (4)</td><td>-</td><td>1 (3.8)</td><td>-</td></tr><tr><td colspan="5">Marital Status</td></tr><tr><td> Married</td><td>22 (88)</td><td>16 (88.9)</td><td>19 (73.1)</td><td>13 (68.4)</td></tr><tr><td> Common Law</td><td>1 (4)</td><td>0 (0)</td><td>2 (7.7)</td><td>1 (5.3)</td></tr><tr><td> Divorced/Separated</td><td>2 (8)</td><td>2 (11.1)</td><td>0 (0)</td><td>0 (0)</td></tr><tr><td> Single</td><td>0 (0)</td><td>0 (0)</td><td>3 (11.5)</td><td>3 (15.8)</td></tr><tr><td> Not Indicated</td><td>0 (0)</td><td>0 (0)</td><td>2 (7.7)</td><td>2 (10.5)</td></tr><tr><td colspan="5">Employment Status</td></tr><tr><td> Full-time</td><td>14 (56)</td><td>8 (44.4)</td><td>12 (46.2)</td><td>6 (31.6)</td></tr><tr><td> Part-time or casual</td><td>2 (8)</td><td>1 (5.6)</td><td>2 (7.7)</td><td>1 (5.3)</td></tr><tr><td> Retired</td><td>9 (36)</td><td>9 (50)</td><td>10 (38.5)</td><td>10 (52.6)</td></tr><tr><td> Unemployed</td><td>0 (0)</td><td>0 (0)</td><td>1 (3.8)</td><td>1 (5.3)</td></tr><tr><td> Not Indicated</td><td>0 (0)</td><td>0 (0)</td><td>1 (3.8)</td><td>1 (5.3)</td></tr><tr><td colspan="5">Highest Level of Education</td></tr><tr><td> Some High School</td><td>0 (0)</td><td>0 (0)</td><td>1 (3.8)</td><td>1 (5.3)</td></tr><tr><td> High School Graduate</td><td>4 (16)</td><td>4 (22.2)</td><td>3 (11.5)</td><td>3 (15.8)</td></tr><tr><td> College Diploma</td><td>4 (16)</td><td>3 (16.7)</td><td>8 (30.8)</td><td>8 (42.1)</td></tr><tr><td> University Degree</td><td>17 (68)</td><td>11 (61.1)</td><td>12 (46.2)</td><td>5 (26.3)</td></tr><tr><td> Not Indicated</td><td>0 (0)</td><td>0 (0)</td><td>2 (7.7)</td><td>2 (10.5)</td></tr></table>
9f6886380594e9fbb4dddde458c6c3b1b4282c219c35772b1cd3c619431a80e2.png
complex
<table><tr><td>Taxon, area, location</td><td>Code</td><td><i>N</i></td><td>Date</td><td>Coordinates</td></tr><tr><td colspan="5"><i>Clupea pallasii</i></td></tr><tr><td>NW Pacific &amp; Bering Sea</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Sea of Japan</td><td>JAP</td><td>24</td><td>2005</td><td>48.40&#176;N, 141.94&#176;E</td></tr><tr><td> Sea of Okhotsk, Taui Bay</td><td>OKH</td><td>37</td><td>5.2005</td><td>59.40&#176;N, 150.12&#176;E</td></tr><tr><td> </td><td> </td><td> </td><td>31.8.2007</td><td>59.18&#176;N, 149.05&#176;E</td></tr><tr><td> Bering Sea, Togiak Bay</td><td>BER</td><td>48</td><td> </td><td>58&#176;N, 160&#176;W</td></tr><tr><td>NE Pacific</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Gulf of Alaska, Kodiak Bay</td><td>KOD</td><td>27</td><td> </td><td>57&#176;N, 154&#176;W</td></tr><tr><td> Washington</td><td>WAS</td><td>28</td><td>2009</td><td>48&#176;N, 125&#176;W</td></tr><tr><td>Pacific, Total</td><td> </td><td>164</td><td> </td><td> </td></tr><tr><td colspan="5">Pechora Sea</td></tr><tr><td> Chesha Bay, Yarnei River</td><td>CHE</td><td>21</td><td>16.6.2010</td><td>67.78&#176;N, 45.99&#176;E</td></tr><tr><td> Indiga Bay, near Svyatoi Nos</td><td>IND</td><td>21</td><td>20.6.2010</td><td>67.87&#176;N, 48.58&#176;E</td></tr><tr><td>White Sea</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Mezen Bay, West Kanin</td><td>MEZ</td><td>24</td><td>16.6.2010</td><td>67.20 N, 43.49 E</td></tr><tr><td> Dvina Bay, Yandovaya Inlet</td><td>YAN</td><td>36+5</td><td>5.2001; 15.6.2010</td><td>64.66&#176;N, 39.82&#176;E</td></tr><tr><td> Onega Bay, Kolezhma Inlet</td><td>KLZ</td><td>21</td><td>11.5.2001</td><td>64.30&#176;N, 35.91&#176;E</td></tr><tr><td> Onega Bay, Kii Island</td><td>KIY</td><td>12</td><td>18.5.2001</td><td>64.00&#176;N, 37.90&#176;E</td></tr><tr><td> Gulf of Kandalaksha, Chupa Inlet*</td><td>CHP</td><td>10</td><td>19.4.2001</td><td>66.30&#176;N, 33.47&#176;E</td></tr><tr><td> Gulf of Kandalaksha, Chupa Inlet</td><td>CHU</td><td>23</td><td>30.8.1994</td><td>66.30&#176;N, 33.47&#176;E</td></tr><tr><td> Gulf of Kandalaksha, Kolvitsa*</td><td>KOL</td><td>38</td><td>30.4.2010</td><td>67.04&#176;N, 32.55&#176;E</td></tr><tr><td> Gulf of Kandalaksha, Umba</td><td>UMB</td><td>32</td><td>16.6.2010</td><td>66.65&#176;N, 34.25&#176;E</td></tr><tr><td>Norwegian Sea</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Balsfjord</td><td>BLS</td><td>39</td><td>28.4.2009</td><td>69.27&#176;N, 19.28&#176;E</td></tr><tr><td>European <i>C. pallasii</i>, Total</td><td> </td><td>282</td><td> </td><td> </td></tr><tr><td colspan="5"><i>Clupea harengus</i></td></tr><tr><td> NW Atlantic, Canada</td><td>CAN</td><td>26</td><td>10.3.2010</td><td>47&#176;N, 47&#176;E</td></tr><tr><td> Norwegian Sea</td><td>NOR</td><td>26</td><td>2010</td><td>72&#176;N, 16&#176;E</td></tr><tr><td> Baltic Sea, Bothnian Sea</td><td>BOT</td><td>30</td><td>2009</td><td>62&#176;N, 19&#176;E</td></tr><tr><td>Total <i>C. harengus</i></td><td> </td><td>85</td><td> </td><td> </td></tr><tr><td>Total, both species</td><td> </td><td>528</td><td colspan="2"> </td></tr></table>
fcbf7f7c8402d7cc047a2cd552781e33c7e5302b5de2aa853de866b009b7e835.png
simple
<table><tr><td>Parameter</td><td>Reference value</td><td>Day 1</td><td>Day 1</td><td>Day 2</td><td>Day 2</td><td>Day 3</td><td>Day 3</td><td>Day 5</td><td>Day 7</td><td>Day 8</td><td>Day 15</td></tr><tr><td> </td><td> </td><td>12:02</td><td>22:58</td><td>05:47</td><td>21.38</td><td>07:42</td><td>18:10</td><td>09:45</td><td>10:42</td><td>08:08</td><td>12:21</td></tr><tr><td>BUN</td><td>9.0-20.0 mg/dl</td><td>25</td><td>21</td><td>21</td><td>NM</td><td>12</td><td>9</td><td>4</td><td>6</td><td>8</td><td>14</td></tr><tr><td>Creatinine</td><td>&#8722;1.1 mg/dl</td><td>1.64</td><td>1.15</td><td>NM</td><td>NM</td><td>0.87</td><td>1.00</td><td>0.74</td><td>0.80</td><td>0.84</td><td>0.81</td></tr><tr><td>GFR</td><td>&gt;90 ml/min/1.73 m</td><td>42</td><td>63</td><td>NM</td><td>NM</td><td>87</td><td>74</td><td>104</td><td>95</td><td>90</td><td>94</td></tr><tr><td>Sodium</td><td>136.0-145.0 mmol/l</td><td>130</td><td>129</td><td>132</td><td>132</td><td>138</td><td>136</td><td>137</td><td>140</td><td>140</td><td>139</td></tr><tr><td>Potassium</td><td>3.3-5.1 mmol/l</td><td>1.1</td><td>1.6</td><td>1.5</td><td>1.4</td><td>1.7</td><td>2.8</td><td>4.5</td><td>5.4</td><td>4.9</td><td>5.0</td></tr><tr><td>Chloride</td><td>98.0-106.0 mmol/l</td><td>90</td><td>92</td><td>97</td><td>98</td><td>101</td><td>97</td><td>100</td><td>NM</td><td>NM</td><td>99</td></tr><tr><td>Calcium</td><td>2.1-2.7 mmol/l</td><td>2.66</td><td>2.0</td><td>2.0</td><td>2.0</td><td>2.1</td><td>2.0</td><td>2.1</td><td>NM</td><td>NM</td><td>2.8</td></tr><tr><td>pH</td><td>7.33-7.42</td><td>7.549</td><td>7.514</td><td>7.468</td><td>7.454</td><td>7.357</td><td>7.453</td><td>7.467</td><td>NM</td><td>NM</td><td>7.371</td></tr><tr><td>HCO<sub>3</sub><sup>-</sup></td><td>22-26 mmol/l</td><td>31.4</td><td>28.6</td><td>29.0</td><td>28.4</td><td>25.3</td><td>30.9</td><td>33.3</td><td>NM</td><td>NM</td><td>29.0</td></tr><tr><td>P<sub>CO2</sub></td><td>38-42 mmHg</td><td>36.1</td><td>34.2</td><td>40.9</td><td>42.3</td><td>52.1</td><td>48.0</td><td>35.7</td><td>NM</td><td>NM</td><td>57.0</td></tr><tr><td>CK</td><td>&#8722;144.0 U/l</td><td>15966</td><td>13143</td><td>11570</td><td>NM</td><td>9882</td><td>12043</td><td>5703</td><td>1867</td><td>1070</td><td>102</td></tr><tr><td>Leukocytes</td><td>4.0-9.0/nl</td><td>18.1</td><td>NM</td><td>NM</td><td>NM</td><td>9.5</td><td>8.9</td><td>NM</td><td>NM</td><td>5.5</td><td>5.9</td></tr><tr><td>Erythrocytes</td><td>4.0-5.2/pl</td><td>5.19</td><td>NM</td><td>NM</td><td>NM</td><td>3.28</td><td>3.48</td><td>NM</td><td>NM</td><td>3.54</td><td>3.55</td></tr><tr><td>Hemoglobin</td><td>12.0-16.0 g/dl</td><td>16.6</td><td>NM</td><td>NM</td><td>NM</td><td>10.4</td><td>11.2</td><td>NM</td><td>NM</td><td>11.4</td><td>12.1</td></tr><tr><td>Hematocrit</td><td>38.0-48.0%</td><td>42.7</td><td>NM</td><td>NM</td><td>NM</td><td>27.8</td><td>29.6</td><td>NM</td><td>NM</td><td>35.0</td><td>35.2</td></tr></table>
144b07a6ee8331c3db4896a4b58f4d1f6e3bb39e7298ca68513868023b9a9a44.png
simple
<table><tr><td>Characteristic</td><td>Distribution</td></tr><tr><td>Sex [n (%)]</td><td></td></tr><tr><td>Female</td><td>117 (12%)</td></tr><tr><td>Male</td><td>848 (88%)</td></tr><tr><td>Age [mean (range)]</td><td>37 (18 &#8211; 67)</td></tr><tr><td>Transmission Risk Factor [n (%)]</td><td></td></tr><tr><td>MSM, not IDU</td><td>567 (59)</td></tr><tr><td>IDU</td><td>189 (20)</td></tr><tr><td>Heterosexual</td><td>160 (17)</td></tr><tr><td>Other/Unknown</td><td>49 (5)</td></tr><tr><td>Race/Ethnicity [n (%)]</td><td></td></tr><tr><td>Black</td><td>139 (14)</td></tr><tr><td>Hispanic</td><td>193 (20)</td></tr><tr><td>White</td><td>559 (58)</td></tr><tr><td>Other/Unknown</td><td>74 (8)</td></tr><tr><td>Prior Antiretroviral Treatment [n (%)]</td><td></td></tr><tr><td>Experienced</td><td>571 (59)</td></tr><tr><td>Naive</td><td>394 (41)</td></tr><tr><td>Absolute CD4 [mean (std dev)]</td><td>233 (337)</td></tr><tr><td>log<sub>10 </sub>HIV Plasma Viral Load [mean (std dev)]</td><td>4.6 (1.7)</td></tr></table>
3072b5f44258b3c81946c838b8f277ea12e2f823b41c442fe0372ce0316f238a.png
simple
<table><tr><td>Age</td><td>Parameter</td><td>Group</td><td>Mean</td><td>SD</td><td><i>t</i></td><td><i>p</i></td></tr><tr><td>3 years</td><td>P1</td><td>Control</td><td>95.40</td><td>16.98</td><td><i>3.013</i></td><td><i>&lt;0.01</i></td></tr><tr><td></td><td></td><td>Experimental</td><td>81.30</td><td>12.22</td><td></td><td></td></tr><tr><td></td><td>N1</td><td>Control</td><td>168.40</td><td>32.10</td><td><i>3.908</i></td><td><i>&lt;0.01</i></td></tr><tr><td></td><td></td><td>Experimental</td><td>134.60</td><td>21.57</td><td></td><td></td></tr><tr><td></td><td>P2</td><td>Control</td><td>235.90</td><td>36.67</td><td><i>5.008</i></td><td><i>&lt;0.01</i></td></tr><tr><td></td><td></td><td>Experimental</td><td>183.55</td><td>28.98</td><td></td><td></td></tr><tr><td></td><td>N2</td><td>Control</td><td>296.80</td><td>38.38</td><td><i>3.695</i></td><td><i>&lt;0.01</i></td></tr><tr><td></td><td></td><td>Experimental</td><td>256.85</td><td>29.40</td><td></td><td></td></tr><tr><td>4 years</td><td>P1</td><td>Control</td><td>79.38</td><td>16.40</td><td><i>0.893</i></td><td><i>&gt;0.05</i></td></tr><tr><td></td><td></td><td>Experimental</td><td>84.05</td><td>17.69</td><td></td><td></td></tr><tr><td></td><td>N1</td><td>Control</td><td>147.61</td><td>36.61</td><td><i>0.152</i></td><td><i>&gt;0.05</i></td></tr><tr><td></td><td></td><td>Experimental</td><td>149.20</td><td>27.40</td><td></td><td></td></tr><tr><td></td><td>P2</td><td>Control</td><td>205.55</td><td>49.03</td><td><i>0.185</i></td><td><i>&gt;0.05</i></td></tr><tr><td></td><td></td><td>Experimental</td><td>208.45</td><td>47.14</td><td></td><td></td></tr><tr><td></td><td>N2</td><td>Control</td><td>259.27</td><td>44.72</td><td><i>0.699</i></td><td><i>&gt;0.05</i></td></tr><tr><td></td><td></td><td>Experimental</td><td>270.30</td><td>51.64</td><td></td><td></td></tr><tr><td>5 years</td><td>P1</td><td>Control</td><td>70.40</td><td>13.70</td><td><i>0.580</i></td><td><i>&gt;0.05</i></td></tr><tr><td></td><td></td><td>Experimental</td><td>72.95</td><td>14.11</td><td></td><td></td></tr><tr><td></td><td>N1</td><td>Control</td><td>120.68</td><td>31.36</td><td><i>0.367</i></td><td><i>&gt;0.05</i></td></tr><tr><td></td><td></td><td>Experimental</td><td>123.95</td><td>23.91</td><td></td><td></td></tr><tr><td></td><td>P2</td><td>Control</td><td>154.30</td><td>36.84</td><td><i>0.840</i></td><td><i>&gt;0.05</i></td></tr><tr><td></td><td></td><td>Experimental</td><td>163.10</td><td>28.98</td><td></td><td></td></tr><tr><td></td><td>N2</td><td>Control</td><td>217.90</td><td>34.87</td><td><i>0.683</i></td><td><i>&gt;0.05</i></td></tr><tr><td></td><td></td><td>Experimental</td><td>211.80</td><td>19.46</td><td></td><td></td></tr></table>
44cbba9fb9ecfe7496aea37d021736f523083f596dcdd20b73e9ed26db3735d8.png
complex
<table><tr><td rowspan="2" colspan="2"></td><td rowspan="2">Estimate</td><td rowspan="2">Std. Error</td><td rowspan="2">Wald</td><td rowspan="2">Df.</td><td rowspan="2">Sig.</td><td colspan="2">95 % Confidence Interval</td></tr><tr><td>Lower Bound</td><td>Upper Bound</td></tr><tr><td rowspan="2">Threshold</td><td>One visit last year</td><td>16.691</td><td>1.861</td><td>80.423</td><td>1</td><td>0</td><td>13.043</td><td>20.339</td></tr><tr><td>2 visits last year</td><td>17.705</td><td>1.86</td><td>90.604</td><td>1</td><td>0</td><td>14.059</td><td>21.35</td></tr><tr><td rowspan="2"></td><td>Distance</td><td>&#8722;0.051</td><td>0.047</td><td>1.163</td><td>1</td><td>0.281</td><td>&#8722;0.143</td><td>0.041</td></tr><tr><td>Family Size</td><td>0.005</td><td>0.09</td><td>0.004</td><td>1</td><td>0.953</td><td>&#8722;0.171</td><td>0.181</td></tr><tr><td rowspan="4">Age</td><td>&lt;20</td><td>0.446</td><td>0.517</td><td>0.744</td><td>1</td><td>0.388</td><td>&#8722;0.567</td><td>1.459</td></tr><tr><td>20&#8211;34</td><td>0.025</td><td>0.376</td><td>0.004</td><td>1</td><td>0.947</td><td>&#8722;0.713</td><td>0.762</td></tr><tr><td>35&#8211;44</td><td>0.161</td><td>0.388</td><td>0.173</td><td>1</td><td>0.678</td><td>&#8722;0.599</td><td>0.921</td></tr><tr><td>&gt;45</td><td>0<sup>a</sup></td><td>.</td><td>.</td><td>0</td><td>.</td><td>.</td><td>.</td></tr><tr><td rowspan="5">House income</td><td>2000&#8211;4000</td><td>&#8722;0.34</td><td>0.537</td><td>0.401</td><td>1</td><td>0.527</td><td>&#8722;1.392</td><td>0.712</td></tr><tr><td>4001&#8211;6000</td><td>0.217</td><td>0.538</td><td>0.163</td><td>1</td><td>0.686</td><td>&#8722;0.838</td><td>1.272</td></tr><tr><td>6001&#8211;8000</td><td>&#8722;0.005</td><td>0.506</td><td>0</td><td>1</td><td>0.992</td><td>&#8722;0.997</td><td>0.986</td></tr><tr><td>8001&#8211;10000</td><td>&#8722;0.06</td><td>0.558</td><td>0.011</td><td>1</td><td>0.915</td><td>&#8722;1.154</td><td>1.034</td></tr><tr><td>&gt;10001</td><td>0<sup>a</sup></td><td>.</td><td>.</td><td>0</td><td>.</td><td>.</td><td>.</td></tr><tr><td rowspan="3">Education</td><td>Less High school</td><td>0.47</td><td>0.44</td><td>1.143</td><td>1</td><td>0.285</td><td>&#8722;0.392</td><td>1.332</td></tr><tr><td>High school</td><td>0.295</td><td>0.381</td><td>0.599</td><td>1</td><td>0.439</td><td>&#8722;0.452</td><td>1.042</td></tr><tr><td>Collage degree</td><td>0<sup>a</sup></td><td>.</td><td>.</td><td>0</td><td>.</td><td>.</td><td>.</td></tr><tr><td>Gender</td><td>Male</td><td>&#8722;0.92</td><td>0.387</td><td>5.658</td><td>1</td><td>0.017</td><td>&#8722;1.678</td><td>&#8722;0.162</td></tr><tr><td></td><td>Female</td><td>0<sup>a</sup></td><td>.</td><td>.</td><td>0</td><td>.</td><td>.</td><td>.</td></tr><tr><td rowspan="4">Transportation</td><td>Always</td><td>&#8722;0.69</td><td>0.576</td><td>1.433</td><td>1</td><td>0.231</td><td>&#8722;1.82</td><td>0.44</td></tr><tr><td>Occasionally</td><td>&#8722;0.857</td><td>0.797</td><td>1.155</td><td>1</td><td>0.282</td><td>&#8722;2.419</td><td>0.706</td></tr><tr><td>Sometimes</td><td>&#8722;0.405</td><td>0.531</td><td>0.582</td><td>1</td><td>0.446</td><td>&#8722;1.446</td><td>0.636</td></tr><tr><td>Never</td><td>0<sup>a</sup></td><td>.</td><td>.</td><td>0</td><td>.</td><td>.</td><td>.</td></tr></table>
b98614ff33c49efe209972d6f248e17f45a9162773d21a6f6c2c1a4cd470ddb5.png
simple
<table><tr><td>Patients</td><td>Cancer classification</td><td>Clinical stage</td></tr><tr><td>1</td><td>Adenocarcinoma</td><td>cT2N + M0, Stage III</td></tr><tr><td>2</td><td>Adenocarcinoma</td><td>cT3N + M0, Stage III</td></tr><tr><td>3</td><td>Adenocarcinoma</td><td>cT3N + M0, Stage III</td></tr><tr><td>4</td><td>Adenocarcinoma</td><td>cT3N0M0, Stage II</td></tr><tr><td>5</td><td>Adenocarcinoma</td><td>cT3N + M0, Stage III</td></tr><tr><td>6</td><td>Adenocarcinoma</td><td>cT3N + M0, Stage III</td></tr><tr><td>7</td><td>Adenocarcinoma</td><td>cT3N + M0, Stage III</td></tr></table>
28d43ea44627bcf56ed3dfd9a1ab9b9aeb145e2d8cf3f268cada64ae2e37be79.png
complex
<table><tr><td>Variable</td><td>CGC n =12</td><td>CyGC n = 20</td><td><i>P </i>^</td></tr><tr><td>Baseline</td><td> </td><td> </td><td> </td></tr><tr><td>Insulin (pmol/L)</td><td>64.59 &#177; 17.36</td><td>53.48 &#177; 18.75</td><td>0.12</td></tr><tr><td>HOMA-IR</td><td>2.2 &#177; 0.79</td><td>1.73 &#177; 0.79</td><td>0.11</td></tr><tr><td>HOMA (&#946;-cell)</td><td>112.8 &#177; 47.8</td><td>113.3 &#177; 63.2</td><td>0.98</td></tr><tr><td colspan="2">Insulin, follow-up week (pmol/L)</td><td> </td><td> </td></tr><tr><td>1</td><td>105.56 &#177; 66.67</td><td>-</td><td>-</td></tr><tr><td>2</td><td>125.70 &#177; 75.01</td><td>-</td><td>-</td></tr><tr><td>3</td><td>142.37 &#177; 57.64</td><td>106.95 &#177; 59.73</td><td>0.11</td></tr><tr><td>4</td><td>154.87 &#177; 88.20</td><td>-</td><td>-</td></tr><tr><td>5</td><td>156.96 &#177; 86.81</td><td>-</td><td>-</td></tr><tr><td>6</td><td>169.46 &#177; 109.73</td><td>125.70 &#177; 73.62</td><td>0.19</td></tr><tr><td>8</td><td>129.87 &#177; 68.75</td><td>-</td><td>-</td></tr><tr><td>9</td><td>-</td><td>120.15 &#177; 70.84</td><td>-</td></tr><tr><td>12</td><td>-</td><td>96.53 &#177; 40.28</td><td>-</td></tr><tr><td>Insulin (pmol/L) [n]</td><td> </td><td> </td><td> </td></tr><tr><td>With DM<sup>1</sup></td><td>63.20 &#177; 15.97</td><td>61.46 &#177; 20.14</td><td>0.88</td></tr><tr><td>Without DM<sup>2</sup></td><td>66.67 &#177; 21.32</td><td>51.39 &#177; 18.75</td><td>0.15</td></tr><tr><td><i>P</i> value (1 <i>vs.</i> 2)</td><td>0.75</td><td>0.39</td><td>-</td></tr><tr><td>HOMA-IR</td><td> </td><td> </td><td> </td></tr><tr><td>With DM<sup>3</sup></td><td>2.20 &#177; 0.74</td><td>2.14 &#177; 0.96</td><td>0.91</td></tr><tr><td>Without DM<sup>4</sup></td><td>2.21 &#177; 0.94</td><td>1.62 &#177; 0.75</td><td>0.17</td></tr><tr><td><i>P</i> value (3 <i>vs.4</i>)</td><td>0.99</td><td>0.35</td><td>-</td></tr><tr><td>HOMA- &#946;-cell</td><td> </td><td> </td><td> </td></tr><tr><td>With DM<sup>5</sup></td><td>98.8 &#177; 21.9</td><td>135.3 &#177; 102</td><td>0.36</td></tr><tr><td>Without DM<sup>6</sup></td><td>132 &#177; 68.9</td><td>107 &#177; 53.1</td><td>0.40</td></tr><tr><td>p value (5 <i>vs.6</i>)</td><td>0.24</td><td>0.45</td><td>-</td></tr><tr><td>MMII<sup>&#8224;</sup> pmol/L(%)</td><td> </td><td> </td><td> </td></tr><tr><td>With DM [week]<sup>7</sup></td><td>145.84(231%) [6]</td><td>154.18(251%) [9]</td><td>0.76</td></tr><tr><td>Without DM [week]<sup>8</sup></td><td>82.64 (116%) [4]</td><td>56.25 (111%) [6]</td><td>0.37</td></tr><tr><td>p value (7 <i>vs.</i> 8)</td><td>0.02*</td><td>0.01*</td><td>-</td></tr></table>
a141e7f103a415f5fe48b2b593280cae18279e8236b8fca31f7c95fdc92ad3c8.png
simple
<table><tr><td>NOPES score</td><td>&#8805;1</td><td>&#8805;2</td><td>&#8805;3</td></tr><tr><td>Sensitivity (%)</td><td>98.7</td><td>68.9</td><td>24.3</td></tr><tr><td>Specificity (%)</td><td>14.1</td><td>59.2</td><td>95.1</td></tr><tr><td>Validity index (%)</td><td>38.4</td><td>62</td><td>74.8</td></tr><tr><td>Positive predictive value (%)</td><td>31.6</td><td>40.5</td><td>66.7</td></tr><tr><td>Negative predictive value (%)</td><td>96.3</td><td>82.6</td><td>75.8</td></tr><tr><td>Youden Index</td><td>0.13</td><td>0.28</td><td>0.19</td></tr><tr><td>Prevalence of BE (%)</td><td>31.6</td><td>40.8</td><td>66.7</td></tr></table>
ce0563487137b431b185927be8cf8054d603f0ba3ca939e692acbfd384777ebf.png
complex
<table><tr><td></td><td colspan="2">ANC</td><td>ALC</td><td>CD3Count</td><td>CD3%</td><td>CD4Count</td><td>CD4%</td><td>CD8Count</td><td>CD4%</td><td>CD4/CD8ratio</td><td>CD19Count</td><td>CD19%</td></tr><tr><td rowspan="2">Serum iron (mg/dl)</td><td><i>p</i></td><td>0.02*</td><td>0.08</td><td>0.5</td><td>0.14</td><td>0.5</td><td>0.001*</td><td>0.05</td><td>0.19</td><td>0.002*</td><td>0.02*</td><td>0.69</td></tr><tr><td><i>r</i></td><td>0.27</td><td>&#8722;0.2</td><td>&#8722;0.07</td><td>0.17</td><td>0.08</td><td>0.5</td><td>&#8722;0.22</td><td>&#8722;0.14</td><td>0.35</td><td>&#8722;0.27</td><td>&#8722;0.05</td></tr></table>
e3f285fca77b19d23786b449e2522832a99803ae65a362c1bd46447c5659c5e4.png
complex
<table><tr><td rowspan="3">Plant</td><td rowspan="3">Material</td><td>Shoot Weight</td><td>Lead Concentration</td><td>Lead Uptake</td></tr><tr><td>(a)</td><td>(b)</td><td>(c = a &#215; b)</td></tr><tr><td>(mg box<sup>&#8722;1</sup> DW)</td><td>(&#956;g g<sup>&#8722;1</sup> DW)</td><td>(&#956;g box<sup>&#8722;1</sup> DW)</td></tr><tr><td rowspan="2">Barley</td><td>+HAP</td><td>410 &#177; 90</td><td>7 &#177; 2</td><td>2.7 &#177; 0.2</td></tr><tr><td>&#8722;HAP</td><td>240 &#177; 40</td><td>90 &#177; 70</td><td>18 &#177; 13</td></tr><tr><td><i>p</i> value</td><td></td><td>0.1513</td><td>0.2964</td><td>0.2867</td></tr><tr><td rowspan="2">Hairy vetch</td><td>+HAP</td><td>700 &#177; 100</td><td>9 &#177; 1</td><td>6.1 &#177; 1.2</td></tr><tr><td>&#8722;HAP</td><td>244 &#177; 24</td><td>24 &#177; 7</td><td>5.5 &#177; 1.3</td></tr><tr><td><i>p</i> value</td><td></td><td>0.0014 **</td><td>0.1005</td><td>0.7530</td></tr></table>
e6d116ef60eaaa0a2f484f049b52f2846e0e070d71237d9a762b8ff7717b375a.png
simple
<table><tr><td></td><td>Clinical Dosage</td><td>Flow Rate</td><td>Volume and Syringe Size</td></tr><tr><td>Loading Dose</td><td>4 g MgSO<sub>4</sub> over 20 min</td><td>60 mL/h</td><td>20 mL in a single 20 mL syringe</td></tr><tr><td>Maintenance Dose</td><td>1 g/h MgSO<sub>4</sub> for 24 h</td><td>5 mL/h</td><td>120 mL in two 60 mL syringes</td></tr></table>
40c4947f5eb7ef0f27ed03f7b857fa573cc6f75649eb35daece4f44ea3156566.png
simple
<table><tr><td></td><td>EE</td><td>EK</td><td><i>P </i>value</td></tr><tr><td></td><td>Mean (95% CI)</td><td>Mean (95% CI)</td><td></td></tr><tr><td>n males/n females</td><td>934/934</td><td>40/42</td><td>-</td></tr><tr><td>Triglycerides (mmol/L)</td><td>1.94 (1.90, 1.99)</td><td>1.61 (1.44, 1.80)</td><td>0.001</td></tr><tr><td>Cholesterol (mmol/L)</td><td>4.86 (4.82, 4.90)</td><td>4.88 (4.69, 5.08)</td><td>0.889</td></tr><tr><td>LDL-cholesterol (mmol/L)</td><td>2.77 (2.73, 2.80)</td><td>2.87 (2.70, 3.04)</td><td>0.237</td></tr><tr><td>HDL-cholesterol (mmol/L)</td><td>1.05 (1.04, 1.06)</td><td>1.10 (1.05, 1.16)</td><td>0.081</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>35.90 (35.87, 35.93)</td><td>35.91 (35.78, 36.03)</td><td>0.940</td></tr><tr><td>Weight (kg)</td><td>100.55 (100.21, 100.90)</td><td>101.51 (99.88, 103.17)</td><td>0.264</td></tr><tr><td>Waist Circumference (cm)</td><td>115.03 (114.69, 115.37)</td><td>116.73 (115.11, 118.37)</td><td>0.043</td></tr><tr><td>Glucose (mmol/L)</td><td>8.38 (8.28, 8.49)</td><td>8.02 (7.56, 8.51)</td><td>0.154</td></tr><tr><td>HbA1c</td><td>7.18 (7.14, 7.23)</td><td>7.00 (6.79, 7.22)</td><td>0.113</td></tr><tr><td>SBP (mm/Hg)</td><td>129.12 (128.31, 129.93)</td><td>124.88 (121.23, 128.64)</td><td>0.031</td></tr><tr><td>DBP (mm/Hg)</td><td>69.38 (68.98, 69.79)</td><td>67.55 (65.71, 69.43)</td><td>0.062</td></tr><tr><td>Triglycerides (mmol/L) on subjects not receiving lipid lowering medication</td><td>1.91 (1.85, 1.98)(n = 771)</td><td>1.54 (1.31, 1.80)(n = 36)</td><td>0.007</td></tr></table>
c3b3c068db0d751cbceb1f7636e445ce9ed46a40ac511171004a0dc96594a898.png
complex
<table><tr><td>Characteristics</td><td colspan="4">Study population N=253</td></tr><tr><td></td><td>ST (n=88)</td><td>ART- nai&#776;ve (n=96)</td><td>EC (n=19)</td><td>HS (n=50)</td></tr><tr><td>Age (years) [Mean &#177; SD (range)]</td><td>48.4&#177;9.4 (29-81)</td><td>39.2&#177;9.2 (23-58)</td><td>49.0&#177;7.1 (40-62)</td><td>45.0&#177;9.9 (19-64)</td></tr><tr><td>Male [n (%)]</td><td>73 (83%)</td><td>76 (79%)</td><td>9 (47%)</td><td>35 (70%)</td></tr><tr><td>Risk factors: </td><td></td><td></td><td></td><td></td></tr><tr><td> Men Who Have Sex with Men [n (%)]</td><td>59 (67%)</td><td>58 (60%)</td><td>6 (32%)</td><td>NA</td></tr><tr><td> Heterosexual [n (%)]</td><td>15 (17%)</td><td>22 (23%)</td><td>10 (53%)</td><td>NA</td></tr><tr><td> Endemic [n (%)]</td><td>11 (13%)</td><td>12 (13%)</td><td>2 (11%)</td><td>NA</td></tr><tr><td> Injection drug users [n (%)]</td><td>3 (3%)</td><td>4 (4%)</td><td>1 (5%)</td><td>NA</td></tr><tr><td>Time since HIV-1 diagnosis (years) [Mean &#177; SD (range)]</td><td>10.1&#177;5.5 (2-24)</td><td>4.2&#177;5.2 (0-23)</td><td>13.1&#177;4.1 (4-20)</td><td>NA</td></tr><tr><td>CD4 T-cell count (cells/&#956;L) [Mean &#177; SD range)]</td><td>531.3&#177;267.4 (37-1282)</td><td>416.1&#177;189.2 (3-1110)</td><td>617.8&#177;209.4 (417-1341)</td><td>812.6&#177;273.0(281-1559)</td></tr><tr><td>CD8 T-cell count (cells/&#956;L)[Mean &#177; SD (range)]</td><td>785.8&#177;332.6 (153-2013)</td><td>761.9&#177;365.2 (237-1933)</td><td>559.7&#177;307.0 (162-1198)</td><td>390.9&#177;188.5 (95-843)</td></tr><tr><td>CD4:CD8 ratio [Mean &#177;SD (range)]</td><td>0.75&#177;0.42 (0.08-2.06)</td><td>0.64&#177;0.38 (0.01-12.09)</td><td>1.35&#177;0.61 (0.35-2.72)</td><td>2.45&#177;0.96 (0.38-4.34)</td></tr><tr><td>VL (log10copies/mL) [Mean &#177;SD (range)]</td><td>&lt; 1.6</td><td> 4.0&#177;0.87 (1.73-6.35)</td><td>&lt; 1.6</td><td>NA</td></tr><tr><td>Time of undetectable VL (years)[Mean &#177; SD (range)]</td><td>3.64&#177;2.7 (1-10)</td><td>NA</td><td>12.8&#177;7.0 (7-20)</td><td>NA</td></tr><tr><td>Time since start of ART (years) [Mean &#177; SD (range)]</td><td>8.1&#177;4.7 (1-20)</td><td>NA</td><td>NA</td><td>NA</td></tr></table>
90d74cca2580b17cd6f5454cde9f26aeb2a00e30380d1c2e157596674fd9a1dc.png
simple
<table><tr><td>Collection$</td><td>LR loci</td><td>ER loci</td><td>RatioER/LR</td><td><i>P </i>value</td></tr><tr><td>P{EP}</td><td>10.6 (273)</td><td>42.3 (1,738)</td><td>4.0</td><td>1.8E-135</td></tr><tr><td>P{EPgy2}</td><td>17.5 (452)</td><td>56.6 (2,325)</td><td>3.2</td><td>2.0E-153</td></tr><tr><td>P{GT1}</td><td>3.0 (78)</td><td>6.7 (274)</td><td>2.2</td><td>5.4E-13</td></tr><tr><td>P{SUPor-P}</td><td>11.9 (307)</td><td>31.2 (1,281)</td><td>2.6</td><td>5.8E-69</td></tr><tr><td>PBac{PB}</td><td>22.0 (566)</td><td>40.7 (1,674)</td><td>1.9</td><td>1.9E-50</td></tr><tr><td>PBac{RB}</td><td>18.4 (473)</td><td>41.7 (1,714)</td><td>2.3</td><td>1.9E-75</td></tr><tr><td>Mi{ET1}</td><td>27.6 (710)</td><td>20.6 (847)</td><td>0.7</td><td>9.7E-15</td></tr><tr><td>Selected set</td><td>12.2 (313)</td><td>46.4 (1,908)</td><td>3.8</td><td>5.1E-144</td></tr><tr><td>Genomic size, Mb</td><td>25.8</td><td>41.1</td><td></td><td></td></tr></table>
5f4c3ed1b79d4728f788a9cac565b64c45dd18458df258917761827b854d212c.png
complex
<table><tr><td></td><td>Direct</td><td>Indirect</td></tr><tr><td rowspan="6">Medical</td><td>Medical consultations (Ch-P)<sup>c</sup></td><td rowspan="6"><sup>d</sup></td></tr><tr><td>Skills training (Ch)</td></tr><tr><td>Parent training (P)</td></tr><tr><td>Day-care treatment (Ch)</td></tr><tr><td>Hospitalization (Ch)</td></tr><tr><td>Medication (Ch-P)</td></tr><tr><td rowspan="6">Non-medical</td><td>Remedial teaching at school (Ch)</td><td>Agency for child welfare (Ch)</td></tr><tr><td>Weekend care (Ch)</td><td>Police (Ch)</td></tr><tr><td>Care after school (Ch)</td><td>Special education (Ch)</td></tr><tr><td>Diet (Ch)</td><td>Productivity losses</td></tr><tr><td></td><td>Absenteeism (P)</td></tr><tr><td></td><td>Presenteeism (P)</td></tr></table>
ec9ffcb006acd1319f835dc6de427f4f2e032831a2cd0ed3d306341ce377579b.png
simple
<table><tr><td>Amino acid</td><td>Casein</td><td>Jinyan-No.13</td><td>Bayou-No.8</td><td>Baiyan-No.2</td><td>Dingyou-No.8</td><td>Baiyan-No.8</td></tr><tr><td>Asparagine</td><td>71.3</td><td>82.6</td><td>78</td><td>123.3</td><td>83.5</td><td>59.9</td></tr><tr><td>Threonine</td><td>40.5</td><td>33.9</td><td>32.5</td><td>52.9</td><td>34.2</td><td>25.0</td></tr><tr><td>Serine</td><td>50.4</td><td>47.4</td><td>44.9</td><td>74.8</td><td>46.5</td><td>34.8</td></tr><tr><td>Glutamine</td><td>244.7</td><td>253.7</td><td>246.5</td><td>392.7</td><td>261.0</td><td>192.8</td></tr><tr><td>Glycine</td><td>18.4</td><td>50.0</td><td>48.7</td><td>80.2</td><td>50.3</td><td>37.2</td></tr><tr><td>Alanine</td><td>31.6</td><td>48.9</td><td>46.1</td><td>76.5</td><td>48.7</td><td>35.6</td></tr><tr><td>Cystine</td><td>16.5</td><td>39.2</td><td>35.9</td><td>58.6</td><td>36.3</td><td>27.6</td></tr><tr><td>Valine</td><td>60.3</td><td>56.8</td><td>55.6</td><td>88.2</td><td>57.3</td><td>42.9</td></tr><tr><td>Methionine</td><td>27.7</td><td>14.7</td><td>15.9</td><td>22.0</td><td>16.7</td><td>12.9</td></tr><tr><td>Isoleucine</td><td>50.3</td><td>38.9</td><td>39</td><td>61.0</td><td>40.8</td><td>29.8</td></tr><tr><td>Leucine</td><td>96.1</td><td>77.6</td><td>76.4</td><td>124.1</td><td>80.0</td><td>60.4</td></tr><tr><td>Tyrosine</td><td>52.7</td><td>39.7</td><td>43.1</td><td>69.3</td><td>41.3</td><td>36.7</td></tr><tr><td>Lysine</td><td>77.9</td><td>59.5</td><td>57.7</td><td>96.3</td><td>58.3</td><td>45.8</td></tr><tr><td>Histidine</td><td>26.2</td><td>41.4</td><td>38.9</td><td>64.3</td><td>40.9</td><td>30.3</td></tr><tr><td>Arginine</td><td>33.5</td><td>30.3</td><td>29.7</td><td>47.3</td><td>30.5</td><td>22.8</td></tr><tr><td>Phenylalanine</td><td>48.7</td><td>62.6</td><td>66.3</td><td>104.8</td><td>68.6</td><td>51.2</td></tr><tr><td>Proline</td><td>104.1</td><td>48.4</td><td>48.9</td><td>85.0</td><td>52.2</td><td>38.6</td></tr><tr><td>Lysine/arginin</td><td>2.33</td><td>0.66</td><td>0.59</td><td>0.61</td><td>0.60</td><td>0.59</td></tr><tr><td>Methionin/glycine</td><td>1.51</td><td>0.29</td><td>0.33</td><td>0.27</td><td>0.33</td><td>0.35</td></tr></table>
729db7836681546f5eb54355b5e10c0495ab413fc39b579ea18a1a3a3808602e.png
simple
<table><tr><td>Attributes</td><td>Levels</td></tr><tr><td>Cervical cancer risk</td><td>0, 2, 4 in 1,000</td></tr><tr><td>Genital wart risk</td><td>0, 50, 100 in 1,000</td></tr><tr><td>Common side effect e.g. mild fever, little pain</td><td>2, 6, 10, 14 in 100</td></tr><tr><td>Costs for 3 doses of HPV vaccine<sup>a</sup></td><td>0 Baht, 5,000 Baht, 10,000 Baht</td></tr></table>
93de3fd043f0d81f86ea8bab08c183cc8bde12ac8f05bc5c89944980a6a8c74b.png
complex
<table><tr><td>Laparoscopic surgery</td><td>Preoperative intraabdominal adhesions evaluation scores</td><td>Success rate</td><td>&#967;<sup>2</sup></td><td><i>P</i> value</td><td>RR</td></tr><tr><td rowspan="2">LC (<i>n</i> = 118)</td><td>&#8804; 3 points, <i>n</i> = 62</td><td>96.8%(60/62)</td><td>59.70</td><td>0.001</td><td>3.38<sup>a</sup></td></tr><tr><td>&gt;3 points, <i>n</i> = 56</td><td>28.6%(16/56)</td><td></td><td></td><td></td></tr><tr><td rowspan="2">LCBDE+LC (<i>n</i> = 171)</td><td>&#8804; 3 points, <i>n</i> = 59</td><td>84.7%(50/59)</td><td>53.41</td><td>0.001</td><td>3.27<sup>b</sup></td></tr><tr><td>&gt;3 points, <i>n</i> = 112</td><td>25.9%(29/112)</td><td></td><td></td><td></td></tr></table>
4242899af14acd3ceb1b9c9619554926c3272493a68523eaab84ae3ae6c1f008.png
complex
<table><tr><td>Variable</td><td>No. (%)</td></tr><tr><td colspan="2">Age at admission (days)</td></tr><tr><td> 21&#8211;90</td><td>8,168 (42.7)</td></tr><tr><td> 91&#8211;180</td><td>5,819 (30.5)</td></tr><tr><td> 181&#8211;270</td><td>3,196 (16.7)</td></tr><tr><td> 271&#8211;365</td><td>1,926 (10.1)</td></tr><tr><td colspan="2">Gestation (weeks)</td></tr><tr><td> 37 1/7&#8211;44</td><td>16,049 (84.0)</td></tr><tr><td> 34 1/7&#8211;37</td><td>2,035 (10.7)</td></tr><tr><td> 29 1/7&#8211;34</td><td>789 (4.1)</td></tr><tr><td> 25&#8211;29</td><td>236 (1.2)</td></tr><tr><td colspan="2">Sex</td></tr><tr><td> Male</td><td>11,277 (59.7)</td></tr><tr><td> Female</td><td>7,832 (40.3)</td></tr><tr><td colspan="2">Ethnicity</td></tr><tr><td> Hispanic</td><td>12,373 (64.8)</td></tr><tr><td> Non-Hispanic</td><td>6,393 (33.5)</td></tr><tr><td> Unknown</td><td>343 (1.7)</td></tr><tr><td colspan="2">Recorded respiratory/cardiac conditions of newborn</td></tr><tr><td> Respiratory distress syndrome</td><td>609 (3.2)</td></tr><tr><td> Bronchopulmonary dysplasia</td><td>85 (0.4)</td></tr><tr><td> Pulmonary anomalies</td><td>63 (0.3)</td></tr><tr><td> Any pulmonary disease</td><td>678 (3.6)</td></tr><tr><td> Cardiac anomalies</td><td>505 (2.6)</td></tr><tr><td colspan="2">Payment source</td></tr><tr><td> MediCal</td><td>11,673 (61.1)</td></tr><tr><td> Private insurance/HMO/PPO</td><td>6,670 (34.9)</td></tr><tr><td> Other</td><td>766 (4.0)</td></tr></table>
07ebf038a5fc0c906d19ef64e76e2927d2a44c940b80c005e61e663242eff513.png
complex
<table><tr><td></td><td colspan="4">Both sexes - all age groups</td><td colspan="4">Males - all age groups</td><td colspan="4">Females - all age groups</td></tr><tr><td>Year</td><td>Mid-year population</td><td>Total deaths from 4 NCDs<sup>a</sup></td><td>Death rate<sup>a</sup></td><td>ASMR</td><td>Mid-year population</td><td>Total deaths from 4 NCDs</td><td>Death rate</td><td>ASMR</td><td>Mid-year population</td><td>Total deaths from 4 NCDs</td><td>Death rate</td><td>ASMR</td></tr><tr><td>2001</td><td>18,797,000<sup>b</sup></td><td>41,808</td><td>2.2</td><td>2.1</td><td>9359,000<sup>b</sup></td><td>25,526</td><td>2.7</td><td>4.8</td><td>9438,000<sup>b</sup></td><td>16,282</td><td>1.7</td><td>3.7</td></tr><tr><td>2002</td><td>18,921,000</td><td>42,485</td><td>2.2</td><td>1.4</td><td>9,350,000</td><td>25,963</td><td>2.8</td><td>3.7</td><td>9,571,000</td><td>16,522</td><td>1.7</td><td>2.1</td></tr><tr><td>2003</td><td>19,173,083</td><td>45,350</td><td>2.4</td><td>1.5</td><td>9,475,000</td><td>27,358</td><td>2.9</td><td>3.9</td><td>9,698,083</td><td>17,992</td><td>1.8</td><td>2.3</td></tr><tr><td>2004</td><td>19,433,360</td><td>47,856</td><td>2.5</td><td>1.6</td><td>9,676,883</td><td>28,798</td><td>3.0</td><td>4.0</td><td>9,756,478</td><td>19,058</td><td>1.9</td><td>2.4</td></tr><tr><td>2005</td><td>19,643,474</td><td>49,013</td><td>2.5</td><td>1.6</td><td>9,782,497</td><td>29,488</td><td>3.0</td><td>4.0</td><td>9,860,977</td><td>19,525</td><td>1.9</td><td>2.4</td></tr><tr><td>2009</td><td>20,476,000</td><td>60,880</td><td>3.0</td><td>1.8</td><td>10,174,000</td><td>34,830</td><td>3.4</td><td>4.4</td><td>10,302,000</td><td>26,050</td><td>2.5</td><td>3.0</td></tr><tr><td>2010</td><td>20,675,000</td><td>62,565</td><td>3.0</td><td>1.8</td><td>10,273,000</td><td>35,584</td><td>3.5</td><td>4.4</td><td>10,402,000</td><td>26,981</td><td>2.6</td><td>3.0</td></tr></table>
7df01a1e4abb474b7dbbf4edde09d167e029e3bc23eaa3bac361f71e34c94dde.png
simple
<table><tr><td>Procedure</td><td>Percent Agreeing quite or very important.</td></tr><tr><td>ACLS/CPR</td><td>91</td></tr><tr><td>Central Venous Catheter Insertion</td><td>93</td></tr><tr><td>Paracentesis</td><td>90</td></tr><tr><td>Endotracheal Intubation</td><td>89</td></tr><tr><td>Lumbar Puncture</td><td>89</td></tr><tr><td>Thoracentesis</td><td>87</td></tr><tr><td>Arterial access and blood gases</td><td>82</td></tr><tr><td>Ambulatory ECG</td><td>79</td></tr><tr><td>Cardioversion</td><td>77</td></tr><tr><td>Exercise Stress Testing</td><td>77</td></tr><tr><td>Hemodynamic Monitoring</td><td>76</td></tr><tr><td>Temporary Pacemaker Insertion</td><td>75</td></tr><tr><td>Mechanical Ventilation</td><td>75</td></tr><tr><td>Transthoracic Pacing</td><td>71</td></tr><tr><td>Arthrocentesis</td><td>70</td></tr><tr><td>Bone Marrow Aspiration and Biopsy</td><td>60</td></tr><tr><td>Chest Tube Insertion</td><td>58</td></tr><tr><td>Venipuncture</td><td>50</td></tr></table>
9b369a7fbd98b4669b7123daa15a745ec1cf8f6cb29417cc5bdc3a28ed259821.png
complex
<table><tr><td>Variable</td><td colspan="2">Frequency in complete baseline sample</td><td colspan="2">Frequency in complete 1-year follow-up sample</td><td colspan="2">Frequency at 1-year follow-up among those who had valid MVPA and travel mode data</td></tr><tr><td> </td><td colspan="2">N (%)</td><td colspan="2">N (%)</td><td colspan="2">N (%)</td></tr><tr><td>Sex</td><td colspan="2">n=2064</td><td colspan="2">n=913</td><td colspan="2">n=812</td></tr><tr><td>Boy</td><td>926</td><td>(45)</td><td>374</td><td>(41)</td><td>333</td><td>(41)</td></tr><tr><td>Girl</td><td>1,138</td><td>(55)</td><td>539</td><td>(59)</td><td>479</td><td>(59)</td></tr><tr><td>Ethnicity</td><td colspan="2">n=1914</td><td colspan="2">n=885</td><td colspan="2">n=794</td></tr><tr><td>White</td><td>1841</td><td>(96)</td><td>857</td><td>(97)</td><td>770</td><td>(97)</td></tr><tr><td>Other</td><td>73</td><td>(4)</td><td>28</td><td>(3)</td><td>24</td><td>(3)</td></tr><tr><td>Urban/rural status</td><td colspan="2">n=2023</td><td colspan="2">n=902</td><td colspan="2">n=802</td></tr><tr><td>Hamlet and isolated dwelling</td><td>142</td><td>(7)</td><td>73</td><td>(8)</td><td>67</td><td>(8)</td></tr><tr><td>Village</td><td>506</td><td>(25)</td><td>248</td><td>(28)</td><td>219</td><td>(27)</td></tr><tr><td>Town and fringe</td><td>575</td><td>(28)</td><td>275</td><td>(30)</td><td>244</td><td>(30)</td></tr><tr><td>Urban &gt;10 k</td><td>800</td><td>(40)</td><td>306</td><td>(34)</td><td>272</td><td>(34)</td></tr><tr><td>Parent education status</td><td colspan="2">n=1882</td><td colspan="2">n=877</td><td colspan="2">n=786</td></tr><tr><td>None</td><td>140</td><td>(7)</td><td>53</td><td>(6)</td><td>45</td><td>(6)</td></tr><tr><td>GCSE or equivalent</td><td>963</td><td>(51)</td><td>454</td><td>(52)</td><td>405</td><td>(51)</td></tr><tr><td>A-levels or equivalent</td><td>468</td><td>(25)</td><td>204</td><td>(23)</td><td>186</td><td>(24)</td></tr><tr><td>Degree or postgraduate degree</td><td>311</td><td>(17)</td><td>166</td><td>(19)</td><td>150</td><td>(19)</td></tr><tr><td>Travel mode</td><td colspan="2">n=2053</td><td colspan="2">n=913</td><td colspan="2">n=812</td></tr><tr><td>Bicycle</td><td>189</td><td>(9)</td><td>73</td><td>(8)</td><td>59</td><td>(7)</td></tr><tr><td>Bus or train</td><td>127</td><td>(6)</td><td>62</td><td>(7)</td><td>57</td><td>(7)</td></tr><tr><td>Car</td><td>923</td><td>(45)</td><td>357</td><td>(39)</td><td>322</td><td>(40)</td></tr><tr><td>Foot</td><td>814</td><td>(40)</td><td>421</td><td>(46)</td><td>374</td><td>(46)</td></tr></table>
4989727fe84c4d34f5adc5cf15e8381387d9b23cf19d187a314db8cf2e28b135.png
simple
<table><tr><td>PATIENT</td><td>SIZE AND POSITION OF CHROMOSOME 15 DELETION</td><td>ADDITIONAL CHROMOSOME ABERRATION</td><td>SEX</td><td>CLEFT PALATE</td><td>HEART DEFECT</td><td>DEVELOPMENTAL DELAY</td><td>FACIES ANOMALIES</td><td>ADDITIONAL ABNORMALITIES</td></tr><tr><td>Present case</td><td>del(15)(q14) (submicroscopic, 1,6 Mb)</td><td>t(1;13)(p31.1;q13),t(3;19)(p23;p12), t(9;15)(p23;q14),t(14;18)(q22;p11.23)</td><td>M</td><td>+</td><td>-</td><td>+</td><td>+</td><td>-</td></tr><tr><td>Chen et al., 2008</td><td>del(15)(q14) (submicroscopic, 5,6 Mb)</td><td>-</td><td>M</td><td>+</td><td>VSD</td><td>+</td><td>+</td><td>Epilepsy; speech and language disorder</td></tr><tr><td>Brunetti-Pierri et al., 2008 case 1</td><td>del(15)(q14) (submicroscopic, 4,2 Mb)</td><td>-</td><td>M</td><td>+ (Bifid uvula)</td><td>+</td><td>+</td><td>+</td><td>Bilateral inguinal hernias, autistic spectrum behavior</td></tr><tr><td>Brunetti-Pierri et al., 2008 case 2</td><td>del(15)(q13-q14) (submicroscopic, 8,9 Mb)</td><td>-</td><td>F</td><td>-</td><td>+</td><td>+</td><td>+</td><td>Hypotonia,feeding difficulties</td></tr><tr><td>Erdogan et al., 2007</td><td>del(15)(q14) (submicroscopic, 5,3 Mb)</td><td>-</td><td>F</td><td>+</td><td>ASD</td><td>+</td><td>+</td><td>Low-set ears, OFC 3rd percentile</td></tr><tr><td>Galan et al., 1991</td><td>del(15)(q12-q14)</td><td>-</td><td>M</td><td>+ (Bifid uvula)</td><td>Pulmonary valve stenosis</td><td>+</td><td>+</td><td>Right cryptorchidism, hearing deficency</td></tr><tr><td>Tonk et al., 1995</td><td>del(15)(q12-q14)</td><td>-</td><td>M</td><td>+</td><td>VSD, PDA, ischemic cardiomyopathy</td><td>+</td><td>+</td><td>Large fontanelles, hearing deficency</td></tr><tr><td>Autio et al., 1988</td><td>del(15)(q13-q15)</td><td>-</td><td>M</td><td>+</td><td>ASD</td><td>+</td><td>+</td><td>Cryptorchidism, kidney defect, corpus callosum agenesis</td></tr><tr><td>Herva and Vuorinen, 1980</td><td>del(15)(q12-q14)</td><td>Mosaic with 46, XY</td><td>M</td><td>-</td><td>VSD, hypoplastic pulmonary artery, atretic tricuspid valve</td><td>Died at 7 days</td><td>+</td><td>Cryptorchidism</td></tr><tr><td>Pauli et al., 1983</td><td>del(15)(pter-q15)</td><td>del(11)(q25-qter)</td><td>M</td><td>+ (Bifid uvula)</td><td>VSD</td><td>+</td><td>+</td><td>Cryptorchidism, unilateral renal ptosis</td></tr><tr><td>Windpassinger et al., 2003</td><td>del(15)(pter-q14)</td><td>del(3)(qter)</td><td>M</td><td>-</td><td>Persistent foramen ovale, PDA</td><td>+</td><td>+</td><td>Cryptorchidism, clubfeet, strabismus</td></tr><tr><td>Kucerova et al., 1979</td><td>del(15)(pter-q15)</td><td>del(3)(pter-p25)</td><td>M</td><td>-</td><td>-</td><td>+</td><td>+</td><td>Cryptorchidism</td></tr><tr><td>Duckett and Roberts, 1981</td><td>del(15)(pter-q14or15)</td><td>Trisomy 13(pter-q32 or 33)</td><td>F</td><td>+ (Bifid uvula)</td><td>VSD, ASD, PDA, transposition of great vessels</td><td>Died at 14 hr</td><td>+</td><td>Microphthalmia, tracheo-oesophageal fistula</td></tr><tr><td>Ming et al., 1977</td><td>del(15)(pter-q21)</td><td>del(6)(q27-qter)</td><td>F</td><td>+</td><td>-</td><td>Died at 3 days</td><td>+</td><td>Microphthalmia</td></tr><tr><td>Schwartz et al., 1985</td><td>del(15)(pter-q14)</td><td>del(22)(pter-q13.2)</td><td>M</td><td>-</td><td>Coarctation of aorta, PDA</td><td>+</td><td>+</td><td>Cleft alveolar ridge, hydronephrosis</td></tr><tr><td>Matsumura et al., 2003</td><td>del(15)(pter-q14)</td><td>Trisomy 22q</td><td>M</td><td>-</td><td>PDA</td><td>+</td><td>+</td><td>Renal failure, cryptorchidism</td></tr></table>
401b0e8d2672dfd6f5d8939bf8fa2a3f10df48aa3cc16127258fb5f6a9bbd286.png
simple
<table><tr><td></td><td>Treatment-nai&#776;ve (<i>n</i> = 42)</td><td>Previously treated (<i>n</i> = 270)</td><td>All(<i>N</i> = 312)</td></tr><tr><td>All adverse events, <i>n</i> (%)</td><td>18 (42.9)</td><td>70 (25.9)</td><td>88 (28.2)</td></tr><tr><td> Treatment-related, <i>n</i> (%)</td><td>11 (26.2)</td><td>37 (13.7)</td><td>48 (15.4)</td></tr><tr><td>Ocular<sup>a</sup></td><td>11 (26.2)</td><td>37 (13.7)</td><td>48 (15.4)</td></tr><tr><td>Ocular hyperemia</td><td>6 (14.3)</td><td>12 (4.4)</td><td>18 (5.8)</td></tr><tr><td>Dark circles under the eyes</td><td>0</td><td>6 (2.2)</td><td>6 (1.9)</td></tr><tr><td>Eye pruritus</td><td>1 (2.4)</td><td>4 (1.5)</td><td>5 (1.6)</td></tr><tr><td>Decreased lacrimation</td><td>1 (2.4)</td><td>4 (1.5)</td><td>5 (1.6)</td></tr><tr><td>Eye allergy</td><td>1 (2.4)</td><td>2 (0.7)</td><td>3 (1.0)</td></tr><tr><td>Ocular discomfort</td><td>1 (2.4)</td><td>1 (0.4)</td><td>2 (0.6)</td></tr><tr><td>Eye pain</td><td>1 (2.4)</td><td>0</td><td>1 (0.3)</td></tr><tr><td>Serious</td><td>0</td><td>0</td><td>0</td></tr><tr><td> Leading to discontinuation, <i>n</i> (%)</td><td>6 (14.3)</td><td>15 (5.6)</td><td>21 (6.7)</td></tr></table>
18005b4b8a495e15c72f745f46a1c23d40fb69bf774ef50a84a71136210844f7.png
simple
<table><tr><td></td><td>Comfortable</td><td>Natural</td><td>Soothed</td></tr><tr><td>Forest area</td><td>4.00 &#177; 0.60</td><td>4.63 &#177; 0.63</td><td>3.63 &#177; 0.91</td></tr><tr><td>Urban area</td><td>0.13 &#177; 0.40</td><td>&#8722;2.00 &#177; 0.53</td><td>0.00 &#177; 0.53</td></tr><tr><td><i>p</i>-value</td><td>0.006 **</td><td>0.006 **</td><td>0.010 *</td></tr></table>
581952584c8237374dc8872c0495181874dc7ac16bf5b53b44308e5c5d58b9f2.png
simple
<table><tr><td>Non-financial COI terms</td><td>n (%)</td></tr><tr><td>Personal relationship</td><td>29 (54)</td></tr><tr><td>Other</td><td>21 (39)</td></tr><tr><td>Non-financial COI</td><td>18 (33)</td></tr><tr><td>Professional</td><td>15 (28)</td></tr><tr><td>Academic competition</td><td>12 (22)</td></tr><tr><td>Personal opinion</td><td>10 (19)</td></tr><tr><td>Academic</td><td>9 (17)</td></tr><tr><td>Intellectual passion</td><td>9 (17)</td></tr><tr><td>Religious views</td><td>8 (15)</td></tr><tr><td>Political</td><td>8 (15)</td></tr><tr><td>Personal</td><td>8 (15)</td></tr><tr><td>Intellectual</td><td>7 (13)</td></tr><tr><td>Ideological</td><td>7 (13)</td></tr><tr><td>Competing loyalties</td><td>5 (9)</td></tr><tr><td>Advocacy groups/institutional advocacy</td><td>5 (9)</td></tr><tr><td>Institutional</td><td>3 (6)</td></tr><tr><td>Legal relationship</td><td>3 (6)</td></tr><tr><td>Governmental</td><td>1 (2)</td></tr></table>
ad1c019ab5436953011527d5e43270b04a4f668b2bbac18f4805f4879451dc1a.png
complex
<table><tr><td rowspan="2">Polymorphisms</td><td rowspan="2">Subgroup</td><td colspan="2">Heterogeneity</td><td colspan="3">Test of association</td></tr><tr><td>OR (95% CI)</td><td><i>P</i> Value</td><td>Model</td><td>I2 (%)</td><td><i>P</i> Value</td></tr><tr><td>Donor</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>rs1800469</td><td>Overall</td><td>0.56 (0.32-0.98)</td><td>0.04</td><td>F</td><td>10</td><td>0.34</td></tr><tr><td></td><td>Caucasian</td><td>0.95 (0.40-2.25)</td><td>0.12</td><td>F</td><td>0</td><td>0.50</td></tr><tr><td></td><td>Asian</td><td>0.38 (0.18-0.80)</td><td>0.01</td><td>F</td><td>0</td><td>0.52</td></tr><tr><td></td><td>HLA-matched</td><td>0.23 (0.04-1.32)</td><td>0.10</td><td>F</td><td>0</td><td>0.80</td></tr><tr><td>rs1800470</td><td>Overall</td><td>0.65 (0.46-0.94)</td><td>0.02</td><td>F</td><td>0</td><td>0.47</td></tr><tr><td></td><td>Caucasian</td><td>0.70 (0.47-1.06)</td><td>0.09</td><td>F</td><td>0</td><td>0.37</td></tr><tr><td>Recipient</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>rs1800469</td><td>Overall</td><td>0.73 (0.63-0.85)</td><td>&lt;0.0001</td><td>F</td><td>7</td><td>0.37</td></tr><tr><td></td><td>Caucasian</td><td>0.51 (0.22-1.18)</td><td>0.12</td><td>F</td><td>0</td><td>0.78</td></tr><tr><td></td><td>Asian</td><td>0.74 (0.63-0.86)</td><td>0.0001</td><td>F</td><td>42</td><td>0.18</td></tr><tr><td></td><td>HLA-matched</td><td>0.32 (0.08-1.27)</td><td>0.11</td><td>F</td><td>0</td><td>0.99</td></tr><tr><td>rs1800470</td><td>Overall</td><td>1.28 (0.81-2.01)</td><td>0.29</td><td>F</td><td>0</td><td>0.72</td></tr><tr><td></td><td>Caucasian</td><td>1.32 (0.80-2.17)</td><td>0.28</td><td>F</td><td>0</td><td>0.44</td></tr></table>
7adbdfaed1d8b25b9c55d817894f68afb26ad31a2dad9e218b1133e961324aa3.png
complex
<table><tr><td>Variables</td><td colspan="2">Management outcomes</td><td>COR (95 % CI)</td><td>AOR (95 % CI)</td><td><i>P</i>-value</td></tr><tr><td></td><td>Favorable [N]</td><td>Unfavorable [N]</td><td></td><td></td><td></td></tr><tr><td colspan="6">Age</td></tr><tr><td> &lt;14 years</td><td>52</td><td>8</td><td>0.287(0.11&#8211;0.76)</td><td>0.99(0.11&#8211;2.13)</td><td>0.998</td></tr><tr><td> 14&#8211;24 years</td><td>21</td><td>7</td><td>0.62(0.21&#8211;1.79)</td><td>0.59(0.109&#8211;3.21)</td><td>0.543</td></tr><tr><td> 25&#8211;34 years</td><td>32</td><td>12</td><td>0.70(0.28&#8211;1.74)</td><td>0.86(0.23&#8211;3.17)</td><td>0.828</td></tr><tr><td> 35&#8211;44 years</td><td>27</td><td>5</td><td>0.34(0.11&#8211;1.08)</td><td>0.35(0.08&#8211;1.48)</td><td>0.158</td></tr><tr><td> 45&#8211;55 years</td><td>45</td><td>9</td><td>0.64(0.242&#8211;1.73)</td><td>0.28(0.07&#8211;1.08)</td><td>0.066</td></tr><tr><td> &gt;55 years</td><td>28</td><td>15</td><td>1</td><td>1</td><td></td></tr><tr><td colspan="6">Occupation</td></tr><tr><td> Farmer</td><td>64</td><td>26</td><td>1</td><td>1</td><td></td></tr><tr><td> Merchant</td><td>18</td><td>7</td><td>0.95(0.35&#8211;2.56)</td><td>1.93(0.56&#8211;6.56)</td><td>0.291</td></tr><tr><td> House wife</td><td>14</td><td>13</td><td>2.28(0.94&#8211;5.52)</td><td>3.28(0.97&#8211;11.11)</td><td>0.056</td></tr><tr><td> Student</td><td>18</td><td>1</td><td>0.14(0.02&#8211;1.07)</td><td>0.97(1.87&#8211;2.61)</td><td>0.998</td></tr><tr><td> Governmental employer</td><td>23</td><td>2</td><td>0.21(0.05&#8211;0.97)</td><td>0.14(0.02&#8211;1.09)</td><td>0.061</td></tr><tr><td colspan="6">Duration of illness</td></tr><tr><td> &#8804;24 h</td><td>101</td><td>18</td><td>0.39(0.21&#8211;0.74)</td><td>0.49(0.25&#8211;0.97)</td><td>0.014*</td></tr><tr><td> &gt;24h</td><td>85</td><td>38</td><td>1</td><td>1</td><td></td></tr><tr><td colspan="6">Intra-operative finding</td></tr><tr><td> Gangrenous SBV</td><td>9</td><td>9</td><td>1</td><td>1</td><td></td></tr><tr><td> Gangrenous SV</td><td>8</td><td>10</td><td>1.25(0.33&#8211;4.63)</td><td>1.95(0.34&#8211;10.95)</td><td>0.447</td></tr><tr><td> Adhesion &amp; bands</td><td>28</td><td>14</td><td>0.50(0.16&#8211;1.54)</td><td>5.90(0.72&#8211;4.80)</td><td>0.098</td></tr><tr><td> Viable SBV</td><td>29</td><td>2</td><td>0.07(0.01&#8211;0.37)</td><td>0.08(0.01&#8211;0.95)</td><td>0.046*</td></tr><tr><td> Viable SV</td><td>34</td><td>7</td><td>0.21(0.06&#8211;0.71)</td><td>0.17(0.03&#8211;0.88)</td><td>0.035*</td></tr><tr><td> Intussusceptions</td><td>49</td><td>7</td><td>0.14(0.04&#8211;0.48)</td><td>0.49(0.07&#8211;3.22)</td><td>0.460</td></tr><tr><td> Colonic Cancer</td><td>8</td><td>4</td><td>0.50(0.11&#8211;2.27)</td><td>0.27(0.04&#8211;1.64)</td><td>0.157</td></tr><tr><td> Hernia</td><td>8</td><td>1</td><td>0.12(0.01&#8211;1.216)</td><td>0.12(0.01&#8211;1.65)</td><td>0.114</td></tr><tr><td> Illiosigmoidal knot</td><td>4</td><td>1</td><td>0.25(0.023&#8211;2.69)</td><td>1.40(0.04&#8211;43.13)</td><td>0.844</td></tr><tr><td colspan="6">Intra-operative procedure done</td></tr><tr><td colspan="3">Resection&amp; Anastomosis</td><td></td><td></td><td></td></tr><tr><td> Yes</td><td>63</td><td>35</td><td>3.02(1.61&#8211;5.69)</td><td>3.05(1.04&#8211;8.94)</td><td>0.041*</td></tr><tr><td> No</td><td>109</td><td>21</td><td>1</td><td>1</td><td></td></tr><tr><td colspan="6">Adhesion release</td></tr><tr><td> Yes</td><td>33</td><td>9</td><td>0.83(0.37&#8211;1.86)</td><td>0.09(0.01&#8211;0.69)</td><td>0.020*</td></tr><tr><td> No</td><td>139</td><td>47</td><td>1</td><td>1</td><td></td></tr><tr><td colspan="6">Manual Reduction</td></tr><tr><td> Yes</td><td>41</td><td>2</td><td>0.12(0.02&#8211;0.52)</td><td>0.15(0.03&#8211;0.68)</td><td>0.014*</td></tr><tr><td> No</td><td>131</td><td>54</td><td>1</td><td>1</td><td></td></tr><tr><td colspan="6">Hospital stay</td></tr><tr><td> &#8804; 7 days</td><td>117</td><td>3</td><td>0.03(0.01&#8211;0.11)</td><td>0.05(0.01&#8211;0.16)</td><td>0.001*</td></tr><tr><td> &gt;7 days</td><td>69</td><td>53</td><td>1</td><td>1</td><td></td></tr></table>
5f98e8a4c8968431d87889c3d7ad3dad1cb1362a00d68fcc7b14ee53a59b5a22.png
simple
<table><tr><td>Lambertian Scattering</td><td>Epidermis</td><td>Dermis</td><td>Veins</td><td>Phalanx</td><td>Proximal Phalanx</td><td>Digital Arteries</td></tr><tr><td>Reflectance</td><td>32%</td><td>26%</td><td>34%</td><td>47%</td><td>26%</td><td>53%</td></tr><tr><td>Transmittance</td><td>68%</td><td>74%</td><td>66%</td><td>53%</td><td>74%</td><td>47%</td></tr></table>
dd5e4418b36441af9287c20608dd1fc8bcd50f7d1ab2ee6bf18ed8b5fd52d595.png
complex
<table><tr><td rowspan="3"></td><td colspan="2">Mazabuka</td><td colspan="2">Kafue</td><td></td></tr><tr><td colspan="2">(Total = 273)</td><td colspan="2">(Total = 361)</td><td></td></tr><tr><td>%</td><td>(n)</td><td>%</td><td>(n)</td><td>p-value</td></tr><tr><td colspan="6">Sex of head of family</td></tr><tr><td>Male</td><td>84</td><td>(226)</td><td>92</td><td>(327)</td><td>0.003</td></tr><tr><td>Females</td><td>16</td><td>(43)</td><td>8</td><td>(30)</td><td></td></tr><tr><td colspan="6">Age of caretaker (years)</td></tr><tr><td>&lt;19</td><td>15</td><td>(41)</td><td>14</td><td>(51)</td><td>0.96</td></tr><tr><td>20-29</td><td>59</td><td>(161)</td><td>59</td><td>(212)</td><td></td></tr><tr><td>30-39</td><td>22</td><td>(60)</td><td>23</td><td>(83)</td><td></td></tr><tr><td>40-59</td><td>3.3</td><td>(9)</td><td>4</td><td>(14)</td><td></td></tr><tr><td colspan="2">Caretaker-child relationship</td><td></td><td></td><td></td><td></td></tr><tr><td>Mother</td><td>98.2</td><td>(268)</td><td>99</td><td>(357)</td><td>0.368</td></tr><tr><td>Other</td><td>1.8</td><td>(5)</td><td>1</td><td>(4)</td><td></td></tr><tr><td>Marital status</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Married</td><td>81.8</td><td>(220)</td><td>85</td><td>(308)</td><td>0.265</td></tr><tr><td>Widowed</td><td>4.1</td><td>(11)</td><td>2</td><td>(8)</td><td></td></tr><tr><td>Divorced</td><td>3</td><td>(8)</td><td>2</td><td>(8)</td><td></td></tr><tr><td>Separated</td><td>1.1</td><td>(3)</td><td>2</td><td>(8)</td><td></td></tr><tr><td>Single</td><td>10</td><td>(27)</td><td>7</td><td>(25)</td><td></td></tr><tr><td colspan="2">Educational level-caretaker</td><td></td><td></td><td></td><td></td></tr><tr><td>None</td><td>5.2</td><td>(14)</td><td>11</td><td>(38)</td><td>&lt;0.001</td></tr><tr><td>Primary</td><td>50.6</td><td>(137)</td><td>67</td><td>(239)</td><td></td></tr><tr><td>Secondary</td><td>38</td><td>(103)</td><td>23</td><td>(81)</td><td></td></tr><tr><td>Tertiary</td><td>6.3</td><td>(17)</td><td>0</td><td>(1)</td><td></td></tr><tr><td colspan="2">Age distribution of the children</td><td></td><td></td><td></td><td></td></tr><tr><td>&lt;6 months</td><td>28</td><td>(76)</td><td>31</td><td>(111)</td><td></td></tr><tr><td>6 &#8211; 11 months</td><td>26.2</td><td>(71)</td><td>30</td><td>(107)</td><td></td></tr><tr><td>&gt;12 months</td><td>45.8</td><td>(124)</td><td>39</td><td>(140)</td><td></td></tr></table>
a5bba4ea19dc9ee08da9f58c0406a9d7bf30987e97961609ccbbcc8582277932.png
simple
<table><tr><td>Diagnosis</td><td>Number OFSO patients</td><td>First line OFSO</td><td>Salvage OFSO</td></tr><tr><td>Chronic frontal sinusitis</td><td>23</td><td>7/23 (30%)</td><td>16/23 (70%)</td></tr><tr><td>Frontal sinus mucocele</td><td>11</td><td>8/11 (72%)</td><td>3/11 (28%)</td></tr><tr><td>Total inflammatory frontal sinus disease patients</td><td>34</td><td>15/34 (44%)</td><td>19/34 (56%)</td></tr></table>
a0e583cc589d4cc9f669b02ac26780e76eaa228ba427d0314be07c647df5c723.png
simple
<table><tr><td><i>Systematic name or TIGR identifier</i></td><td><i>Description</i></td></tr><tr><td>Tc00.1047053506811.120</td><td>Hypothetical protein 1 <i>(HYPO1)</i></td></tr><tr><td>UP|Q9NIQ8 (Q9NIQ8)</td><td>Mucin-like protein</td></tr><tr><td>UP|Q72DX6 (Q72DX6)</td><td>Sensor histidine kinase</td></tr><tr><td>UP|Q25325 (Q25325)</td><td>Heat shock protein 70-related protein</td></tr><tr><td>UP|Q7TPK7 (Q7TPK7)</td><td>Ac2-048</td></tr><tr><td>UP|Q9XY95 (Q9XY95)</td><td>Neurotrophin</td></tr><tr><td>UP|H2A_TRYCR (P35066)</td><td>Histone H2A</td></tr><tr><td>UP|RL29_DROME (Q24154)</td><td>60S ribosomal protein L29 (L43)</td></tr><tr><td>UP|RS6_LEIMA (Q9NE83)</td><td>40S ribosomal protein S6</td></tr><tr><td>PDB|1II2_A.0|17942708|</td><td>1II2_A Chain A, Crystal Structure Of Phosphoenolpyruvate Carboxykinase (Pepck)</td></tr><tr><td>UP|O48239 (O48239)</td><td>Cytochrome b (Fragment)</td></tr><tr><td>gb|L22334.1|TRBS3RRBN</td><td>5.8S ribosomal RNA, internal transcribed spacers 1&#8211;7, and 28S ribosomal RNA</td></tr></table>
d21ee40170c9e4f27753082f401629709e6a4cb2246be257e4ec8841cbe7f9b5.png
simple
<table><tr><td>Attributes</td><td>Format</td></tr><tr><td>Date</td><td>MM/DD/YY</td></tr><tr><td>Time</td><td>(H) H:MM (military time)</td></tr><tr><td>Count</td><td>Number of cars measured for the previous five minutes</td></tr><tr><td>Beginning event time</td><td>HH:MM:SS (military)</td></tr><tr><td>Ending event time</td><td>HH:MM:SS (military)</td></tr><tr><td>Away team</td><td>&#8212;</td></tr><tr><td>Game attendance</td><td>&#8212;</td></tr><tr><td><i>W</i>/<i>L</i> score</td><td>&#8212;</td></tr></table>
ba64f62b8444aa40b9bc5d0219cd4f65acab74ffd899b71b95aea7fc6327e144.png
simple
<table><tr><td>Subject</td><td>Age</td><td>Weight</td><td>Height</td><td>BMI</td><td>FSH</td></tr><tr><td>No.</td><td>(y)</td><td>(kg)</td><td>(m)</td><td>(kg/m<sup>2</sup>)</td><td>(IU/L) </td></tr><tr><td>1</td><td>52</td><td>57.00</td><td>1.60</td><td>22.27</td><td>49.20</td></tr><tr><td>2</td><td>53</td><td>52.50</td><td>1.53</td><td>22.43</td><td>48.50</td></tr><tr><td>3</td><td>54</td><td>54.00</td><td>1.51</td><td>23.68</td><td>33.50</td></tr><tr><td>4</td><td>54</td><td>60.00</td><td>1.56</td><td>24.65</td><td>49.40</td></tr><tr><td>5</td><td>56</td><td>48.50</td><td>1.45</td><td>23.07</td><td>38.60</td></tr><tr><td>6</td><td>56</td><td>42.00</td><td>1.44</td><td>20.25</td><td>68.50</td></tr><tr><td>7</td><td>49</td><td>58.50</td><td>1.66</td><td>21.23</td><td>128.20</td></tr><tr><td>8</td><td>55</td><td>58.00</td><td>1.53</td><td>24.78</td><td>68.80</td></tr><tr><td>9*</td><td>57</td><td>48.50</td><td>1.50</td><td>21.56</td><td>101.00</td></tr><tr><td>10</td><td>62</td><td>60.50</td><td>1.60</td><td>23.63</td><td>53.33</td></tr><tr><td>11</td><td>59</td><td>49.00</td><td>1.51</td><td>21.50</td><td>40.79</td></tr><tr><td>12</td><td>62</td><td>48.00</td><td>1.42</td><td>23.81</td><td>63.49</td></tr><tr><td>Mean</td><td>55.75</td><td>53.04</td><td>1.53</td><td>22.74</td><td>61.94</td></tr><tr><td>SD</td><td>3.70</td><td>5.63</td><td>0.07</td><td>1.37</td><td>26.43</td></tr></table>
2bfb543a5772c0798e35b6a1c15374838aa7abcb97311d7984cecefb8c8a51ff.png
complex
<table><tr><td></td><td></td><td colspan="3">IE &gt;10%</td><td colspan="3">AI &gt;10%</td></tr><tr><td></td><td></td><td>Absent(<i>n </i>= 55)</td><td>Present(<i>n </i>= 14)</td><td><i>P</i></td><td>Absent(<i>n </i>= 48)</td><td>Present(<i>n </i>= 21)</td><td><i>P</i></td></tr><tr><td><i>Pathology</i></td><td>Restrictive</td><td>29 (53)</td><td>10 (71)</td><td>0.24</td><td>24 (50)</td><td>15 (71)</td><td>0.12</td></tr><tr><td></td><td>Obstructive</td><td>26 (47)</td><td>4 (29)</td><td></td><td>24 (50)</td><td>6 (29)</td><td></td></tr></table>
2cfca277967958ee7a9e4bec3ec0b3d9e5e80a315b7f55cc6218450303265f5b.png
complex
<table><tr><td></td><td colspan="2">Total population (R<sup>2</sup> = 0.69*)</td><td colspan="2">Type 1 (R<sup>2</sup> = 0.73*)</td><td colspan="2">Type 2 (R<sup>2</sup> = 0.66*)</td></tr><tr><td><i>Covariate</i></td><td><i>&#223;</i></td><td>p-<i>value</i></td><td><i>&#223;</i></td><td>p-<i>value</i></td><td><i>&#223;</i></td><td>p-<i>value</i></td></tr><tr><td>Systolic blood pressure (mmHg)</td><td>0.301</td><td>&lt; 0.001</td><td>0.442</td><td>&lt; 0.001</td><td>0.233</td><td>0.001</td></tr><tr><td>Low eGFR (ml/min/1.73 m2)</td><td>0.131</td><td>0.007</td><td>0.009</td><td>0.909</td><td>0.150</td><td>0.024</td></tr><tr><td>Low stress-corrected MWS (%)</td><td>0.239</td><td>&lt; 0.001</td><td>0.493</td><td>&lt; 0.001</td><td>0.156</td><td>0.017</td></tr><tr><td>Isovolumic relaxation time (ms)</td><td>0.170</td><td>0.001</td><td>0.180</td><td>0.041</td><td>0.155</td><td>0.016</td></tr><tr><td>LV mass/height<sup>2.7</sup></td><td>0.187</td><td>0.001</td><td>0.091</td><td>0.284</td><td>0.189</td><td>0.008</td></tr><tr><td>Circumferential end-systolic stress (dyne/cm<sup>2</sup>)</td><td>&#8211;0.584</td><td>&lt; 0.001</td><td>&#8211;0.682</td><td>&lt; 0.001</td><td>&#8211;0.602</td><td>&lt; 0.00</td></tr><tr><td>Male gender</td><td>0.083</td><td>0.065</td><td>&#8211;0.009</td><td>0.905</td><td>0.123</td><td>0.051</td></tr></table>
5ee45e2d29f375606048e0a98a7e0b40dc178e170a69112152fbe4421e5f9c4c.png
complex
<table><tr><td>Characteristic</td><td>Community level (n=32)</td><td>Patch level (n=62)</td></tr><tr><td>Communities in cattle corridor (percent)</td><td>59.7%</td><td>&#8211;</td></tr><tr><td colspan="3">Perceived patch condition (percent)</td></tr><tr><td> Bad</td><td></td><td>9.80%</td></tr><tr><td> Average</td><td></td><td>42.70%</td></tr><tr><td> Good</td><td></td><td>47.50%</td></tr><tr><td>Patch usage by community members (percent)</td><td>40%</td><td>30%</td></tr><tr><td>Area of communal grazing land (hectares)*</td><td>24</td><td>6</td></tr><tr><td>Grazing lands with use restrictions (percent)*</td><td></td><td>8.06%</td></tr></table>
9b28f2a05374b84cc73d1557e1899f5ebea993fa8ff6b4f708dfd52778fdb4d8.png
complex
<table><tr><td rowspan="2">Bentonite symbol</td><td colspan="5">Grain size distribution, %</td></tr><tr><td>0.5&#8211;1 &#956;m</td><td>1&#8211;5 &#956;m</td><td>5&#8211;10 &#956;m</td><td>10&#8211;50 &#956;m</td><td>50&#8211;100 &#956;m</td></tr><tr><td>B</td><td>4.1</td><td>13.4</td><td>20.4</td><td>30.6</td><td>31.5</td></tr><tr><td>BP1</td><td>3.5</td><td>10.6</td><td>18.3</td><td>33.2</td><td>34.4</td></tr><tr><td>BP2</td><td>2.6</td><td>9.3</td><td>17.4</td><td>31.8</td><td>38.9</td></tr></table>
81e9b56b1f886094173f24009afa4f2fa93d98dd59023f43cd620d20616221ab.png
simple
<table><tr><td>Practice Visitor as:</td><td>Assessor</td><td>Expert/Educator</td><td>Facilitator</td><td>Interpreter</td></tr><tr><td>Whose role is:</td><td>External assessment against standards.</td><td>Knowledge and skill transfer.</td><td>Consensus building to achieve group view.</td><td>Helping practice teams decide what and how they would like to improve.</td></tr><tr><td>Based upon:</td><td>Historical competence.</td><td>Best practice.</td><td>A template for process.</td><td>Practice based issues.</td></tr><tr><td>Controlling:</td><td>Outcome.</td><td>Outcome and process.</td><td>Process.</td><td>Neither outcome nor process, simply participation.</td></tr><tr><td>Theoretical basis:</td><td>Systems.</td><td>Systems and organisational development.</td><td>Organisational development.</td><td>Complexity.</td></tr><tr><td>Examples:</td><td>Accreditation systems.</td><td>Outreach project to set up systems for chronic disease management.</td><td>Maturity Matrix.</td><td>Action research.</td></tr></table>
6a2b8ccc0981227e59eb29bc49c9270d1a1c102240357af1270408f045b5b28c.png
simple
<table><tr><td>Parameters</td><td>overall(<i>n</i> = 1447)</td><td>cf-PWV &#8805;12(<i>n</i> = 571)</td><td>cf- PWV &lt; 12(<i>n</i> = 876)</td><td><i>P</i> value</td></tr><tr><td>Age (year)</td><td>61.30 &#177; 11.4</td><td>65.59 &#177; 10.9</td><td>52.46 &#177; 11.5</td><td>&lt;0.001</td></tr><tr><td>Male [n (%)]</td><td>601(41.53)</td><td>270(47.28)</td><td>331(37.78)</td><td>&lt;0.001</td></tr><tr><td>BMI</td><td>25.41 &#177; 3.32</td><td>25.41 &#177; 3.28</td><td>25.26 &#177; 4.17</td><td>0.583</td></tr><tr><td>Systolic BP(mmHg)</td><td>128.7 &#177; 17.7</td><td>135.38 &#177; 18.37</td><td>124.37 &#177; 15.93</td><td>&lt;0.001</td></tr><tr><td>Diastolic BP(mmHg)</td><td>77.11 &#177; 10.26</td><td>77.00 &#177; 10.92</td><td>77.18 &#177; 9.82</td><td>0.762</td></tr><tr><td>Fasting glucose (mmol/L)</td><td>5.39 &#177; 1.65</td><td>5.63 &#177; 1.87</td><td>5.21 &#177; 1.35</td><td>&lt;0.001</td></tr><tr><td>2-HpBG(mmol/L)</td><td>6.96 &#177; 1.11</td><td>7.71 &#177; 1.10</td><td>6.47 &#177; 1.23</td><td>&lt;0.001</td></tr><tr><td>Triglyceride(mmol/L)</td><td>1.80 &#177; 1.24</td><td>1.92 &#177; 1.27</td><td>1.74 &#177; 1.24</td><td>0.017</td></tr><tr><td>Total cholesterol (mmol/L)</td><td>5.01 &#177; 0.93</td><td>5.02 &#177; 0.97</td><td>5.01 &#177; 0.89</td><td>0.845</td></tr><tr><td>HDL2-C (mg/dL)</td><td>29.85 &#177; 9.13</td><td>29.69 &#177; 9.44</td><td>30.05 &#177; 9.08</td><td>0.593</td></tr><tr><td>HDL3-C (mg/dL)</td><td>20.98 &#177; 4.22</td><td>20.62 &#177; 4.12</td><td>21.42 &#177; 4.38</td><td>0.006</td></tr><tr><td>HDL cholesterol (mmol/L)</td><td>1.34 &#177; 0.42</td><td>1.30 &#177; 0.43</td><td>1.37 &#177; 0.41</td><td>0.247</td></tr><tr><td>LDL cholesterol (mmol/L)</td><td>2.91 &#177; 0.71</td><td>2.96 &#177; 0.73</td><td>2.87 &#177; 0.69</td><td>0.030</td></tr><tr><td>Waist-hip ratio</td><td>0.87 &#177; 0.05</td><td>0.88 &#177; 0.06</td><td>0.86 &#177; 0.0.07</td><td>&lt;0.001</td></tr><tr><td>eGFR (ml/min)</td><td>94.2 &#177; 14.3</td><td>88.18 &#177; 14.19</td><td>98.63 &#177; 12.45</td><td>&lt;0.001</td></tr><tr><td>Current smoking [n (%)]</td><td>380(26.26)</td><td>175(30.65)</td><td>205(23.40)</td><td>&lt;0.001</td></tr><tr><td>Hypertension [n (%)]</td><td>755(52.17)</td><td>418(73.20)</td><td>337(38.47)</td><td>&lt;0.001</td></tr><tr><td>Diabetes mellitus [n (%)]</td><td>302(20.87)</td><td>183(24.22)</td><td>119(18.45)</td><td>&lt;0.001</td></tr></table>
12828c6d65370df98a85564a202ac5f1e3ee8c156ba6c4a4696f0bc5059491f1.png
simple
<table><tr><td>Component</td><td>Consumers (n = 347)</td><td>Non-consumers (n = 17,220)</td><td>p-value</td></tr><tr><td>Calories, kcal</td><td>2250 &#177; 65<sup>2</sup></td><td>2190 &#177; 11</td><td>n.s.<sup>3</sup></td></tr><tr><td>Total fats (g)</td><td>92.0 &#177; 1.6</td><td>82.9 &#177; 0.3</td><td>&lt;0.0001</td></tr><tr><td>Monounsaturated fat (g)</td><td>36.3 &#177; 0.6</td><td>30.7 &#177; 0.1</td><td>&lt;0.0001</td></tr><tr><td>Polyunsaturated fat (g)</td><td>19.5 &#177; 0.5</td><td>17.4 &#177; 0.1</td><td>&lt;0.0001</td></tr><tr><td>Carbohydrates (g)</td><td>250 &#177; 4.2</td><td>266 &#177; 0.9</td><td>&lt;0.001</td></tr><tr><td>Dietary fiber (g)</td><td>21.5 &#177; 0.8</td><td>15.8 &#177; 0.2</td><td>&lt;0.0001</td></tr><tr><td>Vitamin E, as &#945;-tocopherol (mg)</td><td>9.0 &#177; 0.4</td><td>7.3 &#177; 0.1</td><td>0.0001</td></tr><tr><td>Vitamin K, &#956;g</td><td>141 &#177; 13</td><td>95.5 &#177; 1.9</td><td>0.0013</td></tr><tr><td>Magnesium (mg)</td><td>328 &#177; 7.9</td><td>290 &#177; 1.8</td><td>&lt;0.0001</td></tr><tr><td>Potassium (mg)</td><td>3133 &#177; 56.9</td><td>2710 &#177;13.7</td><td>&lt;0.0001</td></tr><tr><td>Sodium (mg)</td><td>3359 &#177; 67.6</td><td>3491 &#177;12.3</td><td>n.s.</td></tr></table>
8fd645580c4a8974389420e55bc3f20d3282c9a2e05d33d368024a8cb72c605d.png
simple
<table><tr><td>Variable</td><td>Anemic</td><td>Non-anemic</td><td><i>P</i>-value</td></tr><tr><td>Dietary intake (n = 336)</td><td>(n = 118)</td><td>(n = 218)</td><td> </td></tr><tr><td>Iron (mg/day)</td><td>1.2 &#177; 1.0</td><td>1.3 &#177; 0.9</td><td>0.746</td></tr><tr><td>Zinc (mg/day)</td><td>1.8 &#177; 0.6</td><td>2.0 &#177; 0.5</td><td>0.299</td></tr><tr><td> Vitamin A (&#956;g/day)</td><td>66.7 &#177; 24.5</td><td>75.3 &#177; 27.3</td><td>0.227</td></tr><tr><td>Serum concentration (n = 55)</td><td>(n = 21)</td><td>(n = 34)</td><td> </td></tr><tr><td> Iron (&#956;g/L)</td><td>881.2 &#177; 449.9</td><td>1227.9 &#177; 566.4</td><td>0.014</td></tr><tr><td> Zinc (&#956;g/L)</td><td>610.0 &#177; 107.8</td><td>679.4 &#177; 117.1</td><td>0.027</td></tr><tr><td>Retinol (&#956;mol/L)</td><td>0.5 &#177; 0.1</td><td>0.8 &#177; 0.1</td><td>&lt;0.001</td></tr></table>
a11451332fea2ac53c2e713a28a4fb1c579b04d695ef492ff43e73d0701c2e74.png
simple
<table><tr><td></td><td>Fatigue factor:Eigenvalue=3.357% variance=30.52</td><td>DB factor:Eigenvalue=1.50% variance=13.62</td><td>RT:Eigenvalue=1.33% variance=12.14</td></tr><tr><td>Drive late at night</td><td>0.774</td><td></td><td></td></tr><tr><td>Drive after prolonged work</td><td>0.774</td><td></td><td></td></tr><tr><td>Drive for long periods</td><td>0.734</td><td></td><td></td></tr><tr><td>Drive when tired</td><td>0.638</td><td></td><td></td></tr><tr><td>Drive with a cold</td><td>0.470</td><td></td><td></td></tr><tr><td>Lapses of concentration</td><td></td><td>0.794</td><td></td></tr><tr><td>Speeding</td><td></td><td>0.747</td><td></td></tr><tr><td>Miss warning signs</td><td></td><td>0.687</td><td></td></tr><tr><td>Hostility to others</td><td></td><td>0.434</td><td></td></tr><tr><td>Risks at work</td><td></td><td></td><td>0.865</td></tr><tr><td>Risks outside work</td><td></td><td></td><td>0.860</td></tr></table>
8c04fd9645ef741faa8241ce5dacd9f7cf66cb81f0a7048b7801c720c95dfb31.png
simple
<table><tr><td>Variable</td><td>Control factor</td><td>Coded value</td><td>Uncoded value</td></tr><tr><td>x<sub>1</sub></td><td>Coating weigh gain</td><td>&#8722;0.6566</td><td>9.0302</td></tr><tr><td>x<sub>2</sub></td><td>Duration of coating</td><td>0.5152</td><td>29.8176</td></tr><tr><td>x<sub>3</sub></td><td>Amount of plasticizer</td><td>1</td><td>120</td></tr></table>
8ab5cbc67c122055aeecf7f564541f4153a8f83587ff4ee84efa641cfaf7296a.png
simple
<table><tr><td>Pretreatments</td><td>Weighted average degree of polymerization</td></tr><tr><td>Untreated Solka-Floc cellulose (control)</td><td>1, 110</td></tr><tr><td>Dilute acid</td><td>260</td></tr><tr><td>Dilute acid/Fe<sup>2+</sup></td><td>150</td></tr></table>
1b15cb2cb0d4e756672e34ae71d9a1aa3288650a0a7e27f75bde5996aebb4b11.png
complex
<table><tr><td rowspan="2"> </td><td rowspan="2">All (<i>n</i> = 55)</td><td colspan="2">Ultrasound-defined active synovitis</td><td rowspan="2"><i>P </i>value<sup>a</sup></td></tr><tr><td>Yes (<i>n</i> = 25)</td><td>No (<i>n</i> = 30)</td></tr><tr><td>Activin A</td><td>6,556 (3,012 to 10,887)</td><td>9,186 (4,846 to 12,297)</td><td>4,175 (2,450 to 10,255)</td><td>0.086</td></tr><tr><td>ANG</td><td>7,670 (6,206 to 10,496)</td><td>8,009 (6,729 to 10,816)</td><td>6867 (5,861 to 9,421)</td><td>0.119</td></tr><tr><td>ANG-1</td><td>32,622 (28,287 to 36,705)</td><td>34,343 (28,615 to 39,515)</td><td>31,066 (27,977 to 35,834)</td><td>0.210</td></tr><tr><td>ANG-2</td><td>726.4 (595.8-1014.8)</td><td>881 (670 to 1,072)</td><td>702 (536 to 869)</td><td>0.038</td></tr><tr><td>Angiostatin</td><td>37,409 (30,333 to 48,183)</td><td>34,326 (28,123 to 46,416)</td><td>39,648 (34,243 to 49,152)</td><td>0.111</td></tr><tr><td>ANGPTL4</td><td>15,120 (6,450 to 6,464)</td><td>1,374 (606 to 6,030)</td><td>2,294 (7,450 to 7,713)</td><td>0.630</td></tr><tr><td>bFGF</td><td>314 (268 to 492)</td><td>384 (288 to 675)</td><td>295 (265 to 318)</td><td>0.007</td></tr><tr><td>CXCL16</td><td>849 (739 to 1,311)</td><td>907 (774 to 1,214)</td><td>848 (682 to 1,454)</td><td>0.967</td></tr><tr><td>ENA-78</td><td>1,186 (813 to 1,746)</td><td>1,146 (871 to 1,664)</td><td>1,241 (780 to 1,886)</td><td>0.927</td></tr><tr><td>GRO</td><td>9,570 (7,592 to 12,000)</td><td>10,724 (8,644 to 12,000)</td><td>9,284 (7,050 to 12,000)</td><td>0.350</td></tr><tr><td>IL-17</td><td>10 (0 to 27)</td><td>13 (5 to 32)</td><td>7 (0 to 25)</td><td>0.141</td></tr><tr><td>IL-17 F</td><td>288 (57 to 4,888)</td><td>344 (59 to 3,351)</td><td>204 (58 to 4,980)</td><td>0.872</td></tr><tr><td>IL-18</td><td>589 (395 to 1,066)</td><td>741 (463 to 1,224)</td><td>514 (341 to 890)</td><td>0.066</td></tr><tr><td>IL-20</td><td>259 (92 to 836)</td><td>422 (145 to 924)</td><td>234 (68 to 727)</td><td>0.098</td></tr><tr><td>IL-23</td><td>249 (176 to 431)</td><td>257 (219 to 699)</td><td>240 (166 to 323)</td><td>0.098</td></tr><tr><td>IL-33</td><td>14 (4 to 73)</td><td>17 (4 to 69)</td><td>11 (4 to 83)</td><td>0.866</td></tr><tr><td>IL-6</td><td>149 (93 to 290)</td><td>177 (106 to 317)</td><td>136 (91 to 226)</td><td>0.136</td></tr><tr><td>IL-8</td><td>30 (21 to 62)</td><td>42 (21 to 64)</td><td>26 (22 to 46)</td><td>0.366</td></tr><tr><td>MMP-2</td><td>2,738 (1,941 to 4,050)</td><td>3,762 (2,294 to 5,574)</td><td>2,404 (1,915 to 3,263)</td><td>0.027</td></tr><tr><td>MMP-9</td><td>28,180 (21,104 to 34,808)</td><td>27,370 (23,526 to 34,009)</td><td>29,008 (17,682 to 35,779)</td><td>0.940</td></tr><tr><td>PlGF</td><td>288 (148 to 979)</td><td>453 (192 to 1,357)</td><td>237 (117 to 721)</td><td>0.043</td></tr><tr><td>SDF-1</td><td>280 (117 to 1,554)</td><td>750 (164 to 3,305)</td><td>165 (84 to 1,006)</td><td>0.035</td></tr><tr><td>TGF-&#946;1</td><td>1,453 (809 to 2,252)</td><td>1,741 (1,065 to 2,424)</td><td>1,196 (649 to 2,053)</td><td>0.089</td></tr><tr><td>Tie-1</td><td>5,099 (1,647 to 19,737)</td><td>6,841 (1,896 to 31,161)</td><td>4,039 (1,556 to 12,210)</td><td>0.112</td></tr><tr><td>Tie-2</td><td>14,735 (6,215 to 32,401)</td><td>20,559 (7,426 to 47,483)</td><td>11,436 (4,101 to 26,744)</td><td>0.317</td></tr><tr><td>TNF&#945;</td><td>6,755 (4,460 to 12,112)</td><td>6,755 (4,539 to 12,869)</td><td>6,362 (4,379 to 10,507)</td><td>0.465</td></tr><tr><td>VEGF</td><td>1,193 (815 to 1,990)</td><td>1,193 (871 to 2,178)</td><td>1,193 (810 to 1,911)</td><td>0.609</td></tr><tr><td>VEGFR-1</td><td>485 (308 to 881)</td><td>634 (366 to 1,001)</td><td>471 (278 to 723)</td><td>0.204</td></tr><tr><td>VEGFR-2</td><td>1,014 (713 to 1,918)</td><td>1,096 (869 to 1,807)</td><td>1,005 (679 to 1,937)</td><td>0.149</td></tr><tr><td>VEGF-D</td><td>32,097 (17,815 to 227,618)</td><td>63,480 (26,776 to 600,000)</td><td>27,545 (12,517 to 76,119)</td><td>0.018</td></tr></table>
199802937563aee2b6c47239a289cbac1d67b7813b3348f960018d18bbcf3bd2.png
complex
<table><tr><td>Treatment</td><td>Jumps (#)</td><td>SEp</td><td><i>p</i>-Value</td><td>Percent Reduction (%)</td></tr><tr><td>NOTH</td><td>11.1</td><td rowspan="2">1.94</td><td rowspan="2">&lt;0.01</td><td rowspan="2">79.3</td></tr><tr><td>H<sub>2</sub>O</td><td>2.3</td></tr><tr><td>NOTA</td><td>7.8</td><td rowspan="2">1.94</td><td rowspan="2">0.03</td><td rowspan="2">79.5</td></tr><tr><td>ANH</td><td>1.6</td></tr><tr><td>NOTS</td><td>8.6</td><td rowspan="2">1.94</td><td rowspan="2">0.01</td><td rowspan="2">84.9</td></tr><tr><td>AND1</td><td>1.3</td></tr><tr><td>NOTI</td><td>6.1</td><td rowspan="2">1.94</td><td rowspan="2">0.07</td><td rowspan="2">82.0</td></tr><tr><td>AND2</td><td>1.1</td></tr></table>
9f06dbb4b9b82f8118b6415c3ab87e9b87bab6962c00361a11d9a0c8aa96538b.png
complex
<table><tr><td rowspan="2"></td><td colspan="3">Depressive disorders</td><td colspan="3">Anxiety disorders</td></tr><tr><td>Hypertension (-)</td><td>Hypertension (+)</td><td>P-value</td><td>Hypertension (-)</td><td>Hypertension (+)</td><td>P-value</td></tr><tr><td>Total</td><td>89</td><td>6</td><td></td><td>67</td><td>11</td><td></td></tr><tr><td>Maternal age</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>&lt; 35 years</td><td>32</td><td>4</td><td>0.29</td><td>49</td><td>6</td><td>0.14</td></tr><tr><td>&#8805; 35 years</td><td>57</td><td>2</td><td>Reference</td><td>18</td><td>5</td><td>Reference</td></tr><tr><td>Parity</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Nulliparity</td><td>53</td><td>4</td><td>Reference</td><td>41</td><td>7</td><td>Reference</td></tr><tr><td>Multiparity</td><td>40</td><td>2</td><td>0.97</td><td>26</td><td>4</td><td>0.85</td></tr><tr><td>Medication</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No</td><td>23</td><td>2</td><td>Reference</td><td>30</td><td>4</td><td>Reference</td></tr><tr><td>Yes</td><td>64</td><td>4</td><td>0.91</td><td>32</td><td>2</td><td>0.67</td></tr><tr><td>Self-interruption</td><td>2</td><td>0</td><td>0.32 and 0.23*</td><td>5</td><td>5</td><td>0.03 and &lt; 0.01*</td></tr><tr><td>Economic problems</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No</td><td>85</td><td>6</td><td>Reference</td><td>56</td><td>10</td><td>Reference</td></tr><tr><td>Yes</td><td>4</td><td>0</td><td>0.6</td><td>11</td><td>1</td><td>0.87</td></tr></table>
a0e45a8c1b0d3a45960c473d7bca9bbda6bac4a7db9e866f9a2bc20769bfa40c.png
complex
<table><tr><td></td><td></td><td colspan="3">15 centromere Profile</td><td colspan="3">Delete-one jackknife&#8224;</td></tr><tr><td>Chr</td><td># aligned</td><td># pass filters</td><td>First Cen</td><td>First FP</td><td># pass filters</td><td>First Cen</td><td>First FP</td></tr><tr><td>1</td><td>230,107</td><td>6</td><td>0.778&#8225;</td><td>0.317</td><td>5</td><td>0.745</td><td>0.303</td></tr><tr><td>2</td><td>813,073</td><td>34</td><td>0.849</td><td>0.401</td><td>23</td><td>&#8211;</td><td>0.420</td></tr><tr><td>3</td><td>316,509</td><td>8</td><td>0.822&#8225;</td><td>0.388</td><td>7</td><td>0.571</td><td>0.426</td></tr><tr><td>4&#167;</td><td>1,531,822</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td><td>31</td><td>&#8211;</td><td>0.394</td></tr><tr><td>5</td><td>576,763</td><td>51</td><td>0.807</td><td>0.611&#182;</td><td>48</td><td>&#8211;</td><td>0.625&#182;</td></tr><tr><td>6</td><td>270,050</td><td>14</td><td>0.726&#8225;</td><td>0.389</td><td>13</td><td>0.723</td><td>0.306</td></tr><tr><td>7</td><td>1,090,829</td><td>33</td><td>0.756&#8225;</td><td>0.450</td><td>32</td><td>0.707</td><td>0.466</td></tr><tr><td>8</td><td>562,532</td><td>7</td><td>0.459&#8225;</td><td>0.346</td><td>4</td><td>&#8211;</td><td>0.293</td></tr><tr><td>9</td><td>439,777</td><td>11</td><td>0.493</td><td>0.375</td><td>2</td><td>&#8211;</td><td>&#8722;0.092</td></tr><tr><td>10</td><td>745,640</td><td>22</td><td>0.626&#8225;</td><td>0.402</td><td>19</td><td>0.579</td><td>0.357</td></tr><tr><td>11</td><td>666,705</td><td>23</td><td>0.634&#8225;</td><td>0.407</td><td>15</td><td>&#8211;</td><td>0.326</td></tr><tr><td>12</td><td>1,078,066</td><td>48</td><td>0.742&#8225;</td><td>0.430</td><td>47</td><td>0.698</td><td>0.453</td></tr><tr><td>13</td><td>924,320</td><td>48</td><td>0.873&#8225;</td><td>0.491</td><td>53</td><td>0.847</td><td>0.498</td></tr><tr><td>14</td><td>784,222</td><td>23</td><td>0.778&#8225;</td><td>0.398</td><td>16</td><td>0.748</td><td>0.384</td></tr><tr><td>15</td><td>1,091,180</td><td>21</td><td>0.796</td><td>0.457</td><td>11</td><td>&#8211;</td><td>0.420</td></tr><tr><td>16</td><td>947,955</td><td>32</td><td>0.764&#8225;</td><td>0.455</td><td>23</td><td>0.464</td><td>0.478</td></tr><tr><td>Median**</td><td>764,931</td><td>22.5</td><td>0.760</td><td>0.402</td><td>17.5</td><td>0.518</td><td>0.407</td></tr></table>
1b26d4ba21a85c61060fa854e127040c7a0ba6c371bd3085e205fd2f4d78c3c1.png
complex
<table><tr><td></td><td></td><td colspan="6">Number of Cancer Patients Treated<sup>2</sup></td></tr><tr><td>Study Site</td><td>Total PopulationService Area<sup>1</sup></td><td>Breast</td><td>Colorectal</td><td>Prostate</td><td>Lung</td><td>Other</td><td>TOTAL</td></tr><tr><td>Billings Clinic, Montana</td><td>283,828</td><td>186</td><td>133</td><td>207</td><td>150</td><td>753</td><td>1,429</td></tr><tr><td>Christiana Hospital, Delaware</td><td>571,322</td><td>533</td><td>258</td><td>367</td><td>447</td><td>1258</td><td>2,863</td></tr><tr><td>Hartford Hospital, Connecticut</td><td>1,054,456</td><td>544</td><td>217</td><td>479</td><td>280</td><td>1075</td><td>2,595</td></tr><tr><td>Our Lady of the Lake Regional Medical Center, Louisiana</td><td>672,319</td><td>362</td><td>250</td><td>365</td><td>539</td><td>1075</td><td>2,591</td></tr><tr><td>St. Joseph's/Candler, Georgia</td><td>385,242</td><td>227</td><td>124</td><td>87</td><td>253</td><td>366</td><td>1,057</td></tr><tr><td>St. Joseph's, Orange, California</td><td>2,432,932</td><td>385</td><td>147</td><td>118</td><td>149</td><td>728</td><td>1,527</td></tr><tr><td>Sanford USD Medical Center, South Dakota</td><td>489,576</td><td>187</td><td>147</td><td>139</td><td>177</td><td>586</td><td>1,236</td></tr><tr><td>Spartanburg Regional Hospital, South Carolina</td><td>353,757</td><td>244</td><td>136</td><td>193</td><td>253</td><td>553</td><td>1,379</td></tr><tr><td>Ascension Health, based in Missouri: St. Vincent Indianapolis Hospital, Indianapolis, Indiana</td><td>1,951,252</td><td>573</td><td>219</td><td>182</td><td>287</td><td>1934</td><td>3,195</td></tr><tr><td>Columbia St. Mary's Hospital, Milwaukee Wisconsin</td><td>685,066</td><td>417</td><td>157</td><td>227</td><td>169</td><td>692</td><td>1,662</td></tr><tr><td>Seton Family of Hospitals, Austin, Texas</td><td>1,544,670</td><td>371</td><td>171</td><td>58</td><td>300</td><td>1132</td><td>2,032</td></tr><tr><td>Catholic Health Initiatives, based in Colorado: Penrose-St. Francis Health Services, Colorado Springs, Colorado</td><td>477,263</td><td>208</td><td>156</td><td>197</td><td>110</td><td>552</td><td>1,223</td></tr><tr><td>St. Joseph Medical Center, Towson, Maryland</td><td>633,814</td><td>205</td><td>128</td><td>155</td><td>124</td><td>463</td><td>1,078</td></tr><tr><td>CHI Nebraska coordinated regional program: Good Samaritan Hospital, Kearney, Nebraska</td><td>205,994</td><td>87</td><td>67</td><td>95</td><td>77</td><td>227</td><td>553</td></tr><tr><td>St. Elizabeth Regional Medical Center, Lincoln, Nebraska</td><td>256,939</td><td>215</td><td>114</td><td>39</td><td>87</td><td>317</td><td>772</td></tr><tr><td>St. Francis Medical Center, Grand Island, Nebraska</td><td>106,724</td><td>104</td><td>106</td><td>82</td><td>59</td><td>208</td><td>559</td></tr><tr><td>TOTAL</td><td>12,105,154</td><td>4848</td><td>2530</td><td>2990</td><td>3461</td><td>11919</td><td>25,751</td></tr></table>
60842076155534c54e8d6f81c31746060536ea4fe5dbec5d0c2b27fa8c7c5223.png
complex
<table><tr><td rowspan="3" colspan="2"></td><td colspan="4">Low blood pressure criteria</td></tr><tr><td>SBP &lt; 110 mmHg</td><td>SBP &lt; 100 mmHg</td><td>SBP &lt; 95 mmHg</td><td>SBP &lt; 90 mmHg</td></tr><tr><td colspan="4">Odds ratio (95% CI)</td></tr><tr><td colspan="2">Crude Model</td><td>1.07 (0.91 to 1.26)</td><td>1.33 (1.14 to 1.56)<sup>***</sup></td><td>1.57 (1.28 to 1.93)<sup>***</sup></td><td>2.07 (1.43 to 2.98)<sup>**</sup></td></tr><tr><td></td><td>Covariates</td><td></td><td></td><td></td><td></td></tr><tr><td>Model I</td><td>Age, Sex, BMI, Total cholesterol level</td><td>1.01 (0.85 to 1.20)</td><td>1.26 (1.06 to 1.49)<sup>**</sup></td><td>1.44 (1.17 to 1.78)<sup>***</sup></td><td>1.87 (1.24 to 2.65)<sup>**</sup></td></tr><tr><td>Model II</td><td>Model I + Household income, Educational level, Marital status</td><td>1.10 (0.92 to 1.32)</td><td>1.34 (1.13 to 1.59)<sup>***</sup></td><td>1.50 (1.21 to 1.87)<sup>***</sup></td><td>1.81 (1.26 to 2.77)<sup>**</sup></td></tr><tr><td>Model III</td><td>Model II + Current smoking status, Alcohol intake</td><td>1.07 (0.89 to 1.29)</td><td>1.35 (1.13 to 1.62)<sup>***</sup></td><td>1.51 (1.19 to 1.90)<sup>***</sup></td><td>1.81 (1.17 to 2.77)<sup>**</sup></td></tr><tr><td>Model IV</td><td>Model III + Sex*Age</td><td>1.03 (0.85 to 1.24)</td><td>1.29 (1.08 to 1.55)<sup>**</sup></td><td>1.44 (1.14 to 1.82) <sup>**</sup></td><td>1.71 (1.11 to 2.62) <sup>*</sup></td></tr><tr><td>Model V</td><td>Model IV + DM, Stroke, MI/Angina pectoris, Depression</td><td>1.04 (0.86 to 1.26)</td><td>1.25 (1.04 to 1.50)<sup>*</sup></td><td>1.43 (1.13 to 1.81) <sup>**</sup></td><td>1.74 (1.14 to 2.68) <sup>*</sup></td></tr></table>
ba79e462d075ccb23cebce943bf8c52a5b18fc46c80dbdc7c0bf5fc16e2c0518.png
complex
<table><tr><td rowspan="2">Species</td><td rowspan="2">Year</td><td colspan="2">Captures</td><td rowspan="2">Odds ratio of capture on pipeline</td></tr><tr><td>On pipeline</td><td>Off pipeline</td></tr><tr><td rowspan="3"><i>D. ordii</i></td><td>1997</td><td>35</td><td>106</td><td>1.663</td></tr><tr><td>1998</td><td>57</td><td>116</td><td>2.473</td></tr><tr><td>1999&#8211;2001</td><td>21</td><td>21</td><td>5.037</td></tr><tr><td rowspan="3"><i>P. flavescens</i></td><td>1997</td><td>0</td><td>27</td><td>0</td></tr><tr><td>1998</td><td>5</td><td>44</td><td>0.572</td></tr><tr><td>1999&#8211;2001</td><td>13</td><td>75</td><td>0.873</td></tr></table>
401f1da8e73d694616dce0ea3e54034bd03e5534989fc6a433f4230a6b186bc6.png
simple
<table><tr><td>Variable </td><td>Frequency (%)</td></tr><tr><td>Sex </td><td></td></tr><tr><td>Male </td><td>138 (76.7)</td></tr><tr><td>Female </td><td>42 (23.3)</td></tr><tr><td>Age (years)</td><td></td></tr><tr><td>&lt; 10</td><td>13 (7.2)</td></tr><tr><td>11-20</td><td>42 (23.3)</td></tr><tr><td>21-30</td><td>49 (27.2)</td></tr><tr><td>31-40</td><td>54 (30.0)</td></tr><tr><td>41-50</td><td>15 (8.3)</td></tr><tr><td>51-60</td><td>7 (3.9)</td></tr></table>
3e19882c215aa664c3e8b98a8d297ecc068f690aefdc917866078b5d70bd3d91.png
complex
<table><tr><td></td><td colspan="2">Left targets</td><td colspan="2">Central targets</td><td colspan="2">Right targets</td></tr><tr><td>Session</td><td>1</td><td>2</td><td>1</td><td>2</td><td>1</td><td>2</td></tr><tr><td></td><td colspan="6">Accuracy (%)</td></tr><tr><td>L-PA</td><td>99.64 &#177; 0.36</td><td>98.93 &#177; 1.07</td><td>98.93 &#177; 0.57</td><td>99.29 &#177; 0.49</td><td>99.64 &#177; 0.36</td><td>100.00 &#177; 0.00</td></tr><tr><td>R-PA</td><td>98.21 &#177; 1.00</td><td>99.29 &#177; 0.49</td><td>100.00 &#177; 0.00</td><td>99.29 &#177; 0.71</td><td>96.79 &#177; 1.62</td><td>99.64 &#177; 0.36</td></tr><tr><td>Neutral</td><td>100.00 &#177; 0.00</td><td>98.21 &#177; 1.79</td><td>99.64 &#177; 0.36</td><td>99.29 &#177; 0.49</td><td>99.64 &#177; 0.36</td><td>98.57 &#177; 1.10</td></tr><tr><td colspan="7">Reaction time (ms)</td></tr><tr><td>L-PA</td><td>388 &#177; 24</td><td>399 &#177; 17</td><td>383 &#177; 24</td><td>385 &#177; 17</td><td>379 &#177; 23</td><td>403 &#177; 19</td></tr><tr><td>R-PA</td><td>408 &#177; 15</td><td>416 &#177; 19</td><td>397 &#177; 15</td><td>403 &#177; 15</td><td>401 &#177; 13</td><td>414 &#177; 15</td></tr><tr><td>Neutral</td><td>375 &#177; 10</td><td>404 &#177; 14</td><td>360 &#177; 10</td><td>383 &#177; 14</td><td>365 &#177; 9</td><td>396 &#177; 10</td></tr></table>
01fd2942bbbee2dd724867d1d3ee8df411d0a0ea96243841dd4333c999efbbc1.png
complex
<table><tr><td rowspan="3">Variables</td><td colspan="4">Rs2910164 (Cases/Controls)</td><td rowspan="3">Crude OR (95% CI)</td><td rowspan="3"><i>P</i></td><td rowspan="3">Adjusted ORa (95% CI)</td><td rowspan="3"><i>P</i>a</td></tr><tr><td colspan="2">CC</td><td colspan="2">CG/GG</td></tr><tr><td><i>N</i></td><td>%</td><td><i>N</i></td><td>%</td></tr><tr><td colspan="9">Age, yr</td></tr><tr><td> &#8804;59 (median)</td><td>202/217</td><td>34.9/35.6</td><td>376/393</td><td>65.1/64.4</td><td>1.03 (0.81-1.30)</td><td>0.822</td><td>1.04 (0.82-1.32)</td><td>0.769</td></tr><tr><td> &gt;59 (median)</td><td>195/203</td><td>35.6/34.6</td><td>352/383</td><td>64.4/65.4</td><td>0.96 (0.75-1.22)</td><td>0.723</td><td>0.95 (0.74-1.22)</td><td>0.677</td></tr><tr><td colspan="9">Gender</td></tr><tr><td> Males</td><td>291/284</td><td>36.4/34.4</td><td>509/542</td><td>63.6/65.6</td><td>0.92 (0.75-1.12)</td><td>0.401</td><td>0.93 (0.76-1.14)</td><td>0.496</td></tr><tr><td> Females</td><td>106/136</td><td>32.6/36.8</td><td>219/234</td><td>67.4/63.2</td><td>1.20 (0.88-1.64)</td><td>0.253</td><td>1.19 (0.86-1.63)</td><td>0.291</td></tr><tr><td colspan="9">Smoking status</td></tr><tr><td> Never</td><td>249/214</td><td>36.3/35.1</td><td>437/396</td><td>63.7/64.9</td><td>0.95 (0.76-1.19)</td><td>0.649</td><td>0.97 (0.77-1.22)</td><td>0.764</td></tr><tr><td> Former</td><td>6/39</td><td>35.3/32.5</td><td>11/81</td><td>64.7/67.5</td><td>0.88 (0.30-2.56)</td><td>0.819</td><td>1.10 (0.36-3.36)</td><td>0.872</td></tr><tr><td> Current</td><td>142/167</td><td>33.6/35.8</td><td>280/299</td><td>66.4/64.2</td><td>1.10 (0.84-1.45)</td><td>0.495</td><td>1.09 (0.82-1.44)</td><td>0.560</td></tr><tr><td colspan="9">Drinking status</td></tr><tr><td> Never</td><td>309/300</td><td>36.1/35.3</td><td>546/551</td><td>63.9/64.7</td><td>0.96 (0.79-1.17)</td><td>0.702</td><td>0.97 (0.80-1.19)</td><td>0.771</td></tr><tr><td> Ever</td><td>88/120</td><td>32.6/34.8</td><td>182/225</td><td>67.4/65.2</td><td>1.10 (0.79-1.55)</td><td>0.569</td><td>1.10 (0.79-1.55)</td><td>0.572</td></tr><tr><td colspan="9">Pack-years</td></tr><tr><td> 0</td><td>249/214</td><td>36.3/35.1</td><td>437/396</td><td>63.7/64.9</td><td>0.95 (0.76-1.19)</td><td>0.649</td><td>0.96 (0.76-1.21)</td><td>0.726</td></tr><tr><td> &#8804;25 (mean)</td><td>72/130</td><td>31.7/36.6</td><td>155/225</td><td>68.3/63.4</td><td>1.24 (0.87-1.77)</td><td>0.226</td><td>1.20 (0.84-1.73)</td><td>0.322</td></tr><tr><td> &gt;25 (mean)</td><td>76/76</td><td>35.8/32.9</td><td>136/155</td><td>64.2/67.1</td><td>0.88 (0.59-1.30)</td><td>0.514</td><td>0.97 (0.64-1.46)</td><td>0.877</td></tr><tr><td colspan="9">Tumor site</td></tr><tr><td> GCA</td><td>110/420</td><td>36.1/35.1</td><td>195/776</td><td>63.9/64.9</td><td>0.96 (0.74-1.25)</td><td>0.756</td><td>0.96 (0.74-1.25)</td><td>0.752</td></tr><tr><td> NGCA</td><td>287/420</td><td>35.0/35.1</td><td>533/776</td><td>65.0/64.9</td><td>1.01 (0.83-1.21)</td><td>0.957</td><td>1.01 (0.84-1.22)</td><td>0.901</td></tr></table>
40529bd6a7b6e67d022b8a98a676743448c9d76b1049032409c1bc98b62fd89d.png
simple
<table><tr><td>Treatment</td><td><i>N</i></td><td>Mean survival &#177; SE</td><td>95% CI</td></tr><tr><td>Nonsurgical</td><td>533</td><td>67 &#177; 3 months</td><td>62&#8211;72</td></tr><tr><td>Surgical</td><td>751</td><td>87 &#177; 4 months</td><td>80&#8211;95</td></tr><tr><td>Overall</td><td>1284</td><td>83 &#177; 3 months</td><td>78&#8211;88</td></tr></table>
b3d6d679dd3fd568c26e9d87ba87598ad2f3f3d2bbbfd874d17c1db195838880.png
simple
<table><tr><td>Parasite density</td><td>Sample size (n)</td><td>Positives</td><td>Detection rate</td></tr><tr><td>&lt;200</td><td>16</td><td>14</td><td>87.50%</td></tr><tr><td>200-1999</td><td>77</td><td>76</td><td>98.70%</td></tr><tr><td>&gt;2000</td><td>229</td><td>229</td><td>100%</td></tr></table>
efedef98f38c939d94b96f4e7e2f08a22c3e6c782b9961aae49ee359b9d9191c.png
complex
<table><tr><td colspan="2">DDS</td><td colspan="2">SDDS</td></tr><tr><td>Food group</td><td>Note</td><td>Food group</td><td>Note</td></tr><tr><td>All starch staples</td><td rowspan="3">With a threshold of 10 g</td><td>Refined grains and cereals</td><td>With a threshold of 10 g</td></tr><tr><td></td><td>Other cereals and grains</td><td>With a threshold of 10 g</td></tr><tr><td></td><td>Starch tubers and roots</td><td>With a threshold of 10 g</td></tr><tr><td>Vitamin A-rich vegetables &amp; fruit</td><td rowspan="3">With a threshold of 10 g</td><td>Vitamin A-rich dark-green leafy vegetables</td><td>With a threshold of 10 g</td></tr><tr><td></td><td>Vitamin A-rich deep yellow/orange/red vegetables</td><td>With a threshold of 10 g</td></tr><tr><td></td><td>Vitamin A-rich fruits</td><td>With a threshold of 10 g</td></tr><tr><td>All other fruits</td><td>With a threshold of 10 g</td><td>Vitamin C-rich vegetables</td><td>With a threshold of 10 g</td></tr><tr><td>All other vegetables</td><td>With a threshold of 10 g</td><td>Vitamin C-rich fruits</td><td>With a threshold of 10 g</td></tr><tr><td></td><td></td><td>All other fruits &amp; vegetables</td><td>With a threshold of 10 g</td></tr><tr><td>All legumes &amp; nuts</td><td>With a threshold of 10 g</td><td>All legumes &amp; nuts</td><td>With a threshold of 10 g</td></tr><tr><td>Oil and fat</td><td>With a threshold of 2 g</td><td>Oil and fat</td><td>With a threshold of 2 g</td></tr><tr><td>Meat, poultry, fish</td><td rowspan="2">With a threshold of 10 g</td><td>Meat, poultry, fish</td><td>With a threshold of 10 g</td></tr><tr><td></td><td>Organ meat</td><td>With a threshold of 10 g</td></tr><tr><td>All dairy</td><td>With a threshold of 10 g</td><td>All dairy</td><td>With a threshold of 10 g</td></tr><tr><td>Eggs</td><td>With a threshold of 10 g</td><td>Eggs</td><td>With a threshold of 10 g</td></tr><tr><td>Other food</td><td rowspan="2">Exclude calculation</td><td>Desserts, candy, sugar-sweetened beverages and Puffing Food</td><td>With a threshold of 10 g</td></tr><tr><td></td><td>Other food</td><td>With a threshold of 10 g</td></tr></table>
2f4c1f84df728fda53454b33c77b3efa0f1f93739190f476c37127e24aeec62d.png
complex
<table><tr><td> </td><td colspan="2">Estimated effect on baseline physical activity (minutes per day)</td><td colspan="2">Estimated effect on physical activity trajectories (minutes per day per semester)</td></tr><tr><td> </td><td>Fixed effect</td><td><i>P</i> value</td><td>Fixed Effect</td><td><i>P</i> value</td></tr><tr><td colspan="5">Student Characteristics</td></tr><tr><td>Gender</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Female</td><td>&#8722;12.5 (2.04)</td><td>&lt;0.0001</td><td>0.596 (0.598)</td><td>0.3194</td></tr><tr><td> Male</td><td>Referent</td><td> </td><td>Referent</td><td> </td></tr><tr><td>Baseline physical activity</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Low</td><td>&#8722;47.7 (1.50)</td><td>&lt;0.0001</td><td>7.11 (0.707)</td><td>&lt;0.0001</td></tr><tr><td> Moderate</td><td>&#8722;25.8 (1.51) </td><td>&lt;0.0001</td><td>4.20 (0.719)</td><td>&lt;0.0001</td></tr><tr><td> High</td><td>Referent</td><td> </td><td>Referent</td><td> </td></tr><tr><td>BMI status</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Overweight or obese</td><td>1.92 (3.21)</td><td>0.5512</td><td>&#8722;0.785 (0.901)</td><td>0.3894</td></tr><tr><td> Healthy weight</td><td>Referent</td><td> </td><td>Referent</td><td> </td></tr><tr><td> Missing</td><td>1.88 (2.35)</td><td>0.4252</td><td>&#8722;0.0527 (0.657)</td><td>0.9362</td></tr><tr><td colspan="5">School neighbourhood characteristics </td></tr><tr><td>School location</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Rural</td><td>&#8722;10.6 (2.25)</td><td>&lt;0.0001</td><td>1.49 (0.658)</td><td>0.0234</td></tr><tr><td> Urban</td><td>Referent</td><td> </td><td>Referent</td><td> </td></tr><tr><td>Socioeconomic status</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Low</td><td>&#8722;9.09 (2.27)</td><td>&lt;0.0001</td><td>1.75 (0.664)</td><td>0.0086</td></tr><tr><td> High</td><td>Referent</td><td> </td><td>Referent</td><td> </td></tr></table>
ed0edadd8a775a953b09054bf0b85ebde296c375c05c97495168cfe99a9f5953.png
complex
<table><tr><td></td><td>Link with violence</td></tr><tr><td colspan="2">Antisocial</td></tr><tr><td>Social norms</td><td>No specific reference within literature.</td></tr><tr><td>Deceitfulness</td><td>No specific reference within literature.</td></tr><tr><td>Impulsivity</td><td>Related to more violent assaults [41].Did not directly predict aggression once emotional dysregulation was controlled for [40].Impulsivity related to history of persistent violence [27]</td></tr><tr><td>Aggressiveness</td><td>Disturbed batterers more physically aggressive [7].Aggressiveness related to ASPD and NPD diagnoses. In BPD aggressiveness linked to poor impulse control. [19].</td></tr><tr><td>Reckless</td><td>Related to more violent assaults [41].</td></tr><tr><td>Irresponsibility</td><td>No specific reference within literature.</td></tr><tr><td>Lack remorse</td><td>No specific reference within literature.</td></tr><tr><td colspan="2">Borderline</td></tr><tr><td>Avoid abandonment</td><td>Avoidant attachment predicted severity of physical partner violence mediated by interpersonal difficulties [31].Female offenders have greater number of traumatic experiences and less secure attachment styles [22].ASPD and BPD diagnoses mediated path between by avoidant attachment intimate partner violence [34].</td></tr><tr><td>Unstable relationships</td><td>See &#8216;Avoid Abandonment&#8217;.</td></tr><tr><td>Identity disturbance</td><td>No specific reference within literature.</td></tr><tr><td>Impulsivity</td><td>See &#8216;Impulsivity&#8217; under Antisocial diagnosis.</td></tr><tr><td>Suicidal behavior</td><td>No specific reference within literature.</td></tr><tr><td>Affective instability</td><td>Emotional Dysregulation predicted physical assault [40].</td></tr><tr><td>Emptiness</td><td>No specific reference within literature.</td></tr><tr><td>Anger</td><td>Impulsivity predicted physical aggression and trait anger. Trait anger mediates relationship between impulsivity and physical aggression. [42].</td></tr><tr><td>Paranoid ideation</td><td>Disturbed batterers higher levels of paranoid ideation [7].</td></tr><tr><td colspan="2">Narcissistic</td></tr><tr><td>Grandiose</td><td>Link between experience grandiose delusions and serious violence. Stronger link to violence when associated with elation or anger [49].</td></tr><tr><td>Fantasies of success</td><td>No specific reference within literature.</td></tr><tr><td>Is &#8220;special&#8221;</td><td>See &#8216;Grandiose&#8217;.</td></tr><tr><td>Excessive admiration</td><td>No specific reference within literature.</td></tr><tr><td>Sense of entitlement</td><td>Evidence of inflated sense of entitlement linked to violent offenders. When violated more likely to be violent [18]</td></tr><tr><td>Exploitative</td><td>No specific reference within literature.</td></tr><tr><td>Lacks empathy</td><td>Violent offenders have reduced ability to recognise facial emotions [41].Poor perspective taking exacerbated anger arousal [9].Violent offender have poorer empathy [7].</td></tr><tr><td>Envious</td><td>No specific reference within literature.</td></tr><tr><td>Arrogant</td><td>No specific reference within literature.</td></tr></table>
5e4d54bfd42501e67c922c7d00e44b9a3ab31d79c76e7fb1661cd0e43bfbda2b.png
complex
<table><tr><td>Number</td><td colspan="3">DPW + SVM</td><td colspan="3">DPW</td><td colspan="3">DTW + SVM</td><td colspan="3">DTW</td></tr><tr><td></td><td>PR</td><td>SE/RE</td><td>F1</td><td>PR</td><td>SE/RE</td><td>F1</td><td>PR</td><td>SE/RE</td><td>F1</td><td>PR</td><td>SE/RE</td><td>F1</td></tr><tr><td>0</td><td>96.72</td><td>100.00</td><td>98.33</td><td>98.15</td><td>89.83</td><td>93.81</td><td>93.10</td><td>91.53</td><td>92.31</td><td>96.36</td><td>89.83</td><td>92.98</td></tr><tr><td>1</td><td>86.15</td><td>94.92</td><td>90.32</td><td>96.30</td><td>88.14</td><td>92.04</td><td>95.08</td><td>98.31</td><td>96.67</td><td>96.61</td><td>96.61</td><td>96.61</td></tr><tr><td>2</td><td>98.28</td><td>96.61</td><td>97.44</td><td>98.33</td><td>100.00</td><td>99.16</td><td>94.83</td><td>93.22</td><td>94.02</td><td>98.21</td><td>93.22</td><td>95.65</td></tr><tr><td>3</td><td>96.67</td><td>98.31</td><td>97.48</td><td>100.00</td><td>96.61</td><td>98.28</td><td>95.08</td><td>98.31</td><td>96.67</td><td>96.61</td><td>96.61</td><td>96.61</td></tr><tr><td>4</td><td>98.00</td><td>83.05</td><td>89.91</td><td>81.82</td><td>91.53</td><td>86.40</td><td>87.72</td><td>84.75</td><td>86.21</td><td>77.05</td><td>79.66</td><td>78.33</td></tr><tr><td>5</td><td>100.00</td><td>98.31</td><td>99.15</td><td>100.00</td><td>96.61</td><td>98.28</td><td>98.31</td><td>98.31</td><td>98.31</td><td>98.28</td><td>96.61</td><td>97.44</td></tr><tr><td>6</td><td>95.16</td><td>100.00</td><td>97.52</td><td>91.67</td><td>93.22</td><td>92.44</td><td>92.19</td><td>100.00</td><td>95.93</td><td>83.10</td><td>100.00</td><td>90.77</td></tr><tr><td>7</td><td>89.47</td><td>86.44</td><td>87.93</td><td>85.07</td><td>96.61</td><td>90.48</td><td>90.57</td><td>81.36</td><td>85.71</td><td>87.72</td><td>84.75</td><td>86.21</td></tr><tr><td>8</td><td>98.33</td><td>100.00</td><td>99.16</td><td>96.72</td><td>100.00</td><td>98.33</td><td>95.08</td><td>98.31</td><td>96.67</td><td>96.61</td><td>96.61</td><td>96.61</td></tr><tr><td>9</td><td>94.92</td><td>94.92</td><td>94.92</td><td>94.44</td><td>86.44</td><td>90.27</td><td>94.83</td><td>93.22</td><td>94.02</td><td>94.55</td><td>88.14</td><td>91.23</td></tr><tr><td>Avg.</td><td>95.37</td><td>95.25</td><td>95.22</td><td>94.25</td><td>93.90</td><td>93.95</td><td>93.68</td><td>93.73</td><td>93.65</td><td>92.51</td><td>92.20</td><td>92.24</td></tr><tr><td>St dev.</td><td>4.33</td><td>5.91</td><td>4.23</td><td>6.27</td><td>4.81</td><td>4.38</td><td>2.94</td><td>6.34</td><td>4.41</td><td>7.35</td><td>6.45</td><td>6.05</td></tr></table>
3870daa508c98d06fae793d41f2af5221c108e94ec8987971b9d3ae7133e81ff.png
simple
<table><tr><td></td><td>Patients (n)</td><td>Coverage (10<sup>6</sup> reads)</td><td>Cassette exons</td><td>Competing 5&#8242; splice sites</td><td>Competing 3&#8242; splice sites</td><td>Retained introns</td><td>Constitutive introns</td><td>Constitutive junctions</td><td>Retained intron ratio</td></tr><tr><td>Acute myeloid leukemia</td><td>169</td><td>75 (8)</td><td>1,219</td><td>326</td><td>377</td><td>973</td><td>6,239</td><td>841</td><td>4.74 (1.2)</td></tr><tr><td>Bladder</td><td>18</td><td>56 (14)</td><td>894</td><td>170</td><td>211</td><td>296</td><td>552</td><td>456</td><td>1.83 (2.2)</td></tr><tr><td>Breast</td><td>104</td><td>72 (17)</td><td>1,052</td><td>210</td><td>268</td><td>266</td><td>612</td><td>569</td><td>-2.01 (2.1)</td></tr><tr><td>Colon</td><td>37</td><td>58 (18)</td><td>597</td><td>165</td><td>200</td><td>307</td><td>376</td><td>291</td><td>3.44 (2.6)</td></tr><tr><td>Endometrium</td><td>21</td><td>35 (16)</td><td>619</td><td>171</td><td>180</td><td>296</td><td>370</td><td>312</td><td>0.48 (2.4)</td></tr><tr><td>Head and neck</td><td>40</td><td>81 (26)</td><td>829</td><td>153</td><td>202</td><td>115</td><td>290</td><td>418</td><td>0.82 (1.7)</td></tr><tr><td>Kidney (chromophobe)</td><td>25</td><td>82 (12)</td><td>941</td><td>184</td><td>228</td><td>207</td><td>481</td><td>484</td><td>1.65 (1.4)</td></tr><tr><td>Kidney (renal clear cell)</td><td>71</td><td>80 (16)</td><td>729</td><td>149</td><td>194</td><td>143</td><td>380</td><td>380</td><td>1.42 (1.7)</td></tr><tr><td>Kidney (renal papillary cell)</td><td>30</td><td>85 (20)</td><td>730</td><td>155</td><td>220</td><td>184</td><td>440</td><td>408</td><td>1.51 (2.1)</td></tr><tr><td>Liver</td><td>50</td><td>70 (15)</td><td>413</td><td>90</td><td>117</td><td>106</td><td>200</td><td>206</td><td>0.82 (2.1)</td></tr><tr><td>Lung (adenocarcinoma)</td><td>51</td><td>43 (28)</td><td>517</td><td>115</td><td>141</td><td>176</td><td>277</td><td>233</td><td>0.20 (2.6)</td></tr><tr><td>Lung (squamous cell)</td><td>50</td><td>83 (31)</td><td>1,068</td><td>190</td><td>252</td><td>236</td><td>609</td><td>547</td><td>0.44 (2.0)</td></tr><tr><td>Prostate</td><td>43</td><td>75 (11)</td><td>607</td><td>133</td><td>185</td><td>130</td><td>358</td><td>337</td><td>1.44 (2.4)</td></tr><tr><td>Stomach</td><td>30</td><td>105 (21)</td><td>1,048</td><td>200</td><td>302</td><td>206</td><td>886</td><td>884</td><td>0.99 (1.7)</td></tr><tr><td>Rectum</td><td>8</td><td>53 (14)</td><td>680</td><td>123</td><td>172</td><td>310</td><td>390</td><td>314</td><td>4.30 (2.3)</td></tr><tr><td>Thyroid</td><td>58</td><td>83 (11)</td><td>533</td><td>132</td><td>177</td><td>174</td><td>488</td><td>332</td><td>0.66 (2.4)</td></tr></table>
cb375b39cfa1fa47466a5396acfb0f4fa02fe136b0059c820cb7ce9ef0a1263a.png
simple
<table><tr><td>Characteristic</td><td>Ranking from electronic survey</td><td>Ranking from paper survey</td></tr><tr><td>Impact on care</td><td>1</td><td>2</td></tr><tr><td>Strength of supporting evidence</td><td>2</td><td>1</td></tr><tr><td>Local health needs of patients/clients</td><td>3</td><td>3</td></tr><tr><td>Costs associated with new ways of working</td><td>4</td><td>4</td></tr><tr><td>Local expertise</td><td>5</td><td>5</td></tr><tr><td>Meeting minimum standards</td><td>6</td><td>6</td></tr><tr><td>National or local priority</td><td>7</td><td>7</td></tr></table>
e4e1e8301122321d2b6670c56735abc7b965b48218f768610b5446bf0fe897fb.png
simple
<table><tr><td>Property</td><td>Explanation</td></tr><tr><td>Citation-related properties</td><td></td></tr><tr><td>occursInChecklist</td><td>Reference to a species checklist</td></tr><tr><td>auctorumYear</td><td>The year of original publication</td></tr><tr><td>completeAuctorumString</td><td>Author name(s) expressed according</td></tr><tr><td></td><td>to the established practices of taxonomy</td></tr><tr><td>Name-related properties</td><td></td></tr><tr><td>hasNonvalidName</td><td>Expresses synonyms, homonyms</td></tr><tr><td></td><td>and orthographic variants of a valid</td></tr><tr><td></td><td>scientific name</td></tr><tr><td>hasVernacularName</td><td>The common name equivalents for</td></tr><tr><td></td><td>the scientific names</td></tr><tr><td>hasNomenclaturalCode</td><td>Specifies the set of rules that are applied</td></tr><tr><td></td><td>(ICN [55] or ICZN [56])</td></tr><tr><td>hasVernacularNameStatus</td><td>Expresses whether a common name is</td></tr><tr><td></td><td>accepted or an alternative one</td></tr><tr><td>rdf:type</td><td>Expresses the hierarchical level in</td></tr><tr><td></td><td>a classification. The ranks are obtained</td></tr><tr><td></td><td>from TDWG Taxon Rank LSID Ontology [57].</td></tr><tr><td></td><td>Every taxon is an instance of a specific</td></tr><tr><td></td><td>taxonomic rank and the class</td></tr><tr><td></td><td><i>TaxonInChecklist</i> (Figure 3).</td></tr></table>
d3970014b28fe5acadc9fa591d0d7c75892c0c32147ffea5a77bee6516127af5.png
complex
<table><tr><td> </td><td> </td><td colspan="2">Attention</td><td colspan="5">Memory</td><td> </td></tr><tr><td> </td><td>MMSE</td><td>SDMT</td><td>SRT</td><td colspan="5">RBMT</td><td>EMC</td></tr><tr><td> </td><td> </td><td>Completing rate</td><td>Correct rate</td><td>SPS</td><td>&#8216;Belonging&#8217;</td><td>&#8216;Appointment&#8217;</td><td>&#8216;Pictures&#8217;</td><td>&#8216;Date&#8217;</td><td> </td></tr><tr><td>Bag use</td><td>0.06</td><td>&#8722;0.29</td><td>&#8722;0.28</td><td>&#8722;0.41</td><td>0.31</td><td>&#8722;0.5</td><td>&#8722;0.65*</td><td>0.11</td><td>0.52</td></tr><tr><td>List use</td><td>&#8722;0.69*</td><td>&#8722;0.5</td><td>&#8722;0.63</td><td>&#8722;0.71*</td><td>&#8722;0.67*</td><td>&#8722;0.73*</td><td>&#8722;0.34</td><td>&#8722;0.59</td><td>0.76*</td></tr><tr><td>Forward movement</td><td>&#8722;0.31</td><td>&#8722;0.43</td><td>&#8722;0.62</td><td>&#8722;0.34</td><td>0.09</td><td>&#8722;0.56</td><td>&#8722;0.53</td><td>&#8722;0.3</td><td>0.01</td></tr><tr><td>Correct purchases</td><td>0.18</td><td>0.39</td><td>0.05</td><td>0.48</td><td>0.47</td><td>0.09</td><td>0.16</td><td>0.67*</td><td>0.26</td></tr><tr><td>Total time</td><td>&#8722;0.6</td><td>&#8722;0.80**</td><td>&#8722;0.89**</td><td>&#8722;0.71*</td><td>&#8722;0.37</td><td>&#8722;0.88**</td><td>&#8722;0.45</td><td>&#8722;0.52</td><td>0.52</td></tr></table>
10d7ad634ba11910e83491ceaa174e7928e974ae0ba5d30f83c78eb2ecb14e5e.png
simple
<table><tr><td>Item*</td><td>Affirmative responses (%)**</td><td>Item calibration***</td><td>SE****</td><td>Item infit</td><td>Item outfit</td></tr><tr><td>AD1 Worried food would run out</td><td>48.7</td><td>3.45</td><td>0.078</td><td>0.76</td><td>1.85</td></tr><tr><td>AD2 Food ran out; did not have money for more</td><td>53.1</td><td>2.86</td><td>0.085</td><td>0.95</td><td>1.47</td></tr><tr><td>AD3 Could not afford to eat nutritious meal</td><td>50.9</td><td>3.17</td><td>0.081</td><td>0.97</td><td>4.20</td></tr><tr><td>AD4 Cut size of meal or skipped meal</td><td>26.7</td><td>5.90</td><td>0.077</td><td>1.03</td><td>1.80</td></tr><tr><td>AD5 Ate less than thought he/she should</td><td>21.3</td><td>6.58</td><td>0.084</td><td>0.90</td><td>1.62</td></tr><tr><td>AD6 Hungry but did not eat</td><td>13.2</td><td>7.93</td><td>0.101</td><td>0.76</td><td>0.81</td></tr><tr><td>AD7 Lost weight</td><td>10.3</td><td>8.60</td><td>0.113</td><td>1.09</td><td>2.03</td></tr><tr><td>AD8 Did not eat for whole day</td><td>7.2</td><td>9.51</td><td>0.134</td><td>1.05</td><td>1.14</td></tr><tr><td>Mean</td><td></td><td>6.00</td><td></td><td></td><td></td></tr><tr><td>Standard deviation</td><td></td><td>2.44</td><td></td><td></td><td></td></tr><tr><td>Discrimination parameter</td><td></td><td>1.00</td><td></td><td></td><td></td></tr><tr><td>Number of cases*****</td><td>2,003</td><td>1,241</td><td>1,241</td><td>1,241</td><td>1,241</td></tr></table>
fedb3f54ab150ab9f384b9233b5ee834d3263ebd6412725a02b4b896ec4eff88.png
complex
<table><tr><td></td><td>FDC (<i>n</i> = 54)</td><td>ST (<i>n</i> = 49)</td><td><i>p</i>-value</td></tr><tr><td>Age, mean &#177; SD</td><td>45 &#177; 8.7</td><td>46.2 &#177; 9.5</td><td>NS</td></tr><tr><td>Asian ethnicity, n (%)<sup>a</sup></td><td>51 (94.4)</td><td>40 (81.6)</td><td>NS</td></tr><tr><td>Male gender, n (%)</td><td>52 (96.3)</td><td>41 (83.7)</td><td>NS</td></tr><tr><td>Weight (kg), mean &#177; SD<sup>b</sup></td><td>59.2 &#177; 9.8</td><td>61.7 &#177; 12.3</td><td>NS</td></tr><tr><td colspan="4">Weight bands, n<sup>b</sup></td></tr><tr><td>&lt; 35 kg</td><td>0</td><td>0</td><td>&#8722;</td></tr><tr><td> 35&#8211;54 kg</td><td>13</td><td>9</td><td>NS</td></tr><tr><td>&gt; 54 kg</td><td>25</td><td>25</td><td>NS</td></tr><tr><td>Height (cm), mean &#177; SD<sup>c</sup></td><td>165.2 &#177; 7.8</td><td>164.1 &#177; 8</td><td>NS</td></tr><tr><td>Smokers, n (%)</td><td>19 (35.2)</td><td>13 (26.5)</td><td>NS</td></tr><tr><td>Hypertension, n (%)</td><td>11 (20.4)</td><td>15 (30.6)</td><td>NS</td></tr><tr><td>Vitamin D level, mean &#177; SD<sup>d</sup></td><td>19.5 &#177; 22.5</td><td>19.2 &#177; 8.5</td><td>NS</td></tr><tr><td>HbA1c, mean &#177; SD</td><td>10.6 &#177; 2.5</td><td>10.8 &#177; 2.1</td><td>NS</td></tr><tr><td colspan="4">AFB load, n (%)</td></tr><tr><td> 1+</td><td>10 (18.5)</td><td>4 (8.2)</td><td>NS</td></tr><tr><td> 2+</td><td>19 (35.2)</td><td>16 (32.7)</td><td>NS</td></tr><tr><td> 3+</td><td>21 (38.9)</td><td>27 (55.1)</td><td>NS</td></tr><tr><td colspan="4">Anti-TB dose (mg/kg), mean &#177; SD</td></tr><tr><td> Isoniazid</td><td>4.8 &#177; 0.5</td><td>5 &#177; 0.9</td><td>NS</td></tr><tr><td> Rifampin</td><td>9.6 &#177; 1.1</td><td>9.6 &#177; 1.4</td><td>NS</td></tr><tr><td> Pyrazinamide</td><td>25.6 &#177; 2.6</td><td>24 &#177; 2.8</td><td>0.011</td></tr><tr><td> Ethambutol</td><td>17.5 &#177; 2</td><td>18.1 &#177; 4.1</td><td>NS</td></tr><tr><td>Patients received metformin, n (%)</td><td>38 (70.4)</td><td>34 (69.4)</td><td>NS</td></tr></table>
fd19856d3fd504d9ac8ff55b65a865f5704e99c8caff081f233d918149e5f67b.png
simple
<table><tr><td></td><td>Items (<i>n</i>)</td><td>Mean (SD)</td><td>Median (range)</td><td>Cronbach's alpha</td><td>MIIC</td><td>Test&#8211;retest*</td></tr><tr><td>PCL-5 subscales</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Intrusion</td><td>5</td><td>0.9 (1.3)</td><td>0.0 (0&#8211;6)</td><td>0.57</td><td>0.23</td><td>0.58**</td></tr><tr><td> Avoidance</td><td>2</td><td>0.5 (1.1)</td><td>0.0 (0&#8211;6)</td><td>0.74</td><td>0.73</td><td>0.49**</td></tr><tr><td> Cognition and mood</td><td>7</td><td>2.5 (3.2)</td><td>1.0 (0&#8211;14)</td><td>0.78</td><td>0.34</td><td>0.63***</td></tr><tr><td> Arousal and reactivity</td><td>6</td><td>1.7 (2.5)</td><td>0.0 (0&#8211;9)</td><td>0.77</td><td>0.40</td><td>0.77***</td></tr><tr><td> PCL-5 total</td><td>20</td><td>5.5 (7.1)</td><td>2.0 (0&#8211;28)</td><td>0.90</td><td>0.32</td><td>0.66***</td></tr><tr><td>Item 1</td><td></td><td>0.52 (0.70)</td><td>0.0 (0&#8211;3)</td><td></td><td></td><td></td></tr><tr><td>Item 2</td><td></td><td>0.03 (0.18)</td><td>0.0 (0&#8211;1)</td><td></td><td></td><td></td></tr><tr><td>Item 3</td><td></td><td>0.10 (0.43)</td><td>0.0 (0&#8211;3)</td><td></td><td></td><td></td></tr><tr><td>Item 4</td><td></td><td>0.18 (0.30)</td><td>0.0 (0&#8211;1)</td><td></td><td></td><td></td></tr><tr><td>Item 5</td><td></td><td>0.10 (0.35)</td><td>0.0 (0&#8211;2)</td><td></td><td></td><td></td></tr><tr><td>Item 6</td><td></td><td>0.35 (0.77)</td><td>0.0 (0&#8211;4)</td><td></td><td></td><td></td></tr><tr><td>Item 7</td><td></td><td>0.13 (0.38)</td><td>0.0 (0&#8211;2)</td><td></td><td></td><td></td></tr><tr><td>Item 8</td><td></td><td>0.34 (0.65)</td><td>0.0 (0&#8211;3)</td><td></td><td></td><td></td></tr><tr><td>Item 9</td><td></td><td>0.31 (0.74)</td><td>0.0 (0&#8211;3)</td><td></td><td></td><td></td></tr><tr><td>Item 10</td><td></td><td>0.60 (0.91)</td><td>0.0 (0&#8211;4)</td><td></td><td></td><td></td></tr><tr><td>Item 11</td><td></td><td>0.47 (0.78)</td><td>0.0 (0&#8211;3)</td><td></td><td></td><td></td></tr><tr><td>Item 12</td><td></td><td>0.19 (0.51)</td><td>0.0 (0&#8211;2)</td><td></td><td></td><td></td></tr><tr><td>Item 13</td><td></td><td>0.32 (0.65)</td><td>0.0 (0&#8211;3)</td><td></td><td></td><td></td></tr><tr><td>Item 14</td><td></td><td>0.23 (0.56)</td><td>0.0 (0&#8211;3)</td><td></td><td></td><td></td></tr><tr><td>Item 15</td><td></td><td>0.23 (0.46)</td><td>0.0 (0&#8211;2)</td><td></td><td></td><td></td></tr><tr><td>Item 16</td><td></td><td>0.08 (0.34)</td><td>0.0 (0&#8211;2)</td><td></td><td></td><td></td></tr><tr><td>Item 17</td><td></td><td>0.45 (0.86)</td><td>0.0 (0&#8211;4)</td><td></td><td></td><td></td></tr><tr><td>Item 18</td><td></td><td>0.31 (0.53)</td><td>0.0 (0&#8211;2)</td><td></td><td></td><td></td></tr><tr><td>Item 19</td><td></td><td>0.26 (0.54)</td><td>0.0 (0&#8211;2)</td><td></td><td></td><td></td></tr><tr><td>Item 20</td><td></td><td>0.34 (0.75)</td><td>0.0 (0&#8211;4)</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td>Mothers (<i>n</i> = 42)</td><td></td><td>Fathers (<i>n</i> = 20)</td><td></td><td></td></tr><tr><td></td><td></td><td>Mean (SD)</td><td></td><td>Mean (SD)</td><td><i>p-value</i></td><td></td></tr><tr><td> Intrusion</td><td></td><td>1.0 (1.3)</td><td></td><td>0.7 (1.2)</td><td><i>ns</i></td><td></td></tr><tr><td> Avoidance</td><td></td><td>0.5 (0.9)</td><td></td><td>0.6 (1.4)</td><td><i>ns</i></td><td></td></tr><tr><td> Cognition and mood</td><td></td><td>2.5 (3.0)</td><td></td><td>2.3 (3.7)</td><td><i>ns</i></td><td></td></tr><tr><td>Arousal and reactivity</td><td></td><td>1.8 (2.6)</td><td></td><td>1.5 (2.1)</td><td><i>ns</i></td><td></td></tr><tr><td>PCL-5 total</td><td></td><td>5.8 (7.0)</td><td></td><td>4.9 (7.3)</td><td><i>ns</i></td><td></td></tr></table>
1ae3378ee942abcf133ea76daf41117dde1d869547ce9bb3e73fb78462b36160.png
simple
<table><tr><td>Characteristics</td><td>Experimental mean (SD)</td><td>Control mean (SD)</td><td><i>p</i></td><td><i>F</i></td></tr><tr><td>Age (Years)</td><td>69.95 (6.73)</td><td>73.20 (6.48)</td><td>0.13</td><td>2.36</td></tr><tr><td>Education (Years)</td><td>13.37 (3.27)</td><td>12.85 (3.36)</td><td>0.62</td><td>0.23</td></tr><tr><td>MMSE</td><td>28.31 (1.00)</td><td>27.75 (1.48)</td><td>0.17</td><td>1.92</td></tr><tr><td>Information</td><td>18.42 (2.61)</td><td>16.95 (3.06)</td><td>0.11</td><td>2.58</td></tr></table>
729ab080abf232099b3716acf248144bb8939afbc6e19acef6b9d0ed227681b0.png
simple
<table><tr><td>Groups</td><td>Normoglycemic(n = 10)</td><td>Hyperglycemic(n = 10)</td><td>Hyperglycemic + vitamin C (n = 9)</td></tr><tr><td>Sperm number in the cauda epididymis (&#215;10<sup>6</sup>)</td><td>111.00 [90.00 - 131.00] <sup>a</sup></td><td>40.16 [33.05 - 71.00] <sup>b</sup></td><td>43.00 [42.63 - 73.80] <sup>ab</sup></td></tr><tr><td>Sperm transit time in the cauda (days)</td><td>3.43 [3.30 - 4.65] <sup>a</sup></td><td>1.56 [1.25 - 2.70] <sup>b</sup></td><td>2.14 [1.72 - 2.88] <sup>ab</sup></td></tr></table>
499d500b3dbd1dd66331fe92684f263992d11692089f6c9864af8354ba68dfad.png
simple
<table><tr><td>Plant</td><td>Feedstock</td><td>Volume of AD digesters (m<sup>3</sup>)</td><td>Dry matter content in digesters (%)</td><td>Organic loading in digesters (kg/day&#8901;m<sup>3</sup>)</td><td>Methane content in biogas (%)</td><td>Installed CHP power (kW)</td><td>Electricity generation (MWh/year)</td><td>Electricity consumption (MWh/year)</td><td>Heat generation (MWh/year)</td><td>Heat consumption by AD (MWh/year)</td></tr><tr><td>Plant 1</td><td>&#8226; Pig slurry&#8226; Tomato peel and seeds&#8226; Maize silage</td><td>1650</td><td>8.7</td><td>0.92</td><td>52.8</td><td>230</td><td>1945</td><td>173</td><td>2549</td><td>809</td></tr><tr><td>Plant 2</td><td>&#8226; Pig slurry&#8226; Maize silage</td><td>2250</td><td>10.6</td><td>1.07</td><td>52.6</td><td>300</td><td>2429</td><td>206</td><td>3184</td><td>814</td></tr><tr><td>Plant 3</td><td>&#8226; Pig slurry&#8226; Maize silage&#8226; Maize ear silage</td><td>2000</td><td>9.7</td><td>0.98</td><td>52.7</td><td>300</td><td>2505</td><td>276</td><td>3514</td><td>799</td></tr><tr><td>Plant 4</td><td>&#8226; Maize silage</td><td>2 &#215; 2750</td><td>10.7</td><td>3.40</td><td>52.1</td><td>999</td><td>7972</td><td>717</td><td>8771</td><td>2505</td></tr><tr><td>Plant 5</td><td>&#8226; Cow slurry</td><td>1850</td><td>8.5</td><td>0.58</td><td>56.0</td><td>100</td><td>781</td><td>86</td><td>1095</td><td>547</td></tr></table>
4309d0975e20405e42b0ea4d538a40da4fc1a6dab74ae361685597db5f0c1b9a.png
simple
<table><tr><td>Medicine</td><td>MIC (mg/L)</td></tr><tr><td>AMPH-B</td><td>0.25</td></tr><tr><td>5-FC</td><td>&lt;=0.12</td></tr><tr><td>MCZ</td><td>0.06</td></tr><tr><td>FLCZ</td><td>8</td></tr><tr><td>ITCZ</td><td>0.12</td></tr><tr><td>MCFG</td><td>&lt;=0.015</td></tr><tr><td>VRCZ</td><td>0.25</td></tr></table>
d924dfd8d2b254af9756e11a113cc8d7f3455d65d03212d28b0880d02d63e08c.png
complex
<table><tr><td rowspan="2"></td><td colspan="4">Men (<i>n</i> = 98)</td><td colspan="4">Women (<i>n</i> = 139)</td></tr><tr><td>CCsa</td><td>Same category</td><td>Same and adjacent category</td><td>Extreme category</td><td>CCsa</td><td>Same category</td><td>Same and adjacent category</td><td>Extreme category</td></tr><tr><td>Energyb</td><td>0.58</td><td>34</td><td>71</td><td>0</td><td>0.59</td><td>37</td><td>81</td><td>1</td></tr><tr><td>Water content</td><td>0.43</td><td>33</td><td>70</td><td>1</td><td>0.64</td><td>42</td><td>79</td><td>1</td></tr><tr><td>Protein</td><td>0.53</td><td>46</td><td>72</td><td>2</td><td>0.47</td><td>33</td><td>78</td><td>4</td></tr><tr><td> The sum of amino acid residues</td><td>0.58</td><td>31</td><td>80</td><td>0</td><td>0.56</td><td>33</td><td>75</td><td>3</td></tr><tr><td>Total fat</td><td>0.49</td><td>33</td><td>73</td><td>1</td><td>0.55</td><td>40</td><td>75</td><td>1</td></tr><tr><td> Total fat in % energyb</td><td>0.50</td><td>23</td><td>57</td><td>5</td><td>0.59</td><td>29</td><td>66</td><td>2</td></tr><tr><td> Saturated fatty acid</td><td>0.49</td><td>34</td><td>67</td><td>2</td><td>0.56</td><td>39</td><td>78</td><td>2</td></tr><tr><td> Monounsaturated fatty acid</td><td>0.50</td><td>34</td><td>66</td><td>0</td><td>0.46</td><td>39</td><td>69</td><td>1</td></tr><tr><td> Polyunsaturated fatty acid</td><td>0.46</td><td>36</td><td>63</td><td>1</td><td>0.42</td><td>36</td><td>67</td><td>3</td></tr><tr><td> n-3 PUFA</td><td>0.50</td><td>27</td><td>72</td><td>0</td><td>0.49</td><td>36</td><td>74</td><td>2</td></tr><tr><td> n-6 PUFA</td><td>0.45</td><td>35</td><td>65</td><td>0</td><td>0.42</td><td>33</td><td>69</td><td>4</td></tr><tr><td> Triacylglycerol equivalents</td><td>0.49</td><td>32</td><td>72</td><td>1</td><td>0.54</td><td>38</td><td>74</td><td>2</td></tr><tr><td> Cholesterol</td><td>0.61</td><td>36</td><td>80</td><td>1</td><td>0.51</td><td>35</td><td>74</td><td>2</td></tr><tr><td>Carbohydrate</td><td>0.60</td><td>44</td><td>77</td><td>1</td><td>0.61</td><td>36</td><td>81</td><td>1</td></tr><tr><td>Total dietary fiber</td><td>0.58</td><td>46</td><td>77</td><td>2</td><td>0.61</td><td>40</td><td>75</td><td>1</td></tr><tr><td> Water soluble fiber</td><td>0.56</td><td>50</td><td>77</td><td>1</td><td>0.59</td><td>34</td><td>73</td><td>1</td></tr><tr><td> Water insoluble fiber</td><td>0.58</td><td>41</td><td>77</td><td>2</td><td>0.61</td><td>43</td><td>73</td><td>1</td></tr><tr><td>Sodium</td><td>0.58</td><td>39</td><td>78</td><td>1</td><td>0.60</td><td>37</td><td>78</td><td>1</td></tr><tr><td>Potassium</td><td>0.68</td><td>43</td><td>82</td><td>0</td><td>0.61</td><td>34</td><td>79</td><td>2</td></tr><tr><td>Calcium</td><td>0.61</td><td>38</td><td>78</td><td>0</td><td>0.49</td><td>34</td><td>73</td><td>3</td></tr><tr><td>Magnesium</td><td>0.67</td><td>41</td><td>80</td><td>1</td><td>0.63</td><td>37</td><td>80</td><td>1</td></tr><tr><td>Phosphorus</td><td>0.61</td><td>35</td><td>72</td><td>0</td><td>0.47</td><td>30</td><td>72</td><td>1</td></tr><tr><td>Iron</td><td>0.75</td><td>46</td><td>90</td><td>1</td><td>0.61</td><td>41</td><td>82</td><td>2</td></tr><tr><td>Zinc</td><td>0.66</td><td>38</td><td>80</td><td>1</td><td>0.47</td><td>40</td><td>74</td><td>4</td></tr><tr><td>Copper</td><td>0.69</td><td>43</td><td>82</td><td>0</td><td>0.59</td><td>45</td><td>82</td><td>0</td></tr><tr><td>Manganese</td><td>0.61</td><td>45</td><td>80</td><td>1</td><td>0.68</td><td>50</td><td>84</td><td>1</td></tr><tr><td>Iodine</td><td>0.44</td><td>40</td><td>71</td><td>2</td><td>0.42</td><td>32</td><td>68</td><td>3</td></tr><tr><td>Selenium</td><td>0.59</td><td>37</td><td>78</td><td>1</td><td>0.36</td><td>33</td><td>64</td><td>3</td></tr><tr><td>Chromium</td><td>0.50</td><td>31</td><td>72</td><td>2</td><td>0.47</td><td>28</td><td>68</td><td>3</td></tr><tr><td>Molybdenum</td><td>0.68</td><td>41</td><td>83</td><td>0</td><td>0.57</td><td>40</td><td>77</td><td>2</td></tr><tr><td>Retinol</td><td>0.41</td><td>47</td><td>73</td><td>3</td><td>0.45</td><td>41</td><td>70</td><td>4</td></tr><tr><td>&#945;-carotene</td><td>0.53</td><td>43</td><td>71</td><td>1</td><td>0.66</td><td>39</td><td>80</td><td>0</td></tr><tr><td>&#946;-carotene</td><td>0.55</td><td>40</td><td>76</td><td>0</td><td>0.64</td><td>37</td><td>78</td><td>1</td></tr><tr><td>Cryptoxanthin</td><td>0.46</td><td>30</td><td>69</td><td>1</td><td>0.53</td><td>32</td><td>78</td><td>1</td></tr><tr><td>Beta carotene equivalents</td><td>0.55</td><td>41</td><td>76</td><td>0</td><td>0.61</td><td>42</td><td>74</td><td>0</td></tr><tr><td>Retinol equivalents</td><td>0.50</td><td>41</td><td>77</td><td>4</td><td>0.60</td><td>41</td><td>78</td><td>2</td></tr><tr><td>Vitamin D</td><td>0.57</td><td>33</td><td>72</td><td>1</td><td>0.53</td><td>36</td><td>76</td><td>2</td></tr><tr><td>&#945;-tocopherol</td><td>0.57</td><td>44</td><td>74</td><td>2</td><td>0.52</td><td>35</td><td>71</td><td>2</td></tr><tr><td>&#946;-tocopherol</td><td>0.51</td><td>35</td><td>72</td><td>3</td><td>0.45</td><td>37</td><td>68</td><td>4</td></tr><tr><td>&#947;-tocopherol</td><td>0.37</td><td>27</td><td>65</td><td>3</td><td>0.50</td><td>36</td><td>71</td><td>2</td></tr><tr><td>&#948;-tocopherol</td><td>0.49</td><td>41</td><td>73</td><td>1</td><td>0.56</td><td>45</td><td>76</td><td>1</td></tr><tr><td>Vitamin K</td><td>0.60</td><td>40</td><td>79</td><td>1</td><td>0.56</td><td>39</td><td>75</td><td>2</td></tr><tr><td>Vitamin B<sub>1</sub></td><td>0.56</td><td>37</td><td>72</td><td>1</td><td>0.57</td><td>38</td><td>73</td><td>1</td></tr><tr><td>Vitamin B<sub>2</sub></td><td>0.66</td><td>38</td><td>85</td><td>1</td><td>0.41</td><td>35</td><td>71</td><td>4</td></tr><tr><td>Niacin</td><td>0.65</td><td>43</td><td>78</td><td>0</td><td>0.64</td><td>42</td><td>80</td><td>2</td></tr><tr><td>Vitamin B<sub>6</sub></td><td>0.65</td><td>43</td><td>77</td><td>0</td><td>0.69</td><td>39</td><td>81</td><td>1</td></tr><tr><td>Vitamin B<sub>12</sub></td><td>0.63</td><td>41</td><td>82</td><td>1</td><td>0.56</td><td>35</td><td>76</td><td>2</td></tr><tr><td>Folate</td><td>0.74</td><td>43</td><td>85</td><td>0</td><td>0.59</td><td>37</td><td>76</td><td>0</td></tr><tr><td>Pantothenic acid</td><td>0.60</td><td>40</td><td>79</td><td>1</td><td>0.44</td><td>34</td><td>70</td><td>2</td></tr><tr><td>Biotin</td><td>0.66</td><td>43</td><td>74</td><td>0</td><td>0.61</td><td>37</td><td>76</td><td>1</td></tr><tr><td>Vitamin C</td><td>0.71</td><td>37</td><td>86</td><td>1</td><td>0.60</td><td>32</td><td>69</td><td>0</td></tr><tr><td>Daidzein</td><td>0.52</td><td>38</td><td>80</td><td>3</td><td>0.65</td><td>43</td><td>77</td><td>0</td></tr><tr><td>Genistein</td><td>0.52</td><td>39</td><td>79</td><td>1</td><td>0.64</td><td>47</td><td>79</td><td>0</td></tr><tr><td>Ethanol</td><td>0.89</td><td>64</td><td>97</td><td>0</td><td>0.85</td><td>61</td><td>93</td><td>0</td></tr><tr><td>Median</td><td></td><td>39</td><td>77</td><td>1</td><td></td><td>37</td><td>75</td><td>2</td></tr></table>
def10a9acdf33412285333e059fb2323bb58813531de7b851416bcd4a822003f.png
complex
<table><tr><td rowspan="2"></td><td colspan="2">Q1</td><td colspan="2">Q2</td><td colspan="2">Q3</td><td colspan="2">Q4</td></tr><tr><td>(Pre)</td><td>(Pos)</td><td>(Pre)</td><td>(Pos)</td><td>(Pre)</td><td>(Pos)</td><td>(Pre)</td><td>(Pos)</td></tr><tr><td>Min</td><td>1</td><td>3</td><td>1</td><td>3</td><td>1</td><td>3</td><td>1</td><td>3</td></tr><tr><td>Max</td><td>5</td><td>5</td><td>5</td><td>5</td><td>5</td><td>5</td><td>5</td><td>5</td></tr><tr><td>Median</td><td>1</td><td>5</td><td>1</td><td>5</td><td>1</td><td>5</td><td>1</td><td>5</td></tr><tr><td><i>P</i></td><td colspan="2">&lt; 0.0001</td><td colspan="2">&lt; 0.0001</td><td colspan="2">&lt; 0.0001</td><td colspan="2">&lt; 0.0001</td></tr></table>
1e697582c716a562a03e02bdc5264d4136e3b87e9b858ab6fb58121f0b3e70d6.png
complex
<table><tr><td>Diagnosis</td><td>Intervention</td><td>Number of Patients</td><td>Reference</td></tr><tr><td colspan="4">Evidence from Pediatric Studies</td></tr><tr><td>msk pain/soft tissue injury</td><td>analgesic</td><td>17</td><td>Clark 2003<sup>[10]</sup></td></tr><tr><td>Asthma exacerbation</td><td>inhaled &#946;-agonist</td><td>12</td><td>Travers 2001<sup>[11]</sup></td></tr><tr><td>radial fracture</td><td>reduction &amp; cast</td><td>10</td><td>McLauchlan 2002<sup>[12]</sup></td></tr><tr><td>otitis media</td><td>PO antibiotics</td><td>10</td><td>Kozyrskyj 2000<sup>[13]</sup></td></tr><tr><td>dehydration (failed PO rehydration)</td><td>IV rehydration</td><td>6</td><td>Atherly-John 2002<sup>[14]</sup></td></tr><tr><td>bronchiolitis</td><td>salbutamol</td><td>6</td><td>Kellner 2000<sup>[15]</sup></td></tr><tr><td>dehydration</td><td>PO rehydration</td><td>5</td><td>Atherly-John 2002<sup>[14]</sup></td></tr><tr><td>urinary tract infection</td><td>PO antibiotics</td><td>5</td><td>Hoberman 1999<sup>[16]</sup></td></tr><tr><td>constipation</td><td>suppository/enema</td><td>5</td><td>Dashshan 1999<sup>[17]</sup></td></tr><tr><td>laceration</td><td>sutures</td><td>4</td><td>Barnett 1998<sup>[18]</sup></td></tr><tr><td>croup</td><td>PO steroids</td><td>4</td><td>Ausejo 2000<sup>[19]</sup></td></tr><tr><td>suspected occult bacteremia</td><td>IM/IV antibiotics</td><td>3</td><td>Bass 1993<sup>[20]</sup></td></tr><tr><td>tonsillitis</td><td>PO antibiotics</td><td>3</td><td>Del Mar 2000<sup>[21]</sup></td></tr><tr><td>urticaria</td><td>cetirizine</td><td>2</td><td>Simons 2000<sup>[22]</sup></td></tr><tr><td>Kawasaki Syndrome</td><td>IVIG &amp; ASA</td><td>2</td><td>Newburger 1986<sup>[23]</sup></td></tr><tr><td>alcohol intoxication</td><td>intubation</td><td>2</td><td>Gausche-Hill 2000<sup>[24]</sup></td></tr><tr><td>generalized tonic-clonic seizure in known epileptic</td><td>increase clobazam dose</td><td>1</td><td>Booth 1998<sup>[25]</sup></td></tr><tr><td>radial head subluxation</td><td>reduction by hyperpronation</td><td>1</td><td>Macias 1998<sup>[26]</sup></td></tr><tr><td>epistaxis</td><td>silver nitrate</td><td>1</td><td>Ruddy 1991<sup>[27]</sup></td></tr><tr><td>behavior problems</td><td>referral for counselling</td><td>1</td><td>Dishion 1995<sup>[28]</sup></td></tr><tr><td>bronchiolitis</td><td>racemic epinephrine</td><td>1</td><td>Menon 1995<sup>[29]</sup></td></tr><tr><td>viral conjunctivitis</td><td>polysporin ointment</td><td>1</td><td>Isenberg 2002<sup>[30]</sup></td></tr><tr><td>laceration</td><td>tissue glue</td><td>1</td><td>Barnett 1998<sup>[18]</sup></td></tr><tr><td>constipation</td><td>polyethylene glycol</td><td>1</td><td>Dashshan 1999<sup>[17]</sup></td></tr><tr><td>dog bite</td><td>IV antibiotics &amp; debridement</td><td>1</td><td>Medeiros 2001<sup>[31]</sup></td></tr><tr><td>burn</td><td>delayed graft</td><td>1</td><td>Desai 1991<sup>[32]</sup></td></tr><tr><td>reflux esophagitis</td><td>conservative reflux measures</td><td>1</td><td>Craig 2004<sup>[33]</sup></td></tr><tr><td>pain (following MVC trauma)</td><td>morphine infusion</td><td>1</td><td>Hendrickson 1990<sup>[34]</sup></td></tr><tr><td>reflux esophagitis</td><td>ranitidine</td><td>1</td><td>Cucchiara 1993<sup>[35]</sup></td></tr><tr><td>varicella zoster</td><td>supportive care</td><td>1</td><td>Klassen 2002<sup>[36]</sup></td></tr><tr><td>atopic dermatitis</td><td>hydrocortisone cream</td><td>1</td><td>Alonso 1999<sup>[37]</sup></td></tr><tr><td>meningitis exposure (H flu)</td><td>PO antibiotics</td><td>1</td><td>Daum 1981<sup>[38]</sup></td></tr><tr><td>dislocated patella</td><td>relocation under sedation</td><td>1</td><td>Nikku 1997<sup>[39]</sup></td></tr><tr><td colspan="4">Evidence from Adult Studies</td></tr><tr><td>migraine headache</td><td>metoclopramide</td><td>3</td><td>Colman 2003<sup>[40]</sup></td></tr><tr><td>proximal humerus fracture</td><td>cast &amp; sling</td><td>3</td><td>Gibson 2003<sup>[41]</sup></td></tr><tr><td>ankle fracture</td><td>cast</td><td>2</td><td>Phillips 1985<sup>[42]</sup></td></tr><tr><td>gastritis</td><td>antacids</td><td>1</td><td>Moayyedi 2003<sup>[43]</sup></td></tr><tr><td>clavicle fracture</td><td>sling</td><td>1</td><td>Andersen 1987<sup>[44]</sup></td></tr><tr><td>prozac overdose (2 hours previous)</td><td>supportive care</td><td>1</td><td>Yeates 2000<sup>[45]</sup></td></tr><tr><td>tibial fracture</td><td>internal fixation</td><td>1</td><td>Wyrsch 1996<sup>[46]</sup></td></tr><tr><td>epididymitis</td><td>PO antibiotics</td><td>1</td><td>Redfern 1984<sup>[47]</sup></td></tr><tr><td>panic attack</td><td>sublingual short-acting benzodiazepine</td><td>1</td><td>Dunner 1986<sup>[48]</sup></td></tr><tr><td>aphthous ulcers</td><td>viscous lidocaine</td><td>1</td><td>Saxen 1997<sup>[49]</sup></td></tr><tr><td>fracture T12 vertebrae</td><td>T11&#8211;12 instrumentation &amp; fusion</td><td>1</td><td>Shen 2001<sup>[50]</sup></td></tr><tr><td>aggression</td><td>haloperidol &amp; lorazepam</td><td>1</td><td>Gillies 2001<sup>[51]</sup></td></tr><tr><td>tibial fracture</td><td>reduction &amp; cast</td><td>1</td><td>Abdel-Salem 1991<sup>[52]</sup></td></tr><tr><td>acetaminophen overdose</td><td>N-acetylcysteine</td><td>1</td><td>Brok 2002<sup>[53]</sup></td></tr><tr><td>gastrostomy tube fell out</td><td>insertion of foley catheter</td><td>1</td><td>Kadakia 1994<sup>[54]</sup></td></tr><tr><td>increased intracranial pressure</td><td>mannitol</td><td>1</td><td>Schierhout 2003<sup>[55]</sup></td></tr><tr><td>migraine headache</td><td>NSAID</td><td>1</td><td>Bussone 1999<sup>[56]</sup></td></tr></table>
eef0e1de265c1867ade4f5106fabca2483f6d05970ada73111683560df7c9629.png
simple
<table><tr><td>Category/name</td><td>Function</td><td>Change (<i>x</i>-fold)</td></tr><tr><td>Cellular defense</td><td> </td><td> </td></tr><tr><td> HSP27</td><td>Protein stabilisation</td><td>++</td></tr><tr><td>Apoptosis/degeneration</td><td> </td><td> </td></tr><tr><td> Cathepsin Z</td><td>Lysosomal proteolysis</td><td>++</td></tr><tr><td>Proliferation</td><td> </td><td> </td></tr><tr><td> Annexin</td><td>Growth factor</td><td>++</td></tr><tr><td>Migration</td><td> </td><td> </td></tr><tr><td> Cofilin</td><td>Actin turnover</td><td>+++</td></tr><tr><td> Tropomodulin 3</td><td>Actin turnover</td><td>++++++</td></tr><tr><td> CLIM1</td><td>Actin kinase adaptor</td><td>++++++</td></tr><tr><td> Galectin</td><td>Cell to cell interaction</td><td>++</td></tr><tr><td> <i>&#946;</i>-Hexosaminidase <i>&#946;</i>-subunit</td><td>Glycosidasis</td><td>++++++</td></tr><tr><td>Metabolism</td><td> </td><td> </td></tr><tr><td> Pyruvate kinase 3</td><td>Glycolysis</td><td>&#8722;</td></tr><tr><td> Enolase 1</td><td>Glycolysis</td><td>&#8722;</td></tr><tr><td>Nuclear transport</td><td> </td><td> </td></tr><tr><td> Ran-binding protein 1</td><td>RanGAP activity</td><td>++</td></tr><tr><td> elF5A</td><td>Cofactor in nuclear export</td><td>++++++</td></tr><tr><td>Translation</td><td> </td><td> </td></tr><tr><td> CRHSP-24</td><td>Translation regulating protein</td><td>++++++</td></tr></table>
56eba3150dcb55b48786318b6dc7154d35874198fdb55d060ff3282706db8a90.png
simple
<table><tr><td><i>Patient</i></td><td><i>Location of sample</i></td><td><i>Size of sample</i><i>(Average;</i><i>mm</i><sup><i>2</i></sup>)</td><td><i>Number of samples taken</i></td></tr><tr><td>P01</td><td>Central and peripheral</td><td>30</td><td>3</td></tr><tr><td>P02</td><td>Central</td><td>24</td><td>4</td></tr><tr><td>P03</td><td>Central</td><td>40</td><td>3</td></tr><tr><td>P04</td><td>Central and peripheral</td><td>20</td><td>4</td></tr><tr><td>P05</td><td>Central</td><td>24</td><td>3</td></tr><tr><td>P06</td><td>Central</td><td>80</td><td>3</td></tr><tr><td>P07</td><td>Central and peripheral</td><td>66</td><td>2</td></tr><tr><td>P08</td><td>Central and peripheral</td><td>72</td><td>3</td></tr></table>
2e3fa20d4949f50182a571fe634fd1fe28f0eab0a38b855a061bea1a00210a2a.png
simple
<table><tr><td>Foot complication</td><td>All<i>n</i> (% (95% CI))</td><td>Diabetes<i>n</i> (% (95% CI))</td><td>Nondiabetes<i>n</i> (% (95% CI))</td><td><i>p</i> value</td></tr><tr><td>Participants</td><td>733</td><td>172</td><td>561</td><td></td></tr><tr><td>Foot complication(s)<sup>a</sup></td><td>336 (46.0% (42.4&#8211;49.7))</td><td>112 (65.5% (58.1&#8211;72.2)</td><td>224 (40.1% (36.2&#8211;44.3))</td><td>&lt;0.001<sup>&#8727;</sup></td></tr><tr><td>Multiple foot complications<sup>b</sup></td><td>175 (23.9% (20.9&#8211;27.1))</td><td>66 (38.6% (31.6&#8211;46.1))</td><td>109 (19.5% (16.4&#8211;23.0))</td><td>&lt;0.001<sup>&#8727;</sup></td></tr><tr><td>Previous foot disease<sup>c</sup></td><td>81 (11.1% (9.0&#8211;13.6))</td><td>38 (22.1% (16.5&#8211;28.9))</td><td>43 (7.7% (5.7&#8211;10.2))</td><td>&lt;0.001<sup>&#8727;</sup></td></tr><tr><td>Previous amputation</td><td>30 (4.1% (2.9&#8211;5.8))</td><td>16 (9.3% (5.7&#8211;14.7))</td><td>14 (2.5% (1.4&#8211;4.2)))</td><td>&lt;0.001<sup>&#8727;</sup></td></tr><tr><td>Previous foot ulcer</td><td>72 (9.8% (7.9&#8211;12.2)</td><td>35 (20.3% (15.0&#8211;27.0))</td><td>37 (6.6% (4.8&#8211;9.0)))</td><td>&lt;0.001<sup>&#8727;</sup></td></tr><tr><td>Peripheral arterial disease</td><td>153 (21.0% (18.2&#8211;24.1))</td><td>60 (35.1% (28.3&#8211;42.5))</td><td>93 (16.7% (13.8&#8211;20.0))</td><td>&lt;0.001<sup>&#8727;</sup></td></tr><tr><td>Peripheral neuropathy</td><td>160 (22.0% (19.1&#8211;25.1))</td><td>74 (43.3% (36.1&#8211;50.8))</td><td>86 (15.4% (12.6&#8211;18.6))</td><td>&lt;0.001<sup>&#8727;</sup></td></tr><tr><td>Foot deformity</td><td>158 (22.4% (19.5&#8211;25.6))</td><td>51 (30.5% (24.0&#8211;37.9))</td><td>107 (19.9% (16.7&#8211;23.5))</td><td>0.004<sup>&#8727;</sup></td></tr></table>